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ABSTRACT OF THE DISSERTATION
ATM Deficiency -- A Multifaceted Defect in Lymphocyte Development
by
Beth Ann Helmink
Doctor of Philosophy in Biology and Biomedical Sciences
(Immunology)
Washington University in St. Louis, 2012
Professor Barry P. Sleckman, Chairperson

The generation of a functional antigen receptor gene in developing lymphocytes requires that the
second exon be assembled through a process known as V(D)J recombination, a process that
necessarily involves the generation and repair of DNA double-strand breaks made by the Rag
endonuclease. Double strand breaks incurred during G1 of the cell cycle activate ATM, a PI3kinase-like kinase that, in response to genotoxic DNA damage, is known to phosphorylate
hundreds of proteins with unique and diverse functions. Notably, deficiencies in ATM lead to
ataxia-telangiectasia, a syndrome characterized by lymphopenia, genomic instability and a
predisposition to tumors involving antigen receptor loci suggesting that ATM likely plays a similar
critical role downstream of Rag-mediated DNA DSBs during V(D)J recombination. In this body of
work, I describe three distinct pathways activated by ATM in response to Rag DNA DSBs and
how defects in these pathways would impair lymphocyte development and contribute to the
phenotype of ATM-deficient mice and humans. First, ATM-deficient lymphocytes have a defect in
the repair of Rag DNA DSBs characterized by an accumulation of unrepaired coding ends and an
increase in aberrant hybrid joint formation during rearrangement by inversion. Furthermore,
these coding ends drift apart and are frequently aberrantly resolved as translocations. We
determine that ATM contributes to the repair of Rag DNA DSBs by maintaining the unrepaired
ends in a stable post-cleavage complex possibly through the phosphorylation of components of
the MRN complex. Secondly, in G1-phase lymphocytes, the ATM-dependent phosphorylation of
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histone H2AX inhibits the robust CtIP-dependent opening and resection of hairpin-sealed coding
ends thereby preventing their aberrant resolution by alternative repair pathways. Finally, in
response to Rag DSBs, through the activation of NF!B and other transcription factors, ATM
activates a broad genetic program that transcends the canonical DNA damage response and
includes genes whose known functions are integral to lymphocyte development. While this work
has significantly increased our understanding of the cellular response to Rag DNA DSBs, given
the diversity of the other known substrates of ATM, it seems likely that we have only begun to
unravel the complexities of the ATM-deficient phenotype.
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Chapter 1

Background
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The immune system has two component arms, the innate and the adaptive immune
systems. The innate immune system is able to rapidly and broadly defend against large numbers
of potential pathogens based on commonalities amongst them. Conversely, the adaptive immune
system, while slow to activate, can recognize and defend against any given pathogen in a specific
manner based on that pathogen’s unique molecular characteristics. Importantly, the adaptive
immune system has memory that enables a more rapid and forceful response on subsequent
encounters. The adaptive immune system relies on B and T lymphocytes each of which contains
a unique receptor (B- and T-cell receptors or BCRs and TCRs, respectively) that enable the cell
to recognize individual foreign antigens either alone (BCR) or in complex with MHC molecules on
antigen presenting cells (TCR)(1).
The BCR is composed of two identical paired immunoglobulin heavy chain (IgH)
molecules and two identical paired immunoglobulin light chain (IgL) molecules of either the
lambda or kappa variety (IgL! or IgL", respectively). The component chains each contain a
unique variable region that confers the specificity of binding and a constant region that provides
structure and enables for a cellular signaling cascade in response to antigen binding. These four
molecules are covalently linked by multiple disulfide bonds and are arranged such that the
variable regions of the light and heavy chains are terminally located and together comprise the
variable region that binds antigen. Similarly, the TCR consists of molecules with both variable
and constant regions. A TCR consists of a single TCR alpha chain (TCR#) and TCR beta chain
(TCR$) for #$ T cells or a single TCR gamma chain (TCR%) and TCR delta chain (TCR&) for
TCR%& cells. The terminus of the assembled TCR also consists of a variable region that binds
antigen in complex with the MHC molecules(1).
The genes encoding the individual components of the BCR and TCR are unique in that
they do not exist in a functional state in the germline configuration. Rather, the genetic loci
encoding these receptor components consist of hundreds of different gene segments (grouped as
V, D and J gene segments) that are joined together somatically to form the functional antigen
receptor gene during a process known as V(D)J recombination(1-3). The formation of a
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functional gene requires a single gene segment from each of these component groups to be
joined together (V and J gene segments for IgL and TCR# and TCR%, and V, D, and J gene
segments for IgH, TCR& and TCR$) and attached to a constant region gene segment(1).
The combination of different component chains and different gene segments for each
component chain results in the diversity of the resultant BCRs or TCRs that is known as
combinatorial diversity. This combined with unique aspects of the V(D)J recombination reaction
discussed below (generating junctional diversity) generates heterogeneity within the cohort of
antigen receptors that would be unattainable by any other means. It is this diversity that enables
the adaptive immune system to recognize a near unlimited number of possible antigens(1). The
development of this powerful arm of the immune system via V(D)J recombination, though, is not
without risk, as this recombination event requires the generation and repair of DNA double-strand
breaks (DSBs) generated by the lymphocyte-specific recombination activating gene (RAG)
endonuclease. Any form of DNA damage including chemical modifications of nucleotide bases,
base-pair mismatches, single-stranded DNA nicks or DSBs is inherently dangerous as it poses a
threat to genomic integrity. The DNA DSB, however, is the most hazardous(4, 5). As such, DNA
DSBs trigger within the cell a collection of pathways known as the DNA damage response that
serves to limit the repercussions of these DNA lesions(6).
The focus of this body of work lies in further characterizing the response to and repair of
the RAG-induced DNA DSB generated in developing lymphocytes undergoing V(D)J
recombination in an attempt to generate a functional antigen receptor gene. We begin with a
brief discussion of the RAG endonuclease and the generation of RAG-mediated DNA DSBs
(RAG DNA DSBs).
The RAG Endonuclease
The RAG endonuclease consists of two protein components, RAG-1 and RAG-2, that are
expressed exclusively in developing lymphocytes; these components can exist singly or as a
heterodimeric pair that can form in the absence of DNA(2, 7, 8). RAG endonuclease activity
requires both RAG-1 and RAG-2(2, 7, 8). As RAG-2 is rapidly degraded upon entry into S-phase
3!

secondary to its phosphorylation at T490 by a cell cycle dependent kinase, RAG endonuclease
activity is limited to the G1-phase of the cell cycle(9-11). The RAG complex, in vitro, also
consists of the HMG (high mobility group) proteins that bind DNA non-specifically and, in doing
so, alter the three-dimensional structure of the double-stranded helix bending the DNA strands
(12, 13). The contribution of the HMG proteins to V(D)J recombination in vivo is not known(14).
The RAG-1 and RAG-2 proteins consist of core regions that are necessary and sufficient
for V(D)J recombination and non-core regions(15, 16). The C-terminal core region of RAG-1
contains DNA binding domains (nonamer-binding domain and heptamer-binding domain), Rag-2
binding sites, a zinc finger domain that may facilitate RAG-2 binding, as well as the DDE motif
that is shared amongst the transposases from which it is evolutionarily derived and affords RAG-1
its enzymatic activity(17-19). The N-terminal non-core region of RAG-1 contains a RING domain
that may have ubiquitylation activity (of histone H3) as well as the second of two zinc finger
domains(17, 19). In contrast to RAG-1, the N-terminus of RAG-2 constitutes its core region and
consists of multiple repeats of a domain that promotes protein-protein binding. Additionally, RAG2 contains a C-terminal acidic region that enhances interaction with histone proteins and a PHD
domain that binds methylated histone H3 (specifically H3K4me3)(20-22). RAG-2 has no
enzymatic activity. However, various mutations in RAG-2 affect the catalytic activity of RAG-1 in
vitro suggesting that it may somehow facilitate RAG-1 enzymatic activity, perhaps by contributing
to the active site of the RAG holocomplex(17, 19, 23). Interestingly, the non-core regions of both
RAG-1 and RAG-2 are highly conserved. Specific functions for these regions are not known this
time; however, many speculate that these non-core regions may have critical activities in the
regulation or enhancement of RAG endonuclease activity or the joining of the resultant DNA
DSBs(17, 19).
RAG DNA DSB Generation
The enzymatic activity of RAG-1 activates hydroxyl groups (-OH) to target the
phosphodiester bond of the sugar-phosphate back of a DNA strand. The active site of RAG-1
consists of three negatively charged acidic residues (the DDE motif) that can bind divalent cations
4!

(Mg

2+

in vivo and Mn

2+

in vitro) that are critical for the activation of the hydroxyl groups as

nucleophiles(24-26). When the activated –OH group is from a water molecule, the result is a
single-stranded DNA nick. When the activated –OH group, however, is the free 3’ OH at the site
of a single-stranded DNA nick, the result is intra-molecular trans-esterification reaction that
results in the formation of a DNA double-strand break with one hairpin-sealed end and a second
blunt phosphorylated end(27-30).
Each of the gene segments comprising the antigen receptor loci is flanked by specific
sequences of DNA recognized by the RAG endonuclease. These are termed recombination
signal sequences or RSSs and consist of a highly conserved heptamer (5’-CACAGTG-3’) and
nonamer (5’-ACAAAAACC-3’) separated by a more variable 12- or 23-base-pair spacer
sequence. The RSS is oriented such that the heptamer abuts the coding region of the gene
segment(1).
Rag-1 and Rag-2 may both have DNA binding abilities(31, 32). However, Rag-2 binds
DNA with very low affinity and in a non-specific manner(31, 32). In contrast, RAG-1 specifically
recognizes the RSS, initially binding the nonamer via its nonamer-binding domain and later
making contact with the heptamer(33-35). RAG-2 may facilitate interaction of RAG-1 with the
heptamer sequence(31, 32). It is thought that the bending action of the HMG proteins on DNA
may also be required to allow for the joining of the more distantly separated heptamer and
nonamer of a 23-bp RSS. In agreement with this notion, the HMG proteins do not enhance RAG
cleavage at the 12-bp RSS as significantly as they do at the 23-bp RSS in vitro(12). Again,
however, no role for the HMG proteins in vivo during V(D)J recombination has been
demonstrated.
Overall, RAG binds 12- or 23-bp RSSs with near equal affinity(36-38). When RAG binds
a single RSS (forming what is known as a signal complex or SC), single-stranded DNA nicks can
occur. The nick is made precisely at the junction of the heptamer and the coding region(39).
RAG, however, does not make DNA DSBs in the setting of a SC in vivo(36-38). DNA DSB
generation occurs only when two gene segments with RSSs of different spacer lengths
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individually bound to RAG are brought together in a pre-cleavage complex known as a paired
complex or PC(36-38). This requirement is known as the 12/23 rule and is important to allow for
efficient joining of the resultant broken DNA ends and to ensure that the antigen receptor gene
contains the right type and number of V, D, and J gene segments. For example, a D gene
segment flanked by 23-bp RSSs will recombine only with upstream V gene segments with 12-bp
RSSs and downstream J gene segments with 12-bp RSSs. Two V, two D, or two J gene
segments will not recombine nor will a V gene segment recombine with a J gene segment when a
D gene segment is required. It is important to note that not all gene segment pairs consisting of
12- and 23-base pair spacers can recombine. An additional level of regulation must exist to
govern the joining of different gene segments. This is known as the Beyond 12/23 rule; however
the mechanism by which this additional level of regulation occurs is not known(40, 41).
Although RAG can bind and nick 12- or 23-bp RSSs with near equal efficiency, only
rarely are 23-BP RSS-containing gene segments found with single-stranded nicks(36-38).
Additionally, 12-bp RSS-containing SCs have a preference for binding 23-bp RSS-containing SCs
over other 12-bp RSS-containing SCCs(42). 23-bp RSS-containing SCs do not exhibit such
specificity. Based on these observations, researchers have proposed a stepwise model for RAG
cleavage that may explain the existence of the 12/23 rule(42, 43). In this model, a 12-bp RSScontaining SC with a single-stranded nick subsequently captures a 23-bp RSS forming a paired
complex (PC)(7, 28, 38, 42). Then and only then does it introduce a single-stranded nick at the
analogous location on the 23-bp RSS(38). The -OH groups of the resulting nicks are activated by
RAG-1 active site to undergo intra-molecular trans-esterification reactions resulting in two hairpinsealed DNA ends bordering the two coding regions of the gene segments to be recombined
(coding ends or CEs) and two blunt phosphorylated ends at the ends containing the RSS (signal
ends or SEs)(28, 43, 44).
The two hairpin-sealed coding ends must be joined together to form a coding joint (CJ) in
subsequent steps to complete V(D)J recombination. The signal ends are likewise joined to from
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signal joints (SJs). The processing of these DNA ends and the joining step are described in detail
in subsequent sections.
Regulation of RAG DNA DSB Generation
Importantly, DNA exists in the context of chromatin that that does not generally allow for
RAG binding or DSB generation. Indeed, in experiments carried out in fibroblasts, the RAG
endonuclease will cleave plasmid substrates existing as naked DNA but will not cleave at the
endogenous antigen receptor locus or elsewhere in the genome(19, 45). Thus, V(D)J
recombination must be preceded by alterations in the chromatin environment that enable RAG
binding and subsequent DNA DSB generation(19, 46). These alterations are thought to be direct
or indirect consequences of the germline transcription of the antigen receptor loci that occurs
coincident with the initiation of V(D)J recombination(19, 45, 46). For one, it is thought that
transcription factor binding and the activity of transcriptional promoters and enhancers that drive
germ-line transcription may directly influence RAG binding(19, 46, 47). For example, Pax5
binding to consensus sites in the distal V gene segments of the IgH locus has been proposed to
facilitate binding of RAG to D gene segments(48-50). Additionally, the types and extent of
histone modifications in the surrounding chromatin distinguish transcriptionally active loci differ
from transcriptionally inactive loci. Histone acetylation and H3K4 methylation, for example, are
increased in areas of the genome actively undergoing V(D)J recombination. These posttranslational modifications of histone proteins might result in the alteration of chromatin structure
that would reveal the RSS allowing for RAG binding. The aforementioned PHD domain of Rag-2
specifically recognizes H3K4me3 and may target RAG to transcriptionally active loci and may
boost the catalytic activity of RAG(20-22). Furthermore, chromatin remodeling complexes like
the Swi-Snf remodeling complex may shift nucleosomes so as to reveal the RSS; an RSS
situated on a nucleosome is resistant to RAG-mediated cleavage(51, 52). The recruitment of
RNA Pol II by these chromatin remodeling complexes and transcriptional elongation are likewise
important(46, 53). All of these activities that promote transcription would also affect the
accessibility of a given antigen receptor locus to the activity of the RAG endonuclease.
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Additionally, the antigen receptor loci condense and de-condense in a manner that correlates with
their recombination. A condensed locus allows for joining between gene segments separated by
great distances(49, 54-57). Finally, just as gene silencing can occur near the nuclear membrane,
actively recombining antigen receptor loci may need to move away from these circumferential
“silencing” environments(19, 41, 46, 57, 58). All these changes occur in a highly regulated
manner that enables tight regulation of the generation of RAG DNA DSBs(47). The regulation of
RAG activity and V(D)J recombination at each of these levels ensures that as few as possible
DNA DSBs are present in the cell at any given time.
These levels of regulation, in addition to preventing unnecessary and potentially
dangerous RAG DNA DSBs, may allow for the multidimensional regulation of antigen receptor
genetic recombination(19, 59). Specifically, V(D)J recombination occurs in a cell-type- and
developmental-stage-specific fashion(1). The genetic loci encoding the BCR rearrange only in B
cells. Similarly, the TCR loci rearrange only in T cells. Additionally, pro-B cells rearrange the IgH
heavy chain. It is not until the developing B cell produces a functional IgH heavy chain,
progresses to the pre-B cell stage and undergoes proliferation that it begins to rearrange the light
chain (IgL" or IgL!) components of the BCR. Again, the same is true for the TCR. The
rearrangement of each locus is ordered with DJ rearrangement occurring before V to DJ
rearrangement. This is termed intra-allelic exclusion(1). Finally, V(D)J recombination occurs at a
single allele prior to rearrangement of the second allele of a given antigen receptor locus. This
additional level of regulation is thought to ensure that each lymphocyte expresses a single
antigen receptor with a single antigen specificity and is termed inter-allelic exclusion(1).
Aberrant RAG DNA DSB Generation
Despite these numerous critical safeguards, aberrant RAG break generation can and
does occur within developing lymphocytes. For instance, the RAG proteins can recognize DNA
sequences elsewhere in the genome that resemble RSSs and cleave at these sites(60).
Additionally, RAG can cleave at certain three-dimensional DNA structures, specifically at the
junction of B and non-B DNA structures(60, 61). Furthermore, the core RAG proteins retain some
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of the activity of the transposases from which they have evolved in vitro under specific conditions;
however, RAG-mediated transposition is not observed to any great extent in vivo(62).
Defects in RAG DNA DSB Generation
As the expression of an assembled antigen receptor gene is absolutely required for
lymphocyte development to proceed, defects in V(D)J recombination would be expected to lead
to decreased numbers of lymphocytes. Proliferation of this smaller cohort of lymphocytes would
also lead to a decreased diversity of the adaptive immune system. Thus, one would expect these
defects to result in both lymphopenia and immunodeficiency. Such is the case. In fact, the
inability to initiate V(D)J recombination as occurs in the absence of a functional RAG
endonuclease leads to a complete absence of B and T cells known as severe combined
immunodeficiency or SCID(63-65).

Deficiencies in RAG activity can lead to a less severe

phenotype known as Omenn Syndrome(65-68).
The DNA DSB Response
The generation of DNA DSBs in such a programmed fashion within a cell is unique and is
limited to V(D)J recombination and immunoglobulin class switch recombination (CSR) in the
developing lymphocyte and to crossover in meiosis in all dividing cells. Most often, we think of
the DNA DSBs that occur in response to ionizing radiation, chemotherapeutic agents, and
reactive oxygen species. In contrast to physiologic DNA DSBs, these genotoxic DNA doublestrand breaks can only prove deleterious to the cells. Indeed, their aberrant resolution can lead
to chromosomal deletions, inversions, or translocations. Such aberrant joints can, in some
cases, lead to malignant transformation through, for example, the deletion of a tumor suppressor
gene, the dysregulation of the expression of an oncogene via the proximity to a strong promoter
sequence, or the creation of a fusion protein that has unique and harmful activities. Indeed,
defects in the various forms of DNA repair including DNA DSB repair are implicated in some
human cancer syndromes(69).
Cells are primed to rapidly activate a multifunctional signaling pathway in response to
DNA DSBs that is commonly referred to as the DNA damage response(69). The initiation of this
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response requires sensors, transducers, and effectors(6). The major sensor of DNA damage is
G1-phase cells is the MRN complex consisting of Mre11, Rad50, and Nbs1(70). The primary
transducer is the ATM (ataxia-telangiectasia mutated) kinase that may phosphorylate over 700
substrates in response to genotoxic DNA damage(71, 72). Given their implication in cancer
etiology and cancer treatment, the pathways activated in the cellular response to genotoxic DSBs
have been extensively characterized(69). This response encompasses pathways that promote
DNA DSB repair, initiate cell cycle checkpoints and cell death pathways. However, given the
sheer number and variety of ATM substrates, the depth and breadth of the DNA damage
response is likely far greater than we appreciate at this point(6, 69, 73, 74).
Only recently has attention turned to the characterization of the cellular response to
physiologic DNA DSBs such as the RAG DNA DSB. The DNA damage response activated in
developing lymphocytes in response to RAG-mediated DNA DSBs and that activated in all cells in
response to genotoxic breaks exhibit significant similarities and differences that are addressed
below and have important implications for both lymphocyte development and function.
MRN as DNA Damage Sensor
The sensor component of the DNA damage response must have two critical capabilities.
First, it must be able to immediately recognize the presence of DNA damage and to localize to
that site. Secondly, it must be able to efficiently recruit and assist in the activation of the
transducer components of the damage response. These roles are fulfilled by a single complex
consisting of three proteins, Mre11, Rad50 and Nbs1. Importantly, the independent factors that
constitute the MRN complex function only in the context of this holocomplex(75, 76). The
properties of these individual components as well as the unique three-dimensional structure of
the resulting protein complex afford MRN the ability to translocate to a DNA break site rapidly
during all phases of the cell cycle and to recruit ATM(77).
The DNA binding ability of the MRN complex is mediated by Mre11 and Rad50 which
form a heterotetramer (M2R2)(78-80). The C-terminal domain of Mre11 contains a DNA binding
domain and also enables association with Rad50(81). The N-terminus of Mre11 contains a
10
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phosphoesterase domain(81). Rad50 consists of N- and C-terminal ATP-binding cassette
(ABC)–ATPase domains (Walker A and B motifs), while the mid-section consists of two coiled-coil
motifs oriented in an anti-parallel fashion and separated by a conserved CxxC motif. The Walker
A and B motifs come together and the coiled-coil motifs intertwine forming a three-dimensional
structure that has a globular end with an extended arm containing a CxxC motif at the tip of that
extension. The CxxC motifs of individual Rad50 molecules can interact through the coordination
of a zinc ion(79, 82-86). When bound to ATP, the globular ends of Rad50 containing the Walker
A and B motifs can dimerize and bind DNA(82, 87).
The N-terminus of Nbs contains an FHA-BRCT-BRCT domain. The C-terminus enables
binding to both Mre11 and ATM(88, 89). Thus, Nbs1 is the link between DNA damage
recognition and localization and transducer recruitment(77). The activation of ATM can be
enhanced by the MRN complex(70, 75, 90-92).
ATM as Transducer of DNA Damage Response
ATM, DNA-PKcs (DNA-dependent protein kinase catalytic subunit), and ATR (ATM- and
Rad3-related) comprise a family of serine/threonine protein kinases that structurally resemble
kinases that phosphorylate inositol phospholipids and are therefore termed phosphoinositide3kinase like kinases (PIKKs). These PIKKs preferentially phosphorylate serine or threonine
residues followed by glutamate (SQ or TQ motifs) (93, 94). ATR is primarily activated by ssDNA
during the S-G2-M phases of the cell cycle. In contrast, DNA-PKcs and ATM are activated by
DNA DSBs during all phases of the cell cycle but predominantly during the G1 phase(69, 71, 73).
As RAG DNA DSBs are initiated in the G1 phase of the cell cycle, here we focus on ATM and
DNA-PKcs activity and not ATR activity. While these kinases have unique substrates, they also
have overlapping cohorts of substrates and some overlapping functions(95-98).
ATM and other PIKK family members are large proteins; ATM is comprised of over 3000
amino acid residues. The catalytic region shared by PIKK family members is located in the far Cterminal portion of the protein. The functions of the various non-catalytic portions of the protein
remain ill-defined but are required to promote the stability of this protein(99). The non-catalytic
11
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portions of ATM include multiple nuclear localization signals, a leucine zipper, a HEAT repeat
(domain shared by Huntington (H), elongation factor 3 (E), ATM (A), and TRRAP (T) proteins),
and FAT and FATC (domain shared by FRAP (F), ATM (A), and TRRAP (T) proteins)
domains(73, 99).
ATM is recruited to DNA DSBs through the binding of protein components like MRN
located at the break site(70, 75, 90-92). ATM, however, does possess some intrinsic DNA
binding capabilities(100). At the site of a DNA DSB, ATM undergoes auto-phosphorylation which
promotes a conversion from its inactive multimeric state to its active monomeric state(101). ATM
can be activated even when this auto-phosphorylation site (serine 1981) has been mutated
however; thus auto-phosphorylation is not absolutely required for its activation(102).
Interaction with the MRN complex bound to broken DNA ends enhances ATM activity(70,
75, 90-92). Moreover, simply targeting ATM to DNA even in the absence of a DNA DSB can lead
to its activation and the phosphorylation of downstream substrates(101, 103). These two findings
underscore the importance of localization and concentration of ATM at a break site in the
activation of downstream pathways. However, this requirement for localization of ATM at the site
of a DNA DSB for activation is debated as ATM activation can be achieved in the absence of a
functional MRN complex where localization of ATM is impaired(76, 104).
ATM activates hundreds of different proteins in response to DNA damage; these proteins
function in numerous diverse cellular pathways. Functional categorization of these 700 different
potential substrates results in the identification of pathways that vary from DNA DSB repair to the
initiation of cell cycle checkpoints and apoptotic pathways to cellular migration and
metabolism(71, 72).
Sensor and Transducer in the Response to RAG DNA DSBs
NBS localizes to sites of RAG DNA DSBs (105). Moreover, RAG DNA DSBs, similar to
genotoxic DNA DSBs, activate ATM (106-110). Thus, during V(D)J recombination in developing
lymphocytes, ATM is likely the predominant regulator of the DNA damage response.
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Phenotype of an Impaired DNA Damage Response
ATM is the kinase mutated in ataxia telangiectasia, a human disease characterized by
cerebellar degeneration leading to ataxia and the development of both ocular and cutaneous
telangiectasias. In addition to these more visible characteristics, ATM patients exhibit retarded
growth patterns and gonadal atrophy and undergo premature aging. Furthermore, they have high
rates of malignancies, especially lymphoid malignancies and breast cancer. Cells isolated from
these patients exhibit sensitivity to ionizing radiation and have large numbers of chromosomal
aberrations indicating genomic instability(111-116). Similarly, patients with deficiencies in
components of the MRN complex have also been described. Hypomorphic mutations in Mre11
cause ATLD (ataxia telangiectasia like disease), deficiencies in Nbs cause Nijmegen break
syndrome and mutations in Rad50 cause Nijmejen-break-syndrome-like-disorder (NBSLD). Like
A-T patients, these patients exhibit sensitivity to ionizing radiation and a propensity towards tumor
development (6, 117-122). Phenotypes shared by these patients underscore the importance of
the DNA damage response and the roles of MRN and ATM as primary sensors and transducers
of this response.
Component Pathways of the ATM-dependent DNA Damage Response
Discussed in more detail below are three important pathways activated by ATM as
components of the DNA damage response during the G1 phase of the cell cycle. First and
foremost, these pathways support the repair of the DNA DSB. Secondly, they allow for the
formation of a DNA repair focus. Finally, ATM activates cell cycle checkpoint and initiates
transcriptional pathways that ultimately determine cell survival versus death.
DNA Repair Pathways
As the persistence or aberrant repair of DNA DSBs can lead to potentially oncogenic
chromosomal lesions, it is critical that DNA lesions be repaired with both accuracy and efficiency.
As such, numerous conserved cellular DNA repair pathways exist with each specifically tailored
for a particular type of DNA damage. DNA DSB repair pathways have historically been
dichotomized into pathways that rely on homologous sequences to template repair (homologous
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mediated repair or HR) and pathways that simply join two broken DNA ends (non-homologous
end joining or NHEJ)(123). However, recent work has revealed a number of pathways that bridge
that divide, requiring short tracts of homology to join the two ends. Below we discuss these
distinct DNA repair pathways.
Homology-Mediated Repair
Homologous recombination (HR) occurs primarily during post-replicative (S-G2-M)
phases of the cell cycle when the replicated sister chromatid or paired homologous chromosome
is readily available to serve as a template for repair and/or recombination respectively (124-126).
HR begins with the 5’ to 3’ resection of the DNA end generating a long 3’ ssDNA overhang on the
opposing strand that is bound by ssDNA binding proteins, replication protein A (RPA), and
subsequently Rad51(125, 127, 128). This end resection is initiated by Mre11, which possesses
both endonucleolytic and exonucleolytic activities (3’ to 5’) and CtIP, a homologue of yeast
endonuclease Sae2(76, 129-136). Further resection is carried out by other nucleases and/or
helicases including Exo1, Dna2, and the RecQ family members(137). The resulting ssDNA
overhang base-pairs with the homologous sequence on the sister chromatid or homologous
chromosome known as the template strand, and, in doing so, disrupts that native DNA strand
(138). This results in the formation of a branched DNA structure known as a Holliday junction
that is subsequently resolved into the two original, distinct DNA fragments(139).
Variants of HR exist including break-induced repair (BIR) which is primarily used to repair
DNA lesions that can occur at a stalled replication fork during the process of DNA replication and
similarly requires long tracts of homology. A second variant of HR is single-stranded annealing
(SSA). For SSA to occur, both broken DNA ends of a single break are resected to form ssDNA
overhangs. These overhangs do not invade homologous sequences in trans, that is on the sister
chromatid or homologous chromosome. Rather, the resection reveals long tracts of homology in
cis that allow for intra-chromosomal joining. Notably, this results in the deletion of the intervening
sequence potentially leading to large chromosomal deletions depending on the amount of
resection that took place(139).
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Non-homologous End Joining
During repair by NHEJ, the two broken DNA ends from a single DNA DSB are simply rejoined. Thus, unlike HR, NHEJ does not rely on long tracts of homology to mediate joining. The
ligation of the two ends must occur efficiently so as to limit processing of those DNA ends prior to
their joining as such processing would result in the alteration or loss of genetic information(140).
If multiple DNA DSBs occur simultaneously within the cell, these broken ends could theoretically
be ligated together by NHEJ, forming chromosomal translocations. The efficiency of NHEJ,
effectively limiting the time and space that these broken ends occupy, is inversely related to the
rate of formation of translocations(140).
NHEJ requires a cohort of factors: the DNA-PK (DNA-dependent protein kinase)
holoenzyme complex consisting of Ku70, Ku80, and DNA-PKcs and the DNA ligase complex
including XRCC4, XLF, and DNA Ligase IV(140). Artemis is another factor that is occasionally
required for NHEJ(140). Ku70 and Ku80 have no known enzymatic activity(140). Rather, they
possess sequence-independent affinity for broken DNA ends, preferentially binding those that are
blunt or those with minimal overhangs but also binding single-stranded nicks and hairpin-sealed
DNA ends(140-142). The three-dimensional structure of the Ku heterodimer reveals a ring-like
structure with a central cavitary pore well-suited for the binding of a DNA double-stranded
helix(141). Ku binding to the broken DNA end results in the recruitment of the final subunit of the
DNA-PK holocomplex, the catalytic subunit of DNA-PK (DNA-PKcs)(140, 143). Binding of DNAPKcs to the C-terminus of Ku80 causes the inward translocation of the Ku heterodimer onto the
broken DNA strand and allows DNA-PKcs to also bind the broken DNA end and undergo the
unique DNA-dependent activation of its kinase activity(42). Interestingly, the region of Ku80 that
binds DNA-PKcs is homologous to the region of Nbs that mediates binding of fellow PIKK family
member ATM(4). Among the key targets of DNA-PKcs kinase activity are DNA-PKcs itself and
Artemis(42, 144). The phenotype resulting from DNA-PKcs deficiency and kinase inactivity are
different, suggesting that DNA-PKcs may also have structural roles in NHEJ(145). DNA-PKcs
can bridge broken DNA ends together through kinase-independent DNA binding; this may be
15
!

done in combination with the Ku proteins which also have DNA binding activity and bind DNA
ends in such a way as to facilitate their alignment(146-149). While this binding by the DNA-PK
complex may initially facilitate the joining of two DNA ends, it may be subsequently inhibitory to
joining. Evidence suggests that the active removal of DNA-PKcs from the broken DNA end
perhaps mediated by an auto-phosphorylation event is required for joining to take place(144,
145). This finding has interesting implications for DNA repair. Specifically, as autophosphorylation is thought to occur in trans, this requirement may function to ensure that a
broken DNA end has another broken DNA end similarly bound to DNA-PKcs that is readily
available to ligate to. Furthermore, the DNA-PK holoenzyme complex may protect DNA ends
from any processing or chemical modification up until the ligation event occurs.
That ligation event is catalyzed by DNA Ligase IV, one of three known mammalian DNA
ligases(140, 150, 151). The DNA-PK holoenzyme complex recruits the ligase complex containing
DNA Ligase IV, XRCC4 and XLF (XRCC4 like factor)(150-152). XRCC4, like the DNA-PK
holoenzyme complex components, may play some ill-defined role in aligning broken DNA ends.
XRCC4, however, is also required to maintain Ligase IV levels within the cell; deficiency in
XRCC4 is effectively a deficiency in Ligase IV(150, 151). On the other hand, while XLF is
structurally similar to XRCC4, XLF is not shown to have DNA binding abilities and its levels do not
affect Ligase IV levels(153, 154). Both XRCC4 and XLF can promote the activity of Ligase
IV(152). XRCC4 promotes the enzymatic activity of Ligase IV by facilitating the adenylation of its
key catalytic residues(150, 151). XLF, on the other hand, facilitates the joining of DNA ends with
small ssDNA overhangs that are not otherwise immediately amenable to ligation by Ligase
IV(155-157). A final NHEJ factor, Artemis, has exonuclease activity but acquires endonuclease
activity upon its phosphorylation by DNA-PKcs(158, 159). Artemis activity is not required for the
repair of all DNA DSBs; in fact, in the setting of ionizing radiation, all but ~10% of breaks are
repaired efficiently in the absence of Artemis. The remaining 10% of breaks are thought to have
undergone chemical modifications that require Artemis-mediated processing prior to their
joining(160-162).
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Alternative End Joining
The black and white view of DNA repair by either HR or NHEJ is being replaced by the
notion that multiple additional pathways exist which have characteristics in common with both HR
and NHEJ(163). This is evidenced by the fact that most IR-induced breaks in NHEJ-deficient
cells do eventually join in a manner that is not dependent on HR factors (140, 164-166). AEJ is
currently defined as joining that takes place in the absence of core NHEJ factors. DNA ends
undergo significant amounts of resection prior to joining. Thus, the joints that form exhibit large
deletions(163). Secondly, AEJ is likely mediated by small regions of homology revealed by the
end resection as the joints form at sequences shared by the two DNA ends(163). In this regard,
AEJ is similar to SSA. The protein components required for and the mechanism of these
potentially multiple AEJ pathways are unknown at this time. As this joining occurs, by definition,
in the absence of Ligase IV, one of the other two mammalian DNA ligases, Ligase I or Ligase III
must function in AEJ(163, 167, 168). Other proteins implicated in this pathway include Mre11
and CtIP which are suggested to initiate the end resection that would reveal potential
microhomologies as they do in homology mediated repair(80, 163, 169-171).
AEJ has been implicated in the formation of translocations. AEJ pathways are normally
suppressed by classical NHEJ. In the absence of classical NHEJ factors, both the frequencies of
AEJ and translocations increase(163, 171, 172). The sequences of translocations found in NHEJ
deficient cells do not differ significantly from those that form in NHEJ-proficient (wild-type or WT)
cells suggesting that even in WT cells, AEJ may be the primary mode of DNA repair that allows
for translocations(172).
DNA Repair Pathway Choice
DNA repair pathway choice is largely determined by the stage of the cell cycle the cell
occupies when that break occurs(139, 173). HR is the predominant repair pathways during the
S-G2- and M phases of the cell cycle where a sister chromatid or paired homologous
chromosome is readily available. NHEJ, on the other hand, occurs primarily during the G1-phase
of the cell cycle but can function at all stages of the cell cycle. All required DNA repair factors for
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both HR and NHEJ are present throughout the cell cycle. Thus, DNA repair pathway choice
relies on both cell cycle-dependent and cell cycle-independent factors(139, 173). Accessing the
inappropriate repair pathway would have negative consequences. For example, attempting HR
during G1 in the absence of a sister chromatid or paired homologous chromosome could lead to
loss of heterozygosity if a mutant homologous chromosome is used as a substrate or
chromosomal deletions, inversions, or translocations if an unrelated but similar sequence is
utilized for repair(139, 173).
DNA repair pathway choice likely occurs early on during the repair process, perhaps
depending on the proteins that initially recognize and bind the broken DNA end and the initial
processing of that end (139, 143). Ku deficiency rescues the embryonic lethality of Ligase IV
deficiency, providing evidence for Ku binding as a key determinant of repair pathway choice(174).
The absence of Ku in cells where NHEJ is crippled (Ligase IV-deficient cells) might allow broken
DNA ends to access alternative repair pathways and enable the cell to escape the activation of
apoptotic pathways(174). Indeed, levels of homology-mediated repair are substantially increased
in Ku70-deficient cells(175). Secondly, end resection is thought to promote homology-mediated
repair and simultaneously prevent NHEJ, as DNA ends with significant overhangs do not bind Ku
efficiently(140-142, 176). End resection can be regulated in a cell cycle-dependent fashion, as
Sae2 (CtIP homologue) activity is enhanced upon phosphorylation of Ser267 (corresponding to
T847 in CtIP) by the cyclin dependent kinase Cdc28 (CDK1)(130, 176-178). The Sae2 mutant
S267E exhibits end resection inappropriately during all stages of the cell cycle including G1
disrupting NHEJ. Conversely, the Sae2 mutant S267A is defective in end resection and is more
apt to repair breaks by NHEJ even in the presence of sister chromatid or a paired homologous
chromosome during the S-G2-M phases of the cell cycle(176).
Repair of RAG DNA DSBs
Defects in the initiation of V(D)J recombination can lead to SCID as discussed above, but
what occurs to developing lymphocytes when RAG-mediated DNA DSBs breaks are mishandled?
Interestingly, subsets of patients with SCID have been identified that, in addition to profound
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lymphopenia and immunodeficiency, also have a sensitivity to ionizing radiation and exhibit
genomic instability and a propensity towards tumor development, specifically lymphoid tumors.
This phenotype is known as radiosensitive SCID or RS SCID(65, 179). These additional features
indicate a defect in DNA repair pathways and suggest that defects in the repair of RAG DNA
DSBs might contribute not only to lymphopenia and a resulting immunodeficiency but also to
lymphoid tumor formation.
Analysis of V(D)J recombination in lymphocytes derived from RS SCID patients and in
mouse models of these diseases have led to many important discoveries regarding the pathways
by which RAG DNA DSBs are repaired. In this regard, humans with RS SCID have been
identified with mutations in Ligase IV, Artemis, DNA-PKcs, and Cernunnos(65, 150). All are
components of the NHEJ pathway of DNA DSB repair. Moreover, mouse models with
deficiencies in any of the core components of the NHEJ DNA repair pathway (collectively referred
to here as NHEJ-deficient mice) exhibit a similar phenotype. Notably, deletion of some NHEJ
factors in mice leads to exhibit embryonic lethality; in these cases, conditional knockout mice
have been shown to have defects in V(D)J recombination(150). While RAG proteins are
expressed exclusively in lymphocytes and RAG-mediated DNA DSBs occur only in developing
lymphocytes, the repair of these breaks occurs via general DNA repair mechanisms, specifically
non-homologous end joining.
Furthermore, just as the mishandling of genotoxic DNA DSBs can result in chromosomal
deletions, inversions, and translocations, the mishandling of RAG DNA DSB can lead to
chromosomal lesions with oncogenic potential. Follicular lymphoma is caused by a translocation
(t14:18) that results in the IgH promoter driving bcl-2 expression(179). IgH to c-myc
translocations (t8:14) in Burkitt’s lymphoma similarly dysregulates the expression of an oncogene
leading to cellular transformation(179). Furthermore, deletion of the tumor suppressor Mts1 in
developing lymphocytes is a frequent cause of T-ALL(180).
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As discussed above, RAG-mediated DNA DSBs result in the formation of two hairpinsealed coding ends and two blunt phospohylated signal ends that must be joined together to form
coding joints (CJs) and signal joints (SJs) respectively.
During V(D)J recombination, the unrepaired signal ends remain bound to RAG in a postcleavage complex(181, 182). RAG must be actively removed from the signal ends to allow for
joining(181, 182). Just as occurs during the NHEJ-mediated repair of genotoxic DNA DSBs,
these broken signal ends recruit the DNA-PK complex consisting of Ku70, Ku80 and DNA-PKcs.
The blunt phosphorylated signal ends can be joined directly by the XRCC4/DNA Ligase IV
forming a signal joint (SJ)(150).
Coding ends, do not bind RAG with the same affinity that signal ends do; thus, other
factors would be required to keep the four free DNA ends tethered to one another(181, 182).
Whether and how coding ends are maintained in the post-cleavage complex is unknown.
Furthermore, coding ends cannot be joined in their native state; these hairpin-sealed ends must
undergo processing(150). As we discuss below, it is this processing that ultimately contributes to
the incredible diversity of the resulting antigen receptors.
The processing of the hairpin-sealed coding ends is initiated by the non-core NHEJ factor
Artemis. As discussed above, the association of Artemis with DNA-PKcs confers endonuclease
activity to Artemis that enables it to “open up” hairpin-sealed DNA ends(158). Artemis creates a
nick in the hairpin at a non-precise location causing it to open; although hairpin-opening does not
occur at exactly the same nucleotide position each time, it more frequently occurs two nucleotides
3’ of the tip(158, 159, 183). In the absence of Artemis or DNA-PKcs, hairpin-sealed broken DNA
ends accumulate and V(D)J recombination cannot be completed(150, 158, 161). These data
suggest that, although proteins such as RAG possess endonuclease activity in vitro, Artemis is
the primary endonuclease that opens hairpin-sealed coding ends during V(D)J recombination in
vivo(184, 185). Importantly, Artemis is not required for SJ formation(186).
The asymmetric opening of the hairpin-sealed DNA end results in palindromic DNA
sequences. The nucleotides comprising these palindromic sequences of varying length are
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termed p nucleotides(150). Hairpin-opened coding ends are susceptible to the activity of
nucleases presumably through those at the site of the RAG DNA DSB such as Artemis, terminal
deoxynucleotidyl transferase (TdT), or RAG which has flap endonuclease activity(158, 187, 188).
Finally, coding ends undergo a third form of processing. Additional nucleotides can be added to
hairpin-opened coding ends in a non-templated fashion though the addition of (N) nucleotides by
TdT or polymerase µ (158, 189, 190). The coding ends processed by these various modalities
can subsequently be joined by the NHEJ ligase complex consisting of XRCC4 and DNA Ligase IV
to form a coding joint (CJ)(150, 191). The processing of coding ends prior to ligation is unique to
NHEJ during V(D)J recombination.
Some mutants of the RAG proteins are efficient in cleavage at the RSS-coding end
junction in vitro but the resulting DNA ends do not join efficiently(192-194). Moreover, RAG-1 can
bind the Ku heterodimer; thus, RAG may participate in recruiting NHEJ factors to the break
site(195). These data suggest that the RAG endonuclease may also play some role in the joining
step of V(D)J recombination. Any role for RAG in DNA end joining would be unique to V(D)J
recombination and not a general component of NHEJ as RAG is expressed only in developing
lymphocytes undergoing V(D)J recombination.
AEJ and RAG DNA DSB Repair
Though mice with deficiencies in core NHEJ factors are profoundly immunodeficient, they
are not typically completely devoid of lymphocytes suggesting that alternative DNA repair
pathways may allow for V(D)J recombination to take place at very low levels in these
animals(140). Some RAG mutants (core RAG-1, core RAG-2 and RAG-2 FS361) allow for
especially high rates of CJ formation in NHEJ-deficient cells(196). Interestingly, the CJs formed
in these NHEJ-deficient cells exhibit significant deletions and microhomology at the site of the
joint suggesting that they did indeed form via alternative end joining(196). Furthermore, cells
expressing these mutant RAG proteins but with intact NHEJ pathways also utilize alternative end
joining to join coding ends at low rates(164). These data suggest that alternative DNA repair
pathways can function during V(D)J recombination(196-198). The RAG proteins themselves may
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function to protect cells from accessing these aberrant repair pathways(196-198). Other cellular
pathways may function to quell the use of alternative repair pathways. Utilization of these
pathways during V(D)J recombination could lead to increased frequency of translocation events.
Furthermore, the utilization of microhomologies to mediate end joining would lead to a decreased
diversity in the antigen receptor repertoire(197, 198).
Deletional versus Inversional Rearrangement
The primary goal of NHEJ is to rapidly ligate the two broken DNA ends so as to preserve
as much genomic information as possible. Deletions and inversions are both considered aberrant
and potentially dangerous products of misguided DNA repair by NHEJ(140). While utilizing
components of the NHEJ pathway, the repair of RAG-mediated DNA DSBs does not simply join
two DNA DSBs together. In V(D)J recombination, rearrangement absolutely requires deletion
(during rearrangement by deletion) or inversion (during rearrangement by inversion) of large
regions of genomic DNA. Rearrangement by deletion or inversion occurs depending on the
orientation of the RSS pair and the transcriptional orientation of the gene segments to be
recombined. Gene segments that are in the same transcriptional orientation recombine by
deletion wherein the intervening sequence is simply excised from the chromosome. The RSS
pair remains on opposite ends of the segment that is excised from the chromosome; SJ formation
leads to the formation of an episomal fragment of DNA that is subsequently lost during cellular
division. Importantly, during rearrangement by deletion, joining of coding ends, but not signal
ends, is required to maintain the linear integrity of the chromosome. Most rearrangements during
V(D)J recombination occur by deletion. However, some antigen receptor loci, such as the IgL
kappa locus, utilize inversional rearrangement with significant frequency. Gene segments that
are in the opposite transcriptional orientation undergo rearrangement by inversion. Upon RAGmediated cleavage, the segment of DNA located between the two RSSs must be inverted to allow
for SJ and CJ formation. Notably, during inversional rearrangement, both coding and signal joint
formation occur within the chromosomal context; as such, both are required to maintain the linear
integrity of the chromosome. Two additional types of joints can occur that do not correctly pair
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coding ends and signal ends and therefore do not result in functional antigen receptor genes.
Importantly, these may exist as backup pathways that would function to preserve the linear
integrity of the chromosome. Occasionally, the coding and signal ends simply rejoin in the
original configuration forming open-and-shut joints. Additionally, hybrid joints can occur in which
a signal end inappropriately joins to the other coding end. During rearrangement by deletion,
hybrid joint formation would require the inversion of the intervening gene segment. During
rearrangement by inversion, this would involve the inappropriate loss of the intervening gene
segment(1, 150, 199).
V(D)J recombination, then, is only successful when NHEJ pathways allow for a controlled
mis-repair, one that allows for deletion or inversion. The mechanism by which signal ends are
joined to signal ends and coding ends to coding ends leading to these desirable deletions or
inversions is not known. However, the answer to this conundrum likely lies in the components of
and the structure of the post-cleavage complex. For example, RAG binding to signal ends may
facilitate SJ formation and prevent open-and-shut and hybrid joint formation(181, 182).
Antigen Receptor Diversity
The unique aspects of the V(D)J recombination reaction described above generates CJs
that vary in both size and sequence. This junctional diversity supplements combinatorial diversity
and results in the diverse antigen receptor repertoire that is the cornerstone of adaptive immunity.
As noted above, combinatorial diversity is a term used to denote the combination of different
antigen receptor components for each functional antigen receptor and the different V, D, and J
gene segments used to construct each receptor component. Neither combinatorial nor junctional
diversity is without constraint. For example, it is clear that some gene segments are used more
frequently than others. Additionally, in some cases, for example in the mouse, more than 95% of
the B cells utilize the kappa light chain(200). With regards to junctional diversity, excessive
deletion or addition of nucleotides to coding ends prior to joint formation would be deleterious.
Some gene segments undergoing V(D)J recombination can be quite small, and large deletions
could lead to the deletion of an entire gene segment and the formation of a non-functional antigen
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receptor(201). Large nucleotide additions could similarly perturb the structure of the resultant
antigen receptor such that it would no longer recognize antigen; this is especially true for the TCR
which must recognize antigen in complex with an MHC molecule. Additionally, as discussed
above, end resection may be a critical determinant of DNA repair pathway choice. Thus,
excessive nuclease activity might allow RAG DNA DSBs to access homology-mediated
alternative repair pathways that could potentially lead to the formation of a non-functional antigen
receptor, limit the diversity or the resulting antigen receptor pool or lead to potentially oncogenic
chromosomal lesions. Pathways must exist to govern the processes and protein factors that
generate both combinatorial and junctional diversity(201).
A role for ATM in RAG DNA DSB Repair
Like RS-SCID patients, A-T patients exhibit characteristics suggesting deficiencies in the
repair of RAG-mediated DNA DSBs in addition to the deficiencies in the repair of genotoxic DNA
DSBs. First, they are lymphopenic and susceptible to infection. Secondly, they exhibit a high
frequency of translocations involving the antigen receptor loci. For example, translocations
involving the human TCR% and the TCR& locus and inversions involving the human TCR% (V%)
and TCR$ (J$) loci are found in circulating non-transformed peripheral T cells in the absence of
ATM; translocations involving the TCR# locus can be found in up to 10% of circulating T cells in
ATM-deficient mice(108, 113, 116, 202, 203). Additionally, A-T patients almost invariably develop
lymphoid tumors, and these tumors harbor translocations involving the antigen receptor loci(111).
This phenotype is recapitulated in ATM-deficient mice(204). These lymphoid tumors are likely a
result of aberrant V(D)J recombination as they do not occur in mice unable to initiate
recombination owing to an absence of RAG endonuclease components(114, 205). Thus, ATMdeficiency leads to decreased efficiency of RAG DNA DSB repair leading to lymphopenia and
increased mis-repair leading to increased numbers of translocations and lymphoid tumor
generation.
We have demonstrated a role for ATM in the repair of RAG DNA DSBs. Specifically,
ATM functions to maintain coding ends within the post-cleavage complex. In its absence, we
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note a decreased efficiency of RAG DNA DSB repair and an increase in the rates of aberrant
repair including hybrid joint formation and translocations(107). Like DNA-PKcs, ATM may have
both kinase dependent and independent functions, and this described role in RAG DNA DSB
repair may directly rely on one or more of the non-catalytic regions of ATM(95-98). However, as
this function requires ATM kinase activity, its role in maintaining DNA ends in the post-cleavage
complex likely lies in the phosphorylation of one of its downstream substrates, possibly the MRN
complex(107). We discuss this further in Chapter 3.
Formation and Function of DNA Repair Foci
In addition to ATM and MRN, many additional proteins are recruited to the site of a
genotoxic DNA DSB forming what is often referred to as a DNA repair focus. The accumulation
of factors at the break site occurs in a spatially and temporally regulated fashion(4). Creation of
the DNA repair focus is a critical feature of the DNA damage response functioning to recruit
various repair factors, to tether the broken DNA ends together allowing for efficient repair, and to
potentiate signaling pathways by concentrating the component enzymes and their substrates at
the break site(4).
The formation of the DNA repair focus begins with the phosphorylation of H2AX by
ATM(206, 207). H2AX is a variant of the histone protein H2A and represents about 10% of the
H2A in the genome(206-208). It is unknown whether H2AX is spread evenly throughout
chromatin or whether it is concentrated in certain regions of the genome(208). Among the
differences between H2AX and its H2A counterpart is the presence of approximately twenty
additional amino acids at its C-terminus; this unique carboxy-terminal tail protrudes from the
nucleosome core around which the DNA is wound(208). The serine residue four amino acids
from the end of H2AX (-SQEY) comprises an SQ motif that is specifically phosphorylated by ATM
(forming %'H2AX) (206). While optimal phosphorylation relies on ATM, in its absence, DNA-PKcs
can perform this function(209-211).
The phosphorylation of H2AX in the chromatin flanking the break is directly or indirectly
required for the maintenance of a large percentage of the factors comprising the DNA repair
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focus at the break site(208, 212). The initial re-localization of these factors to the break site can
still occur in H2AX deficient cells, but in the absence of %-H2AX, they drift from the break site
more rapidly(213). A number of factors can bind phosphorylated tail of H2AX directly including
Nbs1, 53BP1, and Mdc1(214-216). However, Mdc1, through its C-terminal tandem BRCT
domains, does so with the highest efficiency and stability(214). How, then, are these other
factors then retained in the DNA repair focus? Mdc1 recruits Rnf8 upon its phosphorylation by
ATM at four TQXF sites (T699, T719, T752, and T765) (217, 218). Rnf8 is an E3 ubiquitin ligase
that can catalyze the ubiquitylation of H2A and H2AX(219-221). This ubiquitylation event leads to
further histone modification through the recruitment of additional ubiquitin ligases such as Rnf168
and also results in the direct recruitment of repair factors such as Rap80 and Brca1(222-224).
However, these histone ubiquitylation events also alter the chromatin environment at the break
site to reveal other histone marks making them available to bind factors such as 53BP1. These
other histone modifications might be generated de novo in response to DSBs, similar to H2AX
phosphorylation. Alternatively, they might exist constitutively in chromatin but be revealed only
upon the chromatin rearrangement initiated by DNA damage responses(208, 225-227). Through
these various pathways, then, H2AX is directly or indirectly responsible for the recruitment of a
large number of factors at the break site.
Mdc1 binds %-H2AX. However, it also binds ATM directly through its FHA-domain and
indirectly by binding Nbs1 which can subsequently recruit ATM(228). Nbs1 contains an Nterminal FHA-BRCT-BRCT domain that binds the SDTD motifs of Mdc1 after the serine and
threonine residues are phosphorylated by Ck2(229-231). Mdc1 physically links ATM to its
substrate H2AX. This creates a feed-forward mechanism that would enable a cell to rapidly
activate a large fraction of nuclear ATM and efficiently initiate ATM-dependent phosphorylation
events and activate downstream pathways in the presence of a single DNA DSB(214, 217, 218,
228). As might be expected, %H2AX levels are lower in Mdc1 deficient cells(218, 228).
Additionally, H2AX- and Mdc1-deficient cells are unable to efficiently activate cell cycle
checkpoints in response to low dose irradiation, but both are able to do so effectively when the
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number of DNA DSBs is increased using high dose irradiation(218, 228, 232). These data
suggest that a critical function of the DNA repair focus is the potentiation of DNA damage
response signaling pathways.
The DNA repair focus may also play a direct role in the repair of a DNA DSB. Indeed, the
phenotype of H2AX-deficient mice is consistent with H2AX having a role in the actual repair of
DNA DSBs. Specifically, this mouse is small in size, infertile, and exhibits genomic instability with
sensitivity to ionizing radiation(208, 233-236). Mice with deficiencies in other known components
of DNA repair foci likewise share these characteristics with H2AX-deficient mice. However, H2AX
and these other components of DNA repair foci are not core components of any of the DNA repair
pathways(140). A primary theory is that %-H2AX and the resulting foci may function as a scaffold
to hold broken DNA ends together, thereby facilitating efficient repair(237). .
DNA Repair Foci Formed at RAG DNA DSBs
Just as genotoxic DNA DSBs promote H2AX phosphorylation and repair focus formation,
RAG DNA DSBs also induce H2AX phosphorylation within the chromatin at the site of a DNA
DSB and at significant distances (> 200 kb) from the break site, and other components of DNA
repair foci can be found at RAG DNA DSBs including 53BP1(105, 211, 238-240). Mice with
deficiencies in some components of the DNA repair focus including H2AX and 53BP1 exhibit mild
lymphopenia and an increased frequency of translocations involving antigen receptor genetic loci;
when H2AX-deficient mice are bred onto a p53-deficient background, they exhibit lymphoid tumor
formation(213, 233-235, 238, 241, 242). Additionally, RIDDLE (radiosensitivity (R),
immunodeficiency (I), dysmorphic features (D), learning disabilities (L)) syndrome patients have a
defect in the ubiquitin ligase Rnf168; components of this phenotype are shared with the RS-SCID
phenotype(222, 223). All of these data suggest that whatever role that the DNA repair focus
plays during the repair of genotoxic DNA DSBs, it likely also plays during V(D)J recombination.
Indeed, persistent unrepaired coding ends in H2AX-deficient cells do more frequently
irreversibly separate and form translocations, perhaps as a result of the scaffolding function of
H2AX and the DNA repair focus(233-236, 243). However, H2AX-deficient lymphocytes undergo
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efficient V(D)J recombination (233, 235). Furthermore, H2AX-deficient lymphocytes do not show
evidence of hybrid joint formation or the accumulation of unrepaired coding ends as we observe
in the setting of ATM and MRN deficiency(243). The exact role of H2AX in the V(D)J
recombination is not completely understood. In Chapter XX, we discuss an additional and novel
role for H2AX in the repair of RAG DNA DSBs in preventing the resection of persistent unrepaired
coding ends.
Transcriptional Pathways Activated by ATM
ATM activates a number of transcriptional pathways in response to genotoxic DNA
damage. These primarily include pathways that mediate cell cycle arrest or influence cell survival
including p53 and NF"B(244-247). The activation of p53 in response to DNA damage functions
to halt cell cycle progression and to promote the death of cells with potentially dangerous
chromosomal lesions. In support of this notion, p53-deficient mice exhibit genomic instability and
develop tumors; furthermore, mutations in p53 and defects in p53-dependent pathways have
been implicated in a number of human cancer syndromes(234, 248-250). On the other hand,
NF"B is commonly described as a pro-survival transcription factor, as a large fraction of the
genes regulated by NF"B have activities in promoting cell survival. Cells deficient in NF"B
signaling pathways exhibit increased cell death in response to ionizing radiation(247). In
response to many stimuli, however, NFkB promotes the expression of a large cohort of genes
with diverse known activities(251-253).
The activity of p53 and its downstream pathways is tightly regulated both through the
regulation of p53 protein levels within the cell and through various post-translational
modifications. ATM activation of p53-dependent pathways relies on its ability to lead to the
abnormal accumulation of p53 within the cell and as well as its ability to phosphorylate and
activate p53(244). Mdm2 is an ubiquitin ligase that normally maintains p53 at negligible levels
within the cell by mediating its degradation(254, 255). ATM phosphorylates Mdm2 in response to
DNA damage and physically prevents its association with p53(244, 254, 255).

ATM additionally

activates p53 primarily via the direct phosphorylation of p53 at Ser15 but also indirectly through
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the phosphorylation of Chk2(244, 256). Chk2 phosphorylation by ATM in response to DNA
damage leads to the formation of catalytically active Chk2 dimers. Dimerized Chk2 subsequently
phosphorylates p53 at a unique site, Ser20, further activating its transcriptional activity(244, 249,
256-260).
This ATM-dependent activation of p53 results in the initiation of the G1-S checkpoint.
Progression from the G1-phase of the cell cycle to S-phase requires the activation of the Cdk2cyclinE complex. This complex is activated by de-phosphorylation of Cdk2 by the phosphatase
Cdc25a. Cdc25a, itself, is a target of the ATM-dependent kinase activity of Chk2, and
phosphorylation of Cdc25a leads to its degradation(261). Cdc25a is therefore unable to
dephosphorylate and activate Cdk2(261). The activation of p53 also affords transcriptional
changes that contribute to the initiation of the G1-S checkpoint; specifically, the expression cyclindependent kinase inhibitor (p21) which prevents binding to Cdk-2 to cyclinE is driven by p53
transcription factor activity(94). In addition to promoting the G1-S cell cycle checkpoint, the p53
transcription factor also activates cell death pathways by promoting the transcription of pro-death
factors including PUMA, Apaf1, NOXA, and Bax(262).
In response to genotoxic DNA damage, ATM simultaneously activates NF"B-dependent
transcriptional activity. DNA damage induced activation of NF"B by ATM is unique as NF"B
signaling is generally initiated through the binding of ligands to cell surface receptors(263, 264).
The transcription factor NF"B, a dimer consisting of p50 and p65 subunits, resides in the
cytoplasm as its nuclear localization signal is obscured by binding to I"B# (inhibitor of NF"B). It
is only upon the phosphorylation of I"B# and its subsequent degradation that the p50/p65
heterodimer translocates to the nucleus, where it affects the transcription of a large cohort of
genes(265-267). The binding of ligands such as LPS and TNF to their cell surface receptors is
normally the stimulus that activates the I"B# kinase (IKK) complex (consisting of IKK#, IKK$ and
the regulatory IKK% (NEMO)) subunit through the phosphorylation of NEMO. All of these
activating events occur within the cytoplasm. However, NEMO does shuttle in and out of the
nucleus, and, interestingly, the balance of nuclear:cytoplasmic NEMO is shifted in response to
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DNA damage by an unknown mechanism(268). In response to DNA damage, the nuclear
fraction of NEMO is phosphorylated by ATM. The phosphorylated NEMO is subsequently
monoubiquitinated and translocates back to the cytoplasm. There it binds IKK#/IKK$, activates
the IKK complex, and leads to the phosphorylation and degradation of I"B# and enables the
translocation of the p50/p65 heterodimer to the nucleus(269). Gene products with pro-survival
activities whose transcription is regulated by ATM and NF"B in response to genotoxic DNA
damage include, among others, Pim2 and Bcl3(247, 270).
Activation of Transcriptional Pathways in Response to RAG DNA DSBs
Like genotoxic breaks, RAG DNA DSBs also activate transcriptional pathways in an
ATM-dependent manner. ATM activates p53 in response to persistent RAG DNA DSBs(271). As
a result, ATM-deficient cells are defective in activating the G1-S checkpoint, and unrepaired
coding ends are detectable in ATM-deficient cells even at post-replicative stages of the cell
cycle(202, 272). In fact, these unrepaired breaks remain even after the cell has undergone
multiple cell divisions(202, 272). The activation of p53 by persistent RAG DNA DSBs also
activates robust pro-apoptotic pathways that eliminate cells harboring these potentially dangerous
DNA lesions(271). Although NHEJ-deficient mice cannot repair RAG-mediated DNA DSBs, they
do not develop lymphoid tumors to any great extent(150). However, mice with deficiencies in p53
and NHEJ develop lymphoid malignancies at a young age(150, 271). These observations
illustrate the oncogenic potential of RAG-mediated DNA DSBs and the necessity of ATM- and
p53-dependent apoptotic pathways. In Chapter 5, we demonstrate that RAG DNA DSBs
simultaneously activate NF"B transcriptional pathways. The activation of NF"B by RAG DNA
DSBs and the implications of activating such a pleiotropic transcription factor in these developing
cells is discussed.
Summary
Indeed, RAG DNA DSBs, similar to genotoxic DNA DSBs, activate an ATM-dependent
DNA damage response. In the individual chapters that follow, we further define components of
this response that occurs in developing lymphocytes undergoing V(D)J recombination.
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Specifically, we discuss how ATM participates in the repair of the RAG DNA DSB (Chapter 3),
how ATM regulates DNA end resection through modulation of H2AX phosphorylation and CtIP
activity (Chapter 4) and, finally, how ATM significant alters gene expression patterns in
developing lymphocytes undergoing V(D)J recombination (Chapter 5).
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Chapter 2

Materials and Methods
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Approach to Analyzing V(D)J Recombination
The difficulty of studying V(D)J recombination in vivo is two-fold. First, RAG DNA DSBs
are made and repaired quickly in a non-synchronized fashion among the developing B cells in the
bone marrow or T cells in the thymus; thus, to capture cells in bone marrow or thymus that are
actively rearranging their antigen receptor loci is a daunting task. Additionally, antigen receptor
loci are complex with hundreds of different V, D, and J gene segments spanning great distances
within the genome. Though some segments are used preferentially, the sheer number of
possible combinations that allows for the powerful adaptive immune system makes the analysis
of rearrangement by methods such as Southern blotting impossible. Southern blotting of DNA
isolated from lymphocytes undergoing V(D)J recombination demonstrates a distinct band
representing the germline state of the un-rearranged alleles and a smear of rearrangement
products of various sizes that is non-interpretable for the most part. An ideal system to analyze
V(D)J recombination would allow for the synchronous induction of RAG DNA DSBs and would
somehow limit the number of possible resultant recombination products. Attempts to develop
these model systems are described here.
The rearrangement of plasmid substrates containing a single RSS pair (thus resulting in a
single rearrangement product) can be analyzed in fibroblasts, CHO cell lines, or other nonlymphoid cells transfected with the RAG endonuclease or transformed B cells that naturally
express the RAG endonuclease(273, 274). However, naked DNA (plasmid recombination
substrates) does not recapitulate the natural chromatin environment that clearly plays a role in
V(D)J recombination(46). Not unexpectedly, numerous proteins have effects in chromosomal
repair but have no demonstrable defect in the repair of these plasmid substrates. In this regard,
-/-

while multiple studies were unable to detect defects in CJ formation in Atm cells by analysis of
V(D)J recombination of extra-chromosomal substrates, we have clearly demonstrated a role for
ATM in the repair of chromosomal RAG DNA DSBs(107, 275-277). Furthermore, assaying repair
in lymphocytes rather than fibroblasts transfected with the RAG proteins is paramount as it is has
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been demonstrated that the requirements for some NHEJ factors (notably XLF) for the repair of
RAG DNA DSBs is different in these two cell types(278).
Significantly improved methods for studying V(D)J recombination have addressed these
major weaknesses. These methods utilize B cells transformed with a temperature sensitive
Abelson murine leukemia virus(279). This virus preferentially targets pre-B cells that are primed
to undergo rearrangement of the endogenous IgL loci. However, once infected with the
temperature sensitive Abelson virus (abl pre-B cells), these cells rapidly cycle and do not express
the RAG proteins or undergo V(D)J recombination(279). Culturing them at non-permissive
temperatures however, turns off abl kinase activity, arrests the cells in G1 where they begin to
express the RAG proteins and undergo V(D)J recombination at the endogenous IgL kappa and
lambda loci(279). The system utilized in the studies detailed in subsequent chapters is an
adaptation of the above. Instead of infecting pre-B cells with the temperature sensitive Abelson
leukemia virus, we introduce the abl kinase to bone marrow cultures via a retrovirus that similarly
transforms the pre-B cell population. Instead of varying culture temperatures, we use a small
molecule inhibitor of the abl kinase, STI571 or Gleevac, to stop cell division, arrest the cells in G1,
and induce RAG endonucleolytic activity and V(D)J recombination(107, 280). Instead of
analyzing rearrangement of the complex endogenous antigen receptor loci, we utilize retroviral
recombination substrates that are integrated into the chromosome of these cells. These retroviral
chromosomal recombination substrates, similar to the extrachromsomal plasmid substrates,
contain a single pair of RSSs (Figure 1 and 2A). These retroviral recombination substrates can
rearrange by deletion (pMX-DEL) or inversion (pMX-INV) based on the orientation of the RSS
pairs just as in the endogenous antigen receptor loci. Additionally, they enable us to study both
CJ and SJ formation in the context of a chromatinized environment. We have developed
Southern blotting strategies to analyze rearrangement of these retroviral recombination
substrates that enable us to not only detect products resulting from the normal repair of a RAG
DNA DSB, but also aberrant repair products as well as V(D)J reaction intermediates as depicted
in Fig 2a(107). Based on findings from initial studies utilizing chromosomal recombination
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substrates in these transformed pre-B cell lines, we can go on to analyze rearrangement of the
endogenous loci in these transformed cells or in primary cell cultures or bone marrow or thymic
extracts. The complexity of the endogenous antigen receptor loci, however, remains an obstacle
to the analysis of V(D)J recombination. We have circumvented this problem in some instances
by utilizing mice with genetically modified antigen receptor loci(108, 276). The TCR SJ# mouse
has a TCR# locus containing a single functional J# gene segment to which the V# gene
segments can recombine. This modified allele enables us to detect unrepaired J# coding ends,
but analyzing joints that do form is still limited by the number of possible V# partners(108).

Specific materials and methods pertinent to each chapter are included below, but
importantly have been published exactly as printed here.

Relevant to Chapter 3 (as published(276))
Cell lines and culture conditions: Nbs1

m/m

(lines 675.3 and 737.3), Mre11

-/-

ATLD1/ATLD1

(line 48.1),

-/-

wild type (WT) (line A70.2), Atm (lines Atm2E and Atm2F), Artemis (lines 5.1, 0.1), Atm
-/-

:Artemis (line 0.1), Nbs1

m/m

-/-

:Artemis (lines 37.1, 37.3) and Mre11

ATLD1/ATLD1

-/-

-/-

:Artemis (lines

61.3, 64.1) v-abl-transformed pre-B cells were generated by culturing bone marrow of 3-5 week
old mice with the pMSCV v-abl retrovirus, as described previously(107). All cells were generated
6

from mice harboring the Eµ-Bcl-2 transgene(281). All Abl pre-B cells (10 /mL) were transduced
with retroviral recombination substrates by co-centrifugation at 1800 rpm for 90 minutes. Clonal
populations of cells with single pMX-INV integrants were isolated by limiting dilution of WT:INV
-/-

(A70.2-2 and -5), Atm :INV (Atm2E-26 and Atm2F-6), Mre11
Nbs1

m/m

ATLD1/ATLD1

:INV (48.1-1 and -3) and

:INV (675.3-2 and 737.3-6) Abl pre-B cell lines. Cells were treated with 3µM STI571
6

(Novartis) for the indicated times at 10 cells/ml. KU-55933 (Sigma) was used at 15µM.
Southern blot and PCR analyses: Southern blot analyses were carried out on genomic DNA
from cells harboring pMX-INV using the indicated restriction enzymes and the C4 probe, as
previously described(107). Southern blot analyses of thymocytes from mice expressing the
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sJ

TCR# allele were carried out using the StuI restriction enzyme and the C#I probe, as reported
previously(108, 282). Southern blot analyses for IgL" locus J" coding ends was carried out on
SacI and EcoRI digested genomic DNA using the J"III probe as previously described(270). pMXINV coding joints were amplified using the pA and pB oligonucleotides and pMX-DEL

SJ

signal

joints were amplified used primers pB and pC oligonucleotides as previously described(107).
V&5, V$14 and V"6-23 coding and hybrid joints, and the IL-2 gene, were amplified by PCR as
previously described(107).
Western blot and EMSA analyses: Western blots were done on whole cell lysates using
antibodies to mouse KAP-1 (GeneTex), phosphorylated KAP-1 (Bethyl Labs), Mre11 (Novus),
and Nbs1 (Cell Signaling). The secondary reagents were horseradish peroxidase (HRP)conjugated goat anti-mouse IgG (Zymed) or donkey anti-rabbit IgG (GE Healthcare). NF!B
EMSA were run as described previously and were analyzed with a Li Cor Odyssey Infrared
Scanner(270).
Immunofluorescent detection of %-H2AX foci: Nuclear %-H2AX foci were detected using
standard protocols with minor modifications(105, 283). Briefly, cells were cyto-spun onto poly-Llysine coated slides (Sigma), fixed in 4% paraformaldehyde for 10 min, washed in phosphatebuffered saline (PBS), permeabilized with 0.15% Triton X-100 in PBS, and blocked in PBS with
2% bovine serum albumin. Cells were incubated in anti "-H2AX antibody (Upstate Biotechnology)
o

at 1-2 #g/ml concentration for 3 hours at 37 C in a moist chamber, washed with PBS, and further
incubated with anti-mouse-FITC conjugate (Vector Labs) for 45 minutes. After washing with PBS
slides were mounted in Vectashield mounting medium with DAPI (Vector Labs). Foci were
observed and imaged as described before on Carl Zeiss Axioplan 2 microscope using
Metasystems In situ Imaging System (ISIS) imaging software(283).

Relevant to Chapter 4
Southern blotting: Southern blot analysis of genomic DNA analyzing rearrangement of the
pMX-DEL

CJ

retroviral substrate was performed as described previously utilizing an EcoRV
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restriction enzyme digest and the C4b probe(107). Southern blot analyses of coding ends
generated during rearrangement of the IgL-" locus was performed as described previously on
genomic DNA digested overnight with SacI and for 5 hours with EcoRI utilizing the J"III
probe(270).
Urea-Agarose Gel Electrophoresis: The denaturing gels were run as described previously(284)
with the following modifications: Briefly, 40ug of genomic DNA was digested overnight with
EcoRV in a 400ul volume and concentrated to 30ul. The DNA was then re-suspended with the
addition of 5 volumes 8M Urea, 1% NP-40, 1mM Tris pH 8.0 and 0.5 mg/ml bromophenol blue.
This DNA solution was divided in two, with one half heated at 90 degrees Celsius for 8 min to
denature while the other half was incubated on ice. After 8 min the heated DNA samples were
placed on ice. All samples were ran on a 1.2% agarose gel made with 1X TAE with 1M urea at
50 volts for ~24hrs in at 4°C in TAE buffer also containing 1M urea.
CJ

TdT-assisted PCR: TdT-assisted PCR analysis of pMX-DEL coding ends was performed as
described previously using the IRES REV5 oligo for the primary PCR reaction, the IRES REV4
oligo for the secondary PCR reaction and the I4 oligo as a probe(238). Primers IRESrev5 and
T17 UNIV (Table 1) were used for the primary PCR reaction and 15 cycles of the PCR program
described above were used. A secondary PCR was then carried out using primers IRESrev4 and
UNIV (Table 1). 30 cycles were used for the secondary PCR. Conditions for PCR were as
follows: 92° for 1 minute, 58° C for 1.5 min, and 72° C for 1.5 min. Similar conditions were used
for PCR analyses of coding ends generated during rearrangement of the endogenous IgL! locus,
using the J!2 ds oligo for amplification and the J! oligo as a probe. IL2 gene PCR, which is
provided as a DNA loading control, was performed as described previously(238).
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Table 1. Oligos used in TdT assisted PCR.
IRES REV5

CTCGACTAAACACATGTAAAGC

IRES REV4

CCCTTGTTGAATACGCTTG

T17 UNIV

GTAAAACGACGGCCAGTCGAC-T17

UNIV

GTAAAACGACGGCCAGTCGAC

IRES4 probe

TAAGATACACCTGCAAAGGCG

J"2 ds 200

CCACAAGAGGTTGGAATGATTTTC

J"2 probe

GTAGTCTTCTCAACTCTTGTTCACT

Western blotting: Western blotting was performed as described previously(276). Primary
antibodies used were mouse monoclonal 14-1 (1:40)(285) and H2AX (1:3000) Millipore, Erk2
(1:2500) Santa Cruz and GAPDH (1:2500) Santa Cruz. Dilutions used are provided in
parentheses. Secondaries were goat anti-mouse (Invitrogen) and donkey anti-rabbit F(ab’)2
Fragment (Fisher).
Retroviral reconstitution and lentiviral knock-down: Reconstitution of
-/-

-/-

-/-

-/-

Artemis :H2AX and Ligase IV :H2AX abl preB cells was performed by
retroviral transduction with either empty retrovirus or retrovirus containing cDNAs
encoding H2AX or H2AX

S139A

. A cDNA encoding H2AX

S139A

(serine 139

changed to alanine) was generated by PCR-based site-directed mutagenesis of
WT H2AX cDNA. cDNAs encoding WT H2AX and H2AX

S139A

were cloned into

the pMX-PIE retroviral vector and cells were transduced by co-centrifugation as
described previously. Cells expressing the retroviral construct were obtained by
flow cytometric cell sorting of cells expressing GFP using a FACSVantage (BD
Biosciences).
shRNA-mediated knockdown: Generation of lentiviral shRNAs vectors was carried using the
previously described pFLRU:YFP lentiviral vector(286, 287). CtIP-specific and nontargeting(NT)
shRNAs were cloned into the pFLRU:YFP lentiviral vector. Sequences targeted by the shRNA
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are shown in Table 2. 4 µg of these PFLRU:shRNA:YFP vectors were individually co-transfected
with 4 µg pHR’(8.2R packaging vector and 1 µg of pCMV-VSVg envelope plasmid into HEK293T
2

cells plated at approximately 80% confluency in 6 cm plates using Lipofectamine 2000
(Invitrogren). Media was replaced at 12 hours post-transfection. Supernatants were harvested 24
hours later. Transduction of abl pre-B cells was performed by co-centrifugation with viral
supernatant at 1800 rpm for 90 min with polybrene added at 5 µg/mL. Cells expessing the
pFLRU-shRNA vectors were obtained by flow cytometric cell sorting gating on cells expressing
YFP using a FACSVantage (BD Biosciences).
Table 2. Target sequences for shRNA mediated knockdown.
CtIP shRNA target 6

GAGCAGACCTTTCTCAGTA

Non-targeting (NT) shRNA

GGTTCGATGTCCCAATTCTG

PCR Amplification of CJs: pMX-DEL

CJ

coding joints were amplified using oligos pC and IRES

REV5 flanking the coding joint as shown in Figure 21a. 300 ng of genomic DNA was used in the
original amplification with serial 5-fold dilutions. Oligo IRES REV4 was used as a probe. Cloning
CJ

and sequencing of pMX-DEL coding joints was performed as described previously(276). Pvalues were calculated by Student’s t-test with Welsh’s correction for unequal variances.
Table 3. Oligos used to PCR amplify pMX-DEL

CJ

coding joints.

pC

GCACGAAGTCTTGAGACCT

IRES rev5

CTCGACTAAACACATGTAAAGC

IRES rev4

CCCTTGTTGAATACGCTTG

pA

CACAGGATCCCACGAAGTCTTGAGACCT

pB

ATCTGGATCCGTGCCGCCTTTGCAGGTGTATC

pD

AGACGGCAATATGGTGGA
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Relevant to Chapter 5 (as published(270))
-/-

Cell culture: Three independently derived RAG-2 (R.1, R.2 and R.3), three independently
-/-

-/-

-/-

derived Artemis (A.1, A.2 and A.3), two independently derived Artemis :Atm (AA.1 and AA.2)
-/-

and individual Scid and Ku-70 v-abl-transformed pre-B cell lines containing the EµBcl-2
-/-

transgene were generated. The three Artemis :I"B#-(N cells (A.3(N1, A.3(N2, A.3(N3) were
generated through standard transfection of the A.3 cells with a cDNA encoding an N-terminally
truncated I"B# (I"B#-(N)(288). Expression of the I"B#-(N protein in these cells was confirmed
by western blotting. STI571 treatments were carried out with 3µM STI571, as previously
described(107). The KU-55933 Atm inhibitor (Sigma) was used at 15µM, the BAY-11-7085
inhibitor (Calbiochem) was used at 20µM. Irradiation was carried out with a Cs

137

source, at

doses of either 0.5 or 4 Gy.
Western blotting and EMSA: Western blotting was carried out as described previously, using an
antibody to Pim-2 (Santa Cruz, 1D12)(276). The secondary reagent was horseradish peroxidase
(HRP)-conjugated goat anti-mouse IgG (Zymed). EMSAs were run as described previously, and
analyzed using a Li-Cor Odyssey Infrared scanner(289). Supershifts were performed using antip50 and anti-p65 antibodies (Santa Cruz, sc-114 X and sc-372 X).
Generation of the NF"B reporter: To generate pMSCV-NRE-GFP, the NF"B responsive
elements and TATA box from pNF-"B-Luc (Stratagene) were amplified using the following
oligonucleotides: pNRE-f: CCAAACTCATCAATGTATCTTATCATG; pNRE-r:
TACCAACAGTACCGGAATGC. This PCR product was cloned upstream of a cDNA encoding
enhanced GFP (Clontech) on the bottom strand of pMSCV containing an IRES upstream of the
Thy1.2 cDNA.
Gene expression profiling: All Abl pre-B cells were harvested 48 hours following treatment with
STI571. RNA was isolated using Qiagen RNeasy technology following the manufacturer’s
instructions. Gene expression analysis was conducted using Affymetrix Mouse Genome 2.0
GeneChip) arrays (Mouse 430 v2, Affymetrix, Santa Clara, CA). One µg of total RNA was
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amplified as directed in the Affymetrix One-Cycle cDNA Synthesis protocol. Fifteen µg of
o

amplified biotin-cRNAs were fragmented and hybridized to each array for 16 hours at 45 C in a
rotating hybridization oven using the Affymetrix Eukaryotic Target Hybridization Controls and
protocol. Array slides were stained with streptavidin/phycoerythrin utilizing a double-antibody
staining procedure and then washed using the EukGE-WS2v5 protocol of the Affymetrix Fluidics
Station FS450 for antibody amplification. Arrays were scanned in an Affymetrix Scanner 3000
and data was obtained using the GeneChip) Operating Software (GCOS; Version 1.2.0.037).
Data pre-processing, normalization, and error modeling was performed with the Rosetta Resolver
system (Version 6.0)(290).
-/-

-/-

In order to identify differentially expressed genes between the RAG-2 and Artemis Abl
pre-B cells, an error-weighted analysis of variance (ANOVA) utilizing the Benjamini Hochberg
false discovery rate was performed using Rosetta Resolver (www.rosettabio.com). At p-value $
0.05, this analysis yielded 1578 probe sets. Fold changes were generated in Resolver, based on
-/-

the ratio of each individual cell line relative to the average of the three RAG-2 cells with 100-fold
being the maximum change that Resolver can report. Of the 1578 probes found using the
ANOVA analysis, only those that had a fold-change % 2.0 (not including anti-correlated genes) in
all ratios for a given genotype were considered for further analysis. A Venn diagram of the
-/-

resulting ANOVA and fold-change data sets for each genotype comparison to RAG-2 was then
used to determine which expression changes were dependent on ATM and NF!B.
+

For gene expression profiling of primary developing B cells, B220 cells were isolated
-/-

-/-

from RAG-1 :IgHtg and Art :IgHtg bone marrow using Mouse Pan B (B220) Dynabeads from
Invitrogen. RNA was isolated using the Qiagen RNeasy Mini Kit. Microarrays were treated as
described above for the Abl pre-B cells. For the probe sets that were identified as being
differentially regulated in response to RAG DSBs in the abl-pre-B cells, we compared the average
-/-

-/-

expression in the two RAG-1 :IgHtg samples to the each of the two Art :IgHtg samples. The
probe sets that were not anti-correlated and changed *1.5-fold in the average of these
comparisons were included.
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Flow cytometry: Flow cytometric analyses were performed on a FACSCaliber (BD Biosciences)
with the normalized geometric mean fluorescence intensity (MFI) calculated as the difference
between the geometric mean fluorescence for the specific antibody and the isotype control. Flow
cytometric cell sorting was performed using a FACSVantage (BD Biosciences). Flow cytometric
analyses were performed using fluorescein isothiocyanate (FITC)-conjugated anti-CD45R/B220,
allophycocyanin (APC)-conjugated anti-IgM, phycoerythrin (PE)-conjugated anti-CD40, PEconjugated anti-CD62L, PE-conjugated anti-CD69, and the appropriate isotype controls (BD
Biosciences).
Analysis of pMX-DEL

CJ

rearrangement: PCR was carried out as described previously on 4-fold

dilutions of genomic DNA(107). IL-2 PCR primers were IMR42 and IMR43, and the product was
probed with IMR042-2, all of which have been described previously(107). Primer sequences for
pMX-DEL

CJ

are included above in Table 3.

RT-PCR gene expression analysis: Quantitative real-time PCR (RT-PCR) was performed using
a Stratagene Mx3000P real-time PCR machine and Platinum® SYBR® Green qPCR SuperMixUDG (Invitrogen). PCRs were carried out using the following program: 95°C, 30 sec; 55°C, 60
sec; 72°C, 30 sec; 40 cycles. Relative expression is calculated as the difference between betaactin expression (C1) and expression of the gene of interest (C2), using the following equation:
relative expression = 2

-(C1-C2)

. C is the PCR cycle where the product detection curve becomes

linear.
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Table 4. Primers used for RT-PCR.
Gene

Forward

Reverse

B-actin

AGTGTGACGTTGACATCCGTA

GCCAGAGCAGTAATCTCCTTCT

Bcl3

TCCAGAATAACATAGCCGCTGT

CATGCCAGGTGAATTGCAGTC

Cd40

GCTGGTCATTCCTGTCGTGAT

ACTGGAGCAGCGGTGTTATG

Cd69

TGGTGAACTGGAACATTGGA

CAGTGGAAGTTTGCCTCACA

IL12!

CTGTGCCTTGGTAGCATCTATG

GCAGAGTCTCGCCATTATGATTC

CD62L

TCTGGGAAATGGAACGATGACG

CCGTAATACCCTGCATCACAGAT

Pim-2

CGGGTGTGATACGCCTTCTTG

GCCCCTTCTCTGTGATATAGTCG

Swap70

ATGAGGGGGTTGAAAGACGAA

AGGTTATGGGAAAGGACCTTGA

Cd80

TCAAAAGAAGGAAAGAGGAACG

CGGAAGCAAAGCAGGTAATC
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Chapter 3

A Requirement for MRN for the
Proper Repair of RAG DNA DSBs
(reprinted with modification(276))
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ATM-deficient mice and humans have a predisposition to lymphoid tumor formation
including a subset resulting from the aberrant repair of RAG DNA DSBs during V(D)J
recombination(111). Interestingly, mice with combined deficiencies in checkpoint pathways and
DNA repair pathways develop lymphoid tumors while mice singly deficient in either do not exhibit
the same frequency or onset of tumor generation(150, 248, 250). In lymphocytes, ATM is known
to activate p53 in response to persistent DNA damage(73, 244). However, given the phenotype
of increased lymphoid tumor formation, it seemed likely that ATM, in addition to promoting
checkpoints and mediating apoptosis, might additionally play a direct role in repair of the RAG
DSB.
In this regard, we have demonstrated that ATM-deficient cells have a defect in the repair
of chromosomal RAG DNA DSBs with an increased frequency of aberrant hybrid joint (HJ)
formation during rearrangements that occur by inversion and a decrease in the efficiency of
coding joint (CJ) formation(107, 108). The unrepaired coding ends drift from one another in the
absence of ATM and are frequently resolved as translocations(107). Taken together (as
discussed later), these data suggest that ATM plays a role in the stabilization of the postcleavage complex thereby facilitating repair of the break and preventing unrepaired ends from
causing translocations. However, how ATM carries out this function is unknown. Most known
functions of ATM including the promotion of repair, however, require its kinase activity(73, 107).
Interestingly, mice and patients with deficiencies in components of the MRN complex
exhibit phenotypes similar to those deficient in ATM exhibiting a mild lymphopenia and sensitivity
to ionizing radiation(117, 291-298). The MRN complex is recognized as a sensor of DNA
damage as it has DNA binding abilities and functions to recruit ATM to the break site(70, 77, 90,
91, 104, 291, 299). ATM, in turn, phosphorylates all three components of the MRN complex(71,
300-302). Although the MRN complex is required for HR, until this point, no known role for the
MRN complex in NHEJ during V(D)J recombination has been clearly defined(75, 76, 277, 299,
303, 304). However, we considered the possibility that MRN might play a role downstream of
ATM in the repair of RAG DNA DSBs functioning to maintain un-repaired coding ends within the
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post-cleavage complex via its unique DNA end alignment and tethering abilities(75, 76, 78, 81,
83, 86). To begin to address this hypothesis, we analyzed the repair of RAG DNA DSBs in MRNdeficient v-abl transformed pre-B cell lines and mice.
Generation of MRN-deficient v-abl transformed pre-B cell lines.
Mice with homozygous-null mutations at the Mre11, Nbs1, or Rad50 loci all exhibit early
embryonic lethality(291, 296-298); thus, we were unable to generate Abl pre-B cells completely
deficient in any of these proteins. However, we were able to generate Abl pre-B cell lines from
mice homozygous for hypomorphic Mre11 (Mre11
Mre11

ATLD1

ATLD1

m

) and Nbs1 (Nbs1 ) alleles. The

allele has a gene-targeted point mutation that generates a premature stop codon,

resulting in a C-terminal truncation of the Mre11 protein, mimicking a mutation in that causes
ataxia-telangiectasia–like disease (ATLD)(294). The Nbs

m/m

mice were generated by replacing
m

exons 2 and 3 of the Nbs1 allele with a neomycin resistance gene generating the Nbs1 allele,
which encodes a truncated Nbs1 protein(292). Importantly, the three MRN components are
thought to function only as a holocomplex; thus, deficiencies in any one component would impact
the function of the entire complex(77). The Mre

ATLD1/ ATLD1

and the Nbs

m/m

mice may be generally
-/-

referred to here as MRN-deficient. We have additionally developed WT and Atm Abl pre-B cell
lines(107).
MRN-deficient cells have defects during rearrangement by inversion.
Atm-deficient pre-B cells have defects in repair during rearrangement by inversion with a
decrease in overall recombination frequency and an increased formation of aberrant hybrid joints
detectable in chromosomal recombination substrates as well as the endogenous IgL-! and TCR"
and # loci(107, 108). Given that MRN-deficient mice and patients have similar phenotypes as
those deficient in ATM, we decided to assay for defects in rearrangement by inversion in the
MRN-deficient cells. To this end, we introduced pMX-INV into the MRN-deficient Abl pre-B cells
(Mre

ATLD1/ATLD1

Abl pre-B and Nbs

m/m

Abl pre-B) and assayed for recombination by Southern

blotting. We purified populations containing pMX-INV integrants by sorting for the expression of
human CD4 that is also encoded by the retrovirus. These bulk populations contain numerous
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pMX-INV integrants at broadly heterogeneous locations thus eliminating potential contributions of
integration effect on recombination. We also isolated clones from these bulk populations by
limiting dilution that each contained a single integrant of the retroviral substrate. Work presented
here is done on the clonal populations though we detected no difference in results of analyses in
these clones and the original bulk populations.
We treated the Abl pre-B cells with STI to induce RAG expression, and this led to
rearrangement of pMX-INV in all cell lines assayed. Analysis of EcoRV/Nco1-digested genomic
DNA from WT Abl pre-B cells reveals a decrease in the 2 kb band representing un-rearranged
substrate and an accumulation of a 3 kb species representing a normal coding joint (CJ) upon
STI treatment (Figure 2a-b). In ATM-deficient Abl pre-B cells, we note an accumulation of CJs,
but we also detect a 4 kb species representing an aberrant hybrid joint (HJ) following STI
treatment (Figure 2a-b). This is in agreement with previously published work in the lab(107). In
the MRN-deficient cells, we detect a similar accumulation of both HJs and CJs following STI
treatment. Thus, MRN-deficient Abl pre-B cells also have a defect in repair by inversion when
using recombination substrates with an increased production of aberrant hybrid joints (Figure 2b).
In ATM-deficient mice, we can also detect defects in rearrangement by inversion in vivo
at the endogenous TCR# and TCR" loci as well as the endogenous IgL! locus by PCR(107,
108). Specifically, we detected both CJ and aberrant HJ formation for rearrangements that occur
between V#5 and DJ#1 and V"14 and DJ"2.7 in thymic DNA preparations (Figure 3a) and
-/-

between V!6-23 and J!1 in splenic DNA samples (Figure 3b) from Atm mice(107, 108). We
isolated thymic and splenic DNA from the Mre

ATLD1/ATLD1

and Nbs

m/m

mice and used the same

PCR-strategy to assay for in vivo defects in rearrangement by inversion. In all cases, we detect
-/-

aberrant hybrid joints in the MRN-deficient cells that are also observed in Atm cells but not
observed in WT cells (Figure 3). Thus, we detect aberrant hybrid joint formation during the
rearrangement of pMX-INV in our Abl pre-B cell lines but also in both primary B and T cells in the
MRN-deficient mice.
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Efficiency of CJ formation is decreased in MRN-deficient cells.
ATM-deficient cells also have a deficiency in CJ formation, and unrepaired coding ends
are readily detectable in ATM-deficient cells undergoing V(D)J recombination at chromosomally
integrated substrates as well as the endogenous antigen receptor loci(107, 108). We decided to
assay for CE accumulation in the MRN-deficient cells as well. Whereas no coding end
intermediates are detected in genomic DNA isolated from WT Abl pre-B cells (WT:INV) upon STI
treatment, these reaction intermediates are readily detectable in samples from Atm
cells and in Mre

ATLD/ATLD

and Nbs

m/m

-/-

Abl pre-B

Abl pre-B cells, although to a lesser extent (Figure 4). These

coding ends are visualized by a 2.2 kb hybridizing fragment in EcoRV-digested genomic samples
from pMX-INV rearrangement (Figure 2a and 4). Next, we wished to determine whether the
MRN-deficient mice also exhibited defects in coding joint formation in vivo.
We have previously demonstrated that ATM-deficient mice have a defect in thymocyte
development, more specifically a decrease in thymocyte counts with the most significant
decrease in the number of CD4+ and CD8+ (single positive SP) thymocytes (Figure 5a)(108).
Furthermore, we have demonstrated a decreased number of pre-selection $"-TCR expressing
-/-

(TCR-" intermediate) CD4+CD8+ (double positive, DP) thymocytes in Atm mice(108). This
defect is visualized by FACS analysis by staining for the surface expression of TCR"; compared
-/-

to wild-type mice, Atm mice have decreased numbers of cells expressing intermediate and high
levels of TCR" (48% as compared to 9.5% of DP thymocytes) population (Figure 5b)(108). In
characterizing the Nbs

m/m

mice, we note a similar, though less severe, decrease in total

thymocyte number with the most significant decreases again in the numbers of CD4+ and CD8+
SP thymocytes (Figure 5a). Furthermore, we note the same block at the DP stage with only 21%
of DP cells expressing intermediate levels of TCR" (Figure 5b). This suggested to us that MRNdeficient mice likely have a similar defect in thymocyte development that we see in the ATMdeficient mice. Cells at the DP stage of thymocyte development are actively assembling their
TCR$ genes in an attempt to generate a functional $"-TCR. Production of a successful TCR,
that is, one that binds peptide-MHC with sufficient affinity to mediate positive selection, but does
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not afford self-reactivity, is a rare occurrence(108). As such, it is rather advantageous that the
TCR$ allele is arranged such that it can undergo multiple rounds of recombination. Specifically,
the locus has over 100 V gene segments and 61 J gene segments all of which undergo
rearrangement by deletion. The initial rearrangements involve the most 3’ V segments and most
5’ J gene segments. If coding joint formation during this first attempt at rearrangement is not
successful, additional rounds of rearrangement are possible utilizing an upstream V and a
downstream J segment. The requirement for multiple rearrangements at this locus might explain
the particular block in thymocyte development seen in the ATM- and MRN-deficient mice(108).
Increasing the number of breaks that must be repaired to generate a functional antigen receptor
would increase the chances that both alleles would be inactivated due to the aberrant repair of
RAG DNA DSBs, and as a result, no $"-TCR expressing DP thymocyte would develop. Thus,
defects in coding joint efficiency might be manifested as a specific decrease in the number of $"TCR expressing DP thymocytes(108).
Similar to the endogenous kappa locus, the noted complexity of the endogenous TCR$
locus prevents us from quantitatively determining the extent of a defect in CJ formation by
Southern blotting. To detect a possible defect in CJ formation at the TCR$ locus in the ATM- and
MRN-deficient mice, we generated mice with a modified TCR$ allele containing two rather than
61 J$ gene segments(108). While any of the 100 V gene segments can be utilized, all TCR$
rearrangements must utilize one of two J$ gene segments, enabling us to detect the
accumulation of unrepaired coding ends (Figure 6a)(108). To assay for the accumulation of
unrepaired ends during recombination of this modified TCR$ allele in ATM- and MRN-deficient
mice, we developed WT:TCR-!

sJ/sJ

"/"

, Atm :TCR!

sJ/sJ

, Mre

A/A

:TCR$

SJ/SJ

and Nbs

m/m

:TCR!

SJ/SJ

mice, isolated thymic DNA, and performed Southern blot analyses as diagrammed in Figure 6a
(Figure 6a). Southern blotting revealed a smattering of non-germline bands that are indicative of
successful V$ to J$ rearrangement in these thymocytes (Figure 6b). However, in contrast to
WT:TCR!

SJ/SJ

"/"

cells, the Atm :TCR-!

sJ/sJ

, Nbs1

m/m
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:TCR-!

sJ/sJ

, and Mre11

ATLD1/ATLD1

:TCR!

sJ/sJ

thymocytes each have a distinct 5.9-kb band that represents unrepaired J!56 coding ends(108).
As observed in the Abl pre-B cells, however, the phenotype of the MRN-deficient cells was less
-/-

-/-

severe than that of Atm cells, as we detect more J$-56 CEs in the Atm :TCR-!
than either the Nbs1

m/m

:TCR-!

sJ/sJ

or the Mre11

ATLD1/ATLD1

:TCR!

sJ/sJ

SJ/SJ

thymocytes

thymocytes. Importantly,

equivalent levels of DNA were ran on the Southern as shown by the loading control (Figure 6b).
Based on these data, we believe that the block in thymocyte development seen in the Nbsdeficient mice (Figure 5) is a result of a decrease in efficiency of CJ formation during
rearrangement of the TCR$ locus as previously demonstrated for ATM-deficient mice(108).
MRN-deficiency does not lead to global defects in ATM activation.
The observed defect in repair of RAG DNA DSBs in the MRN-deficient cells and mice is
remarkably similar to that we described for ATM-deficient cells(107, 108). Given the role for MRN
in recruiting ATM to the site of a DNA DSB and the ability of MRN to augment ATM activity in
vitro, it was important to demonstrate that the phenotype of MRN-deficient cells was not simply
due to decreased ATM-activity in these cells(77). We decided to assay for the phosphorylation of
known substrates of ATM in response to DNA damage to determine whether or not ATM was
capable of being activated in the absence of a functional MRN complex during V(D)J
recombination.
We reasoned that the assays available to detect ATM activity would not be sensitive
enough to detect signaling events following the induction of a small number of RAG DNA DSBs
that are made and repaired quickly as they are in WT cells. Thus, to better assess signaling
downstream of RAG DNA DSBs, we utilized cells deficient in components of the NHEJ-pathway.
-/-

Specifically, we used Artemis Abl pre-B cells. Artemis is the endonuclease required to open the
hairpin-sealed coding ends during V(D)J recombination, and in its absence, coding ends
accumulate unrepaired(150, 158, 161). As mentioned above, in our Abl pre-B cells,
rearrangement at the endogenous IgL! locus occurs upon STI treatment. Cleavage at the
endogenous kappa locus in NHEJ-deficient cells generates four distinct J! coding ends that are
readily detectable by Southern blotting providing evidence that RAG DNA DSBs are being made
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but not repaired in these cells (Figure 7). To assess the status of ATM activity in the absence of
-/-

-/-

-/-

a functional MRN-complex, we generated Abl pre-B cells from Artemis , Artemis :Atm , Artemis
/-

:Mre

ATLD1/ATLD1

-/-

, and Artemis :Nbs

m/m

-

mice. Differences in the number of unrepaired coding

ends could potentially lead to changes in the activation of ATM. Thus, it was important to
demonstrate that all cells used in these assays had similar accumulation of unrepaired RAG DNA
DSBs upon STI treatment as assayed by Southern blotting for J! coding ends (Figure 9a).
ATM, in response to DNA damage, phosphorylates a large number of proteins including
histone variant H2AX and Kap1(71, 206, 305, 306). Furthermore, it is known to lead to NF"B
activation (as further discussed in Chapter 5)(263, 270). We chose to assess ATM activity in the
MRN-deficient cells using these particular substrates and ATM-dependent functions as readouts.
-/-

In Artemis Abl pre-B cells, we detect RAG dependent phosphorylation of H2AX as assayed by
immunostaining of these cells with an antibody specific to the phosphorylated form of H2AX (%-/-

H2AX). We detect %-H2AX foci formation in 60% of the Artemis cells at 24 hours of STI
-/-

-/-

treatment and less than 5% of the Artemis :Atm cells (Figure 8a); thus, the phosphorylation of
H2AX in response to persistent Rag DNA DSBs is predominantly mediated by ATM. We detect
-/-

levels of H2AX phosphorylation in the Artemis :Mre

ATLD1/ATLD1

-/-

and Artemis :Nbs

m/m

cells similar to

those deficient in Artemis alone; furthermore, incubating these cells with a kinase inhibitor of ATM
decreases %-H2AX foci formation demonstrating that ATM is active in these cells (Figure 9b). We
also detect Kap1 phosphorylation by Western blotting in response to RAG DNA DSBs in Artemis
-/-

-/-

-/-

but not Artemis :Atm cells (Figure 8b). Neither Artemis :Mre

ATLD1/ATLD1

-/-

nor Artemis :Nbs

-/-

m/m

exhibit a significant defect in Kap1 phosphorylation following RAG DNA DSBs (Figure 9c).
Finally, we are able to detect activation of NF"B in response to RAG DNA DSBs in STI-treated
-/-

Artemis (as discussed in Chapter 5) Abl pre-B cells by EMSA which detects translocation of the
active p50:p65 NF#B heterodimer to the nucleus (Figure 8c). NF"B similarly readily translocates
-/-

to the nucleus following RAG DNA DSBs in the Artemis :Mre
-/-

ATLD1/ATLD1

-/-

and Artemis :Nbs

m/m

cells

-/-

but not in the Artemis :Atm cells (Figure 9D and Figure 8c). Each of these assays suggest that
ATM is being activated in the absence of the MRN complex. Moreover, the addition of the ATM51
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inhibitor to the MRN-deficient cells increases the severity of the joining phenotype discussed
above leading to an increase in the amount of unrepaired coding ends and further demonstrating
that ATM is active in these MRN-deficient cells (Figure 10). Thus, we conclude that ATM activity
is not grossly defective in the absence of a fully functional MRN complex.
Conclusion
Here, we demonstrate that MRN-deficient cells exhibit a defect in repair by NHEJ during
V(D)J recombination that is similar to the repair defect previously described for ATM with an
increase in aberrant hybrid joint formation during rearrangement by inversion and a decrease in
the efficiency of coding joint formation(107, 108). While we cannot rule out isolated defects in the
phosphorylation of specific targets of ATM that might affect repair, we demonstrate that ATM is
activated in these cells. These data suggest, then, that the MRN complex might have important
roles downstream of ATM in these cells.
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a.

+STI571

v-Abl
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V

J

V

J
-STI571

J

V J

b.
- STI
38% G1
33% S

+ STI
98% G1
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DNA Content

Figure 1. Assaying the repair of RAG DNA DSBs with Abl pre-B cells. (a) Schematic demonstrating the creation of Abl pre-B cell lines. Infection of BM samples with a retrovirus encoding the
v-abl kinase transforms a pre-B cell population causing them to cycle rapidly. Upon STI treatment,
these cells arrest in G1, express the Rag proteins and begin to undergo V(D)J recombination (as
indicated by the deletion of the intervening sequence between the V and J gene segments and
their subsequent joining). (b) FACS analysis of Abl pre-B cells before and after STI treatment
demonstrating G1-arrest. Cells were either treated or not treated with STI571 for 48 hours and
incubated with Hoechst dye to assay for DNA content. % of cells in G1 and S phase are indicated.
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Figure 2. ATM- and MRN-deficient Abl pre-B cells have defects in rearrangement by
inversion. (a) Schematic of the pMX-INV retroviral recombination substrate, rearrangement intermediates, and products. The retroviral packaging signal (ψ), GFP cDNA, and
IRES-human CD4 (I-hCD4) cassette are labeled. The viral LTRs (open arrows) and the
RSSs (open triangles) are shown. The non-rearranged (NR) pMX-INV and pMX-INV
coding ends (CE), coding joint (CJ) and hybrid joint (HJ) are indicated. The relative
position the C4 probe (bar) and EcoRV (E) and NcoI (N) endonuclease restriction sites are
shown as are the expected sizes of hybridizing fragments. (b) Southern blot analysis of
EcoRV/NcoI digested genomic DNA from wild type (WT), Atm-/-, Mre11ATLD1/ATLD1 (Mre11A/A)
and Nbs1m/m abl pre-B cell clones containing the pMX-INV (INV) retroviral recombination
substrate that had been treated with STI571 for the indicated time (hours, h). The abl pre-B
cell clones analyzed each have single pMX-INV integrants and were derived from parental
lines as indicated (parental line – clone number). Expected sizes for bands generated by
non-rearranged pMX-INV (NR), coding joints (CJ), hybrid joints (HJ) and coding ends (CE)
are indicated.
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a.

Nbs1m/m
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Figure 3. Defects in rearrangement by inversion at endogenous antigen receptor loci
in ATM- and MRN-deficient mice. (a) PCR analysis of Vδ5DδJδ1 coding joints (Vδ5 CJ),
Vδ5Dδ1 hybrid joints (Vδ5 HJ), Vβ14DβJβ2.7 coding joints (Vβ14 CJ) and Vβ14Dβ2 hybrid
joints (Vβ14 HJ) in wild type (WT), Atm-/-, Nbs1m/m and Mre11ATLD1/ATLD1 thymocytes. (b) PCR
analysis of Vκ6-23 to Jκ1 coding joints (Vκ6-23 CJ) and hybrids joints (Vκ6-23 HJ) in WT,
Atm-/-, Nbs1m/m and Mre11ATLD1/ATLD1 splenocytes. The IL-2 gene PCR is shown as a DNA
quantity control.
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Figure 4. Defects in CJ formation in ATM- and MRN-deficient Abl pre-B cells. EcoRV
digested genomic DNA from wild type (WT), Atm-/-, Mre11ATLD1/ATLD1 (Mre11A/A) and Nbs1m/m
abl pre-B cell clones containing the pMX-INV (INV) retroviral recombination substrate that
had been treated with STI571 for the indicated time (hours, h). The abl pre-B cell clones
analyzed each have single pMX-INV integrants and were derived from parental lines as
indicated (parental line – clone number). Expected sizes for bands generated by nonrearranged pMX-INV (NR), coding joints (CJ), hybrid joints (HJ) and coding ends (CE) are
indicated.
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Figure 5. Block in thymocyte development in Atm-/- and Nbsm/m mice. (a) Number of
thymocytes in Atm-/- (n=16) and Nbs1m/m (n=9) mice at the indicated stages of development expressed as a percentage of the number of thymocytes found at each stage in
wild type Atm+/+ (n=12) and Nbs1+/+ (n=3) littermate controls. Calculations were done
using mean numbers of thymocytes from mice of each genotype and propagated error.
DN: CD4-CD8- (double negative); DP: CD4+CD8+ (double positive); SP: single positive.
+
(b) Representative flow cytometric analysis of
CD8 + double
β
m/m
-/positive thymocytes from wild type, Nbs1 and Atm mice. Numbers indicate percentage of DP cells that are
βint.
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58

Helmink & Bredemeyer et al. JEM--2009.

a.

b.
3 kb
E

S
1

2

4

GL

5
JκIII probe

Rag-/-

2 kb
S
1

2

5

4

Jκ1 CE

0 48 96

Atm-/- :
Artemis-/- Artemis-/0

48 96

0 48 96 STI571 (h)

1.5 kb
S
2

4

Jκ2 CE

5
0.8 kb
S

4

5

Jκ4 CE

3 kb

GL

2 kb

Jκ1 CE

1.5 kb

Jκ2 CE

0.5 kb
S
5

Jκ5 CE

Figure 7. Accumulation of unrepaired coding ends at the endogenous kappa
locus in NHEJ-deficient Abl pre-B cells. (a) Schematic of Southern blotting strategy
for analysis of unrepaired coding ends generated in NHEJ-deficient cells at the endogenous IgL-kappa locus showing relative positions of the restriction sites (EcoRI and
SacI) and the JκIII probe (black bar) used for analysis. Expected sizes for coding ends
generated by cleavage at each of the 4 Jκ gene segments are shown. (b) Southern
blot analysis showing Jκ1 and Jκ2 coding ends (CE) generated in Rag2-/-, Artemis-/- and
Artemis-/-:Atm-/- abl pre-B cells treated with STI571 for the indicated times (hours, h).
SacI and EcoRI digested genomic DNA
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κ
corresponding to the IgLκ locus in the germline configuration (GL) and Jκ1 and Jκ2
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Figure 8. Evidence of ATM activation in NHEJ-deficient Abl pre-B cells. (a) Quantification of
γ−H2AX nuclear foci following 24 hours of STI571 treatment. Shown is the percentage of cells
containing 1, 2, or 3-5 foci γ−H2AX foci. Total number of cells analyzed for each genotype was 500
and p-values were calculated using a two-tailed Fischer’s Exact test. Note that γ−H2AX foci were not
detected in any of the STI571-treated Rag-/- abl pre-B cells. (b) Western blot analysis of phosphoα
α
treated cells shown. (c) NFκB EMSA of
nuclear lysates from Rag2-/-, Artemis-/- and Artemis-/-:Atm-/- abl pre-B cells treated with STI571 for the
indicated number of hours. NFY EMSA is shown as a control.
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Figure 9. ATM is activated in MRN-deficient Abl pre-B cells. (a) Southern blot analysis
showing Jκ1 and Jκ2 coding ends (CE) generated in Artemis-/-, Nbs1m/m:Artemis-/-, and
Artemis-/-:MreA/A abl pre-B cells treated with STI571 for the indicated times (hours, h). The
bands corresponding to the IgLκ locus in the germline configuration (GL) and Jκ1 and Jκ2
CEs are indicated. (b) Percentage of Artemis-/- , Nbs1m/m:Artemis-/-, and
γ
Mre11ATLD1/ATLD1:Artemis-/treatment with STI571 for 24 hours and either DMSO (-) or the Atm inhibitor (iAtm)
KU-55933 (+). Total number of cells analyzed for each genotype was 500 and p-values
were calculated using a two-tailed Fischer’s Exact test. (c) Western blot analysis for
α
α
Artemis-/-, Nbs1m/m:Artemis-/-, and
ATLD1/ATLD1
-/Mre11
:Artemis abl pre-B cell lines treated with STI571 for 96 hours and either
DMSO (-) or the Atm inhibitor (iAtm) KU-55933 (+). (d)
κ
of nuclear lysates
from Artemis-/-, Atm-/-: Artemis-/-, and two independent Nbs1m/m :Artemis-/- and
Mre11ATLD1/ATLD1:Artemis-/- abl pre-B cell lines treated with STI571 for 36 hours. NFY EMSA
is shown as a control.
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Figure 10. ATM functions during repair of Rag DNA DSBs in MRN-deficient cells.
Atm inhibition in MRN-deficient cells leads to increased coding end accumulation.
Southern blot analysis of EcoRV digested genomic DNA from wild type, Atm-/-, and two
Mre11ATLD1/ATLD1 (labeled as Mre11A/A) and Nbs1m/m abl pre-B clones containing pMX-INV.
Cells were treated with STI571 for the indicated time (hours, h) and either DMSO (-) or
the ATM inhibitor (iAtm) KU-55933 (+). Expected sizes for bands generated by nonrearranged substrate (NR), coding joints (CJ), hybrid joints (HJ) and coding ends (CE)
are indicated.
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Chapter 4

ATM Regulates the Processing of Persistent Coding
Ends by Phosphorylating Histone H2AX
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Previous work has demonstrated that ATM plays a critical role in the repair of RAGmediated DNA DSBs by maintaining unrepaired ends in a post-cleavage complex thereby
promoting their efficient joining, suppressing hybrid joint formation and preventing
translocations(107). Furthermore, we show here that ATM may perform these functions via the
phosphorylation of downstream substrates such as the MRN-complex. Interestingly, ATM also
phosphorylates histone H2AX at the site of a RAG DNA DSB; we detect phosphorylation of H2AX
in chromatin flanking the RAG DNA DSB up to 200 kb from the site of the break(211). The
phosphorylation of H2AX is required for the accumulation of repair and signaling factors at the
site of a break. Furthermore, H2AX-deficient mice have a mild defect in lymphocyte development
and an increase in lymphoid tumors involving antigen receptor loci. Thus, we considered the
possibility that H2AX might also play a critical role downstream of ATM in the repair of RAG DNA
DSBs. However, in contrast to MRN-deficient cells, we and others have shown that there is no
overt defect in V(D)J recombination in H2AX-deficient cells(233, 235, 243).
Millions of RAG DNA DSBs are generated each day. Although most RAG DNA DSBs are
repaired efficiently, if even a fraction of those persist unrepaired, it could have significant
deleterious effects on genomic stability. We reasoned that ATM might have additional roles in the
response to or repair of DSBs that persist for some period of time. We reasoned that ATM might
function in ensuring that the cells harboring these persistent breaks activate p53-mediated
apoptosis rather than accessing alternative repair pathways that would lead to aberrant resolution
and result in genomic instability. Furthermore, the substrates downstream of ATM that might
carry out these functions might differ from those that are required for repair during V(D)J
-/-

recombination. H2AX mice have a high degree of genomic instability that is much increased in
the absence of p53(234, 236); thus H2AX is a putative candidate for enabling this ATMdependent effector function.
We considered the possibility that the phosphorylation of H2AX in response to persistent
RAG DNA DSBs is required to prevent persistent coding ends from accessing aberrant repair
pathways. As mentioned in the introduction, a key determinant in repair pathway choice is
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whether and how the DNA ends are resected. Ends that are resected even a few base pairs are
poor substrates for NHEJ, but end resection is required for homology mediated repair(140-142,
176). Therefore, we designed experiments to analyze the processing of persistent RAG DNA
DSBs in the absence of H2AX.
Determining the outcome of unrepaired breaks in the absence of H2AX.
To determine whether H2AX affects the processing of persistent RAG DNA DSBs, we
again made use of our Abl pre-B cell lines deficient in components of the NHEJ pathway;
specifically, we generated cell lines deficient in Artemis or Artemis and H2AX and additionally
lines deficient in DNA Ligase IV (Lig IV) or Ligase IV and H2AX and isolated clones containing
single integrants of the pMX-DEL
-/-

:H2AX :DEL

CJ

-/-

CJ

-/-

CJ

retroviral recombination substrate (Artemis :DEL , Artemis

CJ

-/-

-/-

-/-

CJ

and Lig IV :DEL , Lig IV :H2AX :DEL ). Artemis is the endonuclease required

to open hairpin-sealed coding end intermediates produced by RAG cleavage, while Ligase IV is
the DNA ligase responsible for joining both SEs and CEs to form the SJ and CJ respectively.
Deficiencies in Artemis lead to the accumulation of hairpin-sealed coding ends while deficiencies
in Ligase4 lead to the accumulation of unrepaired SEs as well as hairpin-open coding ends.
pMX-DEL

CJ

differs from pMX-INV in the orientation of the RSSs such that rearrangement occurs

by deletion of the intervening sequence with the coding joint being formed within the
chromosomal context (Figure 2a and Figure 11a).
STI induction in WT:DEL

CJ

CJ

cells leads to the robust rearrangement of pMX-DEL ; this is

evidenced by the presence of a 4 kb band on Southern blot, the size expected for a normal CJ
(Figure 11). STI induction in the NHEJ-deficient cells leads to the accumulation of un-repaired
-/-

coding ends with variable but low levels of CJ formation in the Artemis :DEL

CJ

Abl pre-B cells but

-/-

no accumulation of CJs in the LigIV Abl pre-B cells. The unrepaired coding ends in Artemis
:DEL

CJ

-/-

and Lig IV :DEL

CJ

-/-

Abl pre-B cells are homogenous in size as depicted by the distinct 2.2

kb band detectable by Southern blotting (Figure 11). In striking contrast, coding ends in Artemis
-/-

:H2AX :DEL

CJ

-/-

-/-

and Lig IV :H2AX :DEL

CJ

Abl pre-B cells are heterogenous in size with many
-/-

significantly smaller (>1kb) than those in Artemis :DEL
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CJ

-/-

and Lig IV :DEL

CJ

Abl pre-B cells

-/-

(Figure 11b and 11c). This demonstrates that unrepaired coding ends are aberrantly processed
in the absence of H2AX. It additionally suggests that H2AX-deficiency permits hairpin-sealed
coding ends to be opened and resected in an Artemis-independent manner, as we note
-/-

-/-

degradation of the unrepaired coding ends in the Artemis :H2AX :DEL
-/-

the Artemis :DEL

CJ

CJ

Abl pre-B cells but not

Abl pre-B cells.

Hairpin-sealed ends are aberrantly opened in the absence of H2AX.
-/-

-/-

To determine whether the hairpin-sealed coding ends in Artemis :H2AX :DEL

CJ

Abl pre-

B cells are being opened aberrantly, we needed to develop assays whereby hairpin-sealed
coding ends can be distinguished from open coding ends. We developed two techniques,
Southern blotting after denaturation and TdT-assisted PCR, that have enabled us to differentiate
between these two recombination intermediates.
-/-

-/-

First, we decided to analyze DNA isolated from STI-treated Artemis :H2AX :DEL

CJ

Abl

pre-B cells by Southern blotting following denaturation. Denaturing an open hairpin forms two
single-stranded fragments that migrate at a lighter molecular weight than the non-denatured
-/-

duplex as evidenced by analysis of Lig IV Abl pre-B cells, where hairpin-sealed coding ends are
efficiently opened by the Artemis endonuclease (Figure 12a and b). In contrast, a denatured
closed hairpin migrates similarly to the non-denatured duplex as evidenced by analysis of
-/-

Artemis :DEL

CJ

Abl pre-B cells where coding ends are predominantly hairpin-sealed (Figure 12a
-/-

-/-

and b). Strikingly, denaturation of coding ends in Artemis :H2AX :DEL

CJ

Abl pre-B cells

revealed that 35-78% are open at early time-points after RAG induction (Figure 12a and b).
A second method developed in our lab to differentiate between hairpin-sealed and open
coding ends is TdT-assisted PCR. This technique utilizes an enzyme, terminal deoxynucleotidyl
transferase (TdT), an enzyme that adds nucleotides in a non-templated fashion to free 3’-hydroxyl
groups but is unable to access hairpin-sealed coding ends. Briefly, we incubate genomic DNA
with dATP and TdT; TdT then adds a string of adenosine molecules only to DNA ends with
opened hairpins. This labeling step is followed by PCR using oligo-dT and substrate-specific
primers as depicted in Figure 13a. Utilizing TdT PCR, we detect a robust Artemis-independent
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-/-

-/-

opening of the hairpin-sealed DNA ends in the Artemis :H2AX :DEL
-/-

CJ

Abl pre-B cells (Figure

-/-

13c). We conclude that hairpin-sealed coding ends in Artemis :H2AX Abl pre-B cells are
efficiently opened and resected by a nucleolytic pathway that cannot efficiently access these DNA
-/-

ends in Artemis :DEL

CJ

Abl pre-B cells.

H2AX prevents end processing in primary pre-B cell cultures.
To eliminate the possibility that this requirement for H2AX in regulating DNA end
processing is unique to our Abl pre-B cell lines, we decided to perform the same analyses in
-/-

primary pre-B cell cultures. Bone marrow cultures were generated from Artemis and Artemis

-/-

-/-

:H2AX mice. Developing B lymphocytes in NHEJ-deficient mice normally do not progress to the
pre-B cell stage as they are unable to undergo V(D)J recombination to form a heavy chain and a
functional pre-B cell receptor. However, we introduced an IgH transgene (IgHtg) that drives the
pro-B to pre-B transition. Thus, these cells are arrested at a pre-B cell stage where they will
attempt rearrangement of the endogenous kappa locus. These cultures proliferate in the
presence of IL-7, but upon withdrawal of IL-7, these cells arrest in G1 of the cell cycle, induce
RAG and undergo recombination at the IgL! locus (Figure 14b). In the NHEJ-deficient cells, just
as we see in the Abl-pre B cells, induction of V(D)J recombination leads to the accumulation of
unrepaired (J!) coding ends (Figure 14).
Withdrawal of IL-7 and the induction of RAG cleavage generates 4 distinct J! coding
-/-

ends that are readily detectable by Southern blotting in the Artemis :IgHtg pre-B cells (Figure 14a
-/-

-/-

-/-

and b). In Artemis : H2AX IgHtg pre-B cells as compared to Artemis :IgHtg pre-B cells, we
note that the ends are partially degraded as indicated by products of sizes intermediate to each of
the four distinct coding end bands (Figure 15a). TdT-assisted PCR using primers downstream of
J!2 corroborates this observation. We detect two bands corresponding to open coding ends
-/-

-/-

produced from cleavage at either J!1 or J!2 in Artemis :H2AX :IgHtg pre-B cells but not
-/-

Artemis :IgHtg pre-B cells (Figure 15b). Furthermore, we detect PCR products at sizes between
the expected bands of J!1 and J!2 and some smaller than the product expected for cleavage at
J!2 demonstrating that the hairpins are open and the ends are resected in the absence of H2AX
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(Figure 15b). Thus, we note a requirement for H2AX in preventing hairpin-opening and resection
-/-

-/-

of the unrepaired coding ends in Artemis :H2AX in our Abl pre-B cell lines and in primary pre-B
cell cultures.
The phosphorylation of H2AX and Mdc1 is required to prevent aberrant end processing.
During DNA damage responses, most H2AX-depndent processes are linked to its
phosphorylation on serine 139 (forming "-H2AX) in chromatin flanking DNA DSBs including those
generated by RAG. To determine whether the phosphorylation of H2AX is required to prevent the
-/-

opening and resection of persistent unrepaired coding ends, we reconstituted the Lig IV :H2AX
:DEL

CJ

-/-

-/-

and Artemis :H2AX :DEL

CJ

-/-

Abl pre-B cells with either WT H2AX or H2AX mutated at

Ser139 (S139A), the site known to be phosphorylated by ATM in response to DNA damage. We
verified the expression of H2AX and equivalent levels of WT and H2AX

S139A

mutants in these cells

by Western blotting (Figure 16). We used an empty retrovirus as a control. We find that the
-/-

-/-

reconstitution of Lig IV :H2AX :DEL

CJ

-/-

-/-

or Artemis :H2AX :DEL

CJ

Abl pre-B cells with wild type

H2AX prevents coding end resection in these cells as we no longer see the degradation of coding
ends by Southern blot that we see in the control cells (Figure 16). These ends are now distinct
-/-

bands similar to what was observed in the Lig IV : DEL

CJ

-/-

or Artemis :DEL

CJ

Abl pre-B cells

demonstrating that the end degradation we see is due to H2AX deficiency (Figure 11). However,
reconstitution with the serine 139 to alanine mutant of H2AX (H2AX

S139A

) does not prevent this

resection (Figure 16). Thus, the function of H2AX in modulating DNA end resection in G1-phase
lymphocytes relies on the formation of "-H2AX.
Several DNA damage response proteins associate with "-H2AX in chromatin flanking
DNA breaks including Mdc1, which directly binds "-H2AX through its BRCT domain, and
functions to amplify DNA damage responses. To determine whether Mdc1 is also required to
prevent hairpin-sealed coding ends from being opened and resected in an Artemis-independent
-/-

-/-

fashion, we developed Artemis :MDC-1 :DEL

CJ

Abl pre-B cells. Upon STI treatment and the
-/-

-/-

induction of RAG, we note that, similar to what was observed in the Artemis :H2AX :DEL
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CJ

Abl

-/-

-/-

pre-B cells, the unrepaired hairpin-sealed coding ends in the Artemis :MDC-1 :DEL

CJ

Abl pre-B

cells are degraded (Figure 17).
ATM activates antagonistic pathways that regulate end processing.
As ATM is required to generate "-H2AX in chromatin flanking RAG DSBs and MDC-1
amplifies DNA damage response signals, in part, by recruiting ATM to the site of a DSB, we
reasoned that ATM would be required to prevent the nucleolytic resection of coding ends in G1-/-

phase cells. To test this hypothesis, we treated the Artemis :DEL

CJ

Abl pre-B cells with an

inhibitor of ATM kinase activity (KU-55933). Interestingly, however, inhibition of ATM kinase
-/-

activity did not lead to the resection of un-repaired coding ends in Artemis :DEL

CJ

Abl pre-B cells

(Figure 18a). This seemed at odds with our hypothesis as H2AX should not be phosphorylated in
these cells and therefore, based on the evidence above, we would have predicted to see
degradation of the unrepaired coding ends. We verified that the kinase inhibitor was working by
assaying for NF!B activation in these cells as described in Chapter 3, and determined that it was,
in fact, preventing ATM kinase activity. Additionally, we do not see degradation of unrepaired
-/-

-/-

coding ends in the Artemis :Atm cells although H2AX is abrogated in these cells (Figure 7b).
We therefore reasoned that ATM might also be required to promote this end processing.
-/-

-/-

To test this hypothesis, we similarly treated the Artemis :H2AX :DEL

CJ

Abl pre-B cells with KU-

55933. This resulted in a near complete block in end resection (Figure 18a). Additionally, by
analyzing these ends by Southern blotting following denaturation, we note that many of these
DNA ends are now hairpin-sealed (Figure 18b). Thus, ATM is required to promote Artemis-/-

-/-

independent hairpin-opening and end resection in the Artemis :H2AX :DEL

CJ

Abl pre-B cells.

We conclude that ATM inhibits DNA end resection through the generation of "-H2AX;
however, ATM activity is also required to promote this resection. Thus, ATM activates
antagonistic pathways to regulate the resection of un-repaired DNA ends in G1-phase cells.
Hairpin-opening and end resection are mediated by CtIP.
During HR, Mre11 and CtIP coordinate to regulate the end resection required to generate
the 3’ ssDNA overhang that is subsequently used for strand invasion. We demonstrate in
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Chapter 3 that Mre11, as a component of the MRN complex, functions during V(D)J
recombination. While CtIP activity is thought to be regulated at the level of protein abundance
and CtIP levels are low in our G1-arrested cells, it is still expressed at a level detectable by
Western. CtIP activity is also regulated by ATM, and we demonstrate that end resection in our
cells is ATM-dependent. Finally, and perhaps most importantly, CtIP and Mre11 have hairpinopening activity in vitro. Therefore, based on these data, we hypothesized that the Artemisindependent hairpin-opening in the absence of H2AX might be mediated by CtIP.
To investigate this possibility, we generated lentiviral shRNA constructs specific for CtIP
-/-

-/-

and knocked down CtIP in Artemis :H2AX :DEL

CJ

Abl pre-B cells. The knockdown in these cells

was confirmed by Western blotting (Figure 19a). Analyses of un-repaired coding ends generated
in cells depleted in CtIP revealed a dramatic reduction in DNA end resection as compared to cell
lines transduced with a non-targeting shRNA (Figure 19a and b). Moreover, we analyzed these
ends by Southern blotting following denaturation and show that many of the DNA ends in the
-/-

-/-

Artemis :H2AX :DEL

CJ

in which CtIP levels had been depleted are hairpin-sealed (Figure 19c).

These data demonstrate that CtIP promotes the endonucleolytic opening and resection of hairpin-/-

-/-

sealed coding ends in Artemis :H2AX cells. Furthermore, depletion of CtIP similarly abrogates
-/-

-/-

end resection in the Lig IV :H2AX :DEL

CJ

Abl pre-B cells (Figure 20a and b). The low level of
-/-

-/-

resection observed in the CtIP-deficient cells (both Lig IV :H2AX :DEL

CJ

-/-

and Artemis :H2AX

-/-

CJ

:DEL ) might reflect the activity of additional nucleolytic pathways inhibited by H2AX or the
activity of the residual CtIP in these cells (Figure 19a, b and 20). We conclude that H2AX
prevents CtIP from efficiently promoting hairpin opening and resection of un-repaired DNA ends
in G1-phase lymphocytes.
H2AX prevents homology-mediated joining in G1-phase cells.
-/-

-/-

Coding ends opened by CtIP in Artemis :H2AX Abl pre-B cells DNA are not efficiently
joined by NHEJ as evidenced by the abundance of unrepaired coding ends in these cells even at
late time-points (Figure 11). This is surprising given that all core components of the NHEJ
pathway are present in these cells, and Artemis is only required for the opening of the hairpin70
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sealed end prior to joining and cells deficient in Artemis do not have a general defect in NHEJ as
-/-

evidenced by normal SJ formation in Artemis cells. The single strand overhangs generated by
CtIP-dependent processing in S-G2-M are essential for homologous recombination; however, in
G1, these ends would be poor substrates for classical NHEJ possibly explaining why we do not
see robust levels of CJ formation in these cells following the opening of the hairpin-sealed end.
We reasoned, though, that if DNA ends processed by CtIP in G1-phase cells are joined
efficiently primarily by homology-mediated pathways, then we might expect to find joints with
significant deletions due to the use of homologous sequences in cis to promote joining. To
address this possibility, we designed PCR primers to detect coding joints with significant deletions
(" 600 bp) in our retroviral recombination substrate (Figure 21a). These analyses revealed that
-/-

-/-

the coding joints formed in Artemis :H2AX :DEL
-/-

compared to Artemis :DEL

CJ

and WT:DEL

CJ

CJ

Abl pre-B cells are heterogenous in size as

Abl pre-B cells (Figure 21b). Sequence analyses

confirmed that these coding joints have significant deletions (Figure 21c and Table 5).
While NHEJ does not require homologous sequences to join broken DNA ends,
alternative pathways exist that do require varying degrees of homology to mediate end joining.
-/-

-/-

CJ

-/-

We decided to clone and sequence individual CJs from Artemis :H2AX :DEL , Artemis :DEL
and WT:DEL
:DEL

CJ

CJ

-/-

Abl pre-B cells to determine whether the CJs that form in the Artemis :H2AX

CJ

-/-

Abl pre-B cells more frequently exhibit homologous sequences at the joint. These
-/-

sequence analyses revealed that a higher fraction of the coding joints formed in Artemis :H2AX
:DEL

CJ

-/-

cells use microhomologies (# 1 base pairs) as compared to coding joints generated in

WT:DEL

CJ

-/-

and Artemis :DEL
-/-

-/-

CJ

Abl pre-B cells (Figure 21d and Table 5). Moreover, coding joints

formed in Artemis :H2AX :DEL

CJ

Abl pre-B cells have generally longer tracts of microhomology

(Figure 21d and Table 5).
Notably, the homologous LTR sequences that flank pMX-DEL

CJ

could be used for

homology-mediated joining if the 5’ and 3’ coding ends were resected as much as 1kb and 2kb,
respectively (Figure 22a). We reasoned, that in the absence of H2AX, we might detect repair
mediated by the homology of these repeats. To address this possibility, we determined the
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location of the retroviral integration site for each of the cell lines. Then, we designed primers to
CJ

genomic regions flanking the integration sites of pMX-DEL in these cells (Figure 22a). PCR
with these primers revealed products of a size expected from LTR-LTR homology mediated
joining. These products increased in abundance after RAG induction in an ATM-dependent
-/-

-/-

CJ

-/-

CJ

manner in Artemis :H2AX :DEL , but not in Artemis :DEL , Abl pre-B cells (Figure 22b).
These data further demonstrate that homology-mediated repair occurs more frequently in the
-/-

-/-

Artemis :H2AX :DEL

CJ

cells.

Conclusion
We demonstrate that, in G1-phase lymphocytes, the ATM-dependent formation of "H2AX inhibits the robust CtIP-dependent opening and resection of hairpin-sealed broken DNA
(coding) ends generated by the RAG endonuclease. The DNA ends that have undergone
aberrant CtIP-dependent processing are not efficiently joined by NHEJ. Furthermore, the joints
that do form exhibit large deletions that would preclude the formation of a functional antigen
receptor gene and usage of homology-mediated repair, which in G1-phase cells, would promote
genomic instability and possibly lead to cellular transformation.
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Figure 11. Aberrant processing of persistent coding ends in the absence of H2AX.
(a) Schematic of the pMX-DELCJ retroviral recombination substrate. Shown are the
un-rearranged substrate (UR), hairpin sealed (hCE) and open (oCE) coding end (CE)
intermediates and coding joints (CJ). The RSs (open triangles), ψ sequence, IRES-hCD4
cDNA (i-hCD4) and the LTRs are indicated. Relative positions of EcoRV sites and the
C4b probe (black bar) are shown. (b) Southern blot analysis of EcoRV-digested genomic
DNA from WT:DELCJ-119, Artemis-/-:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-124 abl pre-B
cells treated with STI571 for the indicated time. Bands reflecting pMX-DELCJ UR, CE and
CJ are indicated. Cβ probe hybridization is shown as a DNA loading control and molecular weight markers (kb) are indicated. Dotted arrow indicates hybridization to resected
CEs. (c) Southern blot analysis of pMX-DELCJ rearrangement on EcoRV-digested
genomic DNA from Rag-/-:DELCJ-35, WT:DELCJ-119.6, LigIV-/-:DELCJ-10 and LigIV-/-:H2AX-/:DELCJ-168 abl pre-B cell lines.
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Figure 12. Persistent hairpin-sealed coding ends are opened in the absence of H2AX.
(a) Southern blot analysis of non-denatured (n) or denatured (d) EcoRV-digested genomic
DNA from Lig IV-/-:DELCJ-10, Artemis-/-:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-95 abl pre-B
cells treated with STI571 for 48 hours as well as from Lig IV-/-:DELCJ-10 abl pre-B cells not
treated with STI. Hybridizing bands reflecting non-denatured hairpin-sealed CEs (hCEn),
denatured hairpin-sealed CEs (hCEd), non-denatured open CEs (oCEn), denatured open
CEs (oCEd), non-denatured UR (URn), denatured UR (URd), non-denatured CJ (CJn) and
denatured CJ (CJd) pMX-DELCJ are indicated. (b) Quantification of denaturing Southern
showing the percentage of coding ends that are open in LigaseIV-/-:DELCJ, Artemis-/-:DELCJ,
and Artemis-/-:H2AX-/-:DELCJ treated with STI571 for 48 or 96 hours as indicated.
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Figure 13. Detection of open coding ends by TdT-assisted PCR. (a) Schematic of South ern blotting strategy for TdT-assisted PCR for pMX-DELCJ rearrangement. Open coding ends
have an accessible 3’-hydroxyl group and a series of adenosine residues will be added to the
3’ end upon incubation with TdT and dATP. PCR with a poly-dT primer and a substrate specific
primer will yield the PCR product shown. Relative position of oligo probe is also shown.
Coding ends that are open and degraded will yield PCR products of smaller size. Hairpinsealed ends are not accessible to TdT labeling and therefore, will yield no product. (b) Southern
blot analysis of pMX-DELCJ rearrangement on EcoRV-digested genomic DNA from WT:DELCJ119, Artemis-/-:DELCJ-13 or Artemis-/-:H2AX-/-:DELCJ-95 abl pre-B cells treated with STI571 for the
indicated amount of time. Southern blots were carried out as described in Figure 11 (c) Southern blot of PCR products from TdT-assisted PCR of pMX-DELCJ coding end intermediates from
Artemis-/- and Artemis-/-:H2AX-/- abl pre-B cells shown in (b) treated with STI571 for 0 or 48h.
Arrow indicates the expected position of an un-processed open coding end. PCR products from
samples not treated with TdT are shown as a negative control. IL2 is provided as a loading
control.
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Figure 14. Utilizing IL7-dependent pre-B cell cultures to analyze V(D)J recombination. (a)
Schematic demonstrating Southern blotting strategy for analyzing rearrangement at the endogenous
IgL-κ locus. Shown is the un-rearranged or germline configuration (GL) as well as the four possible
coding ends (CE) corresponding to cleavage at each of the four Jκ gene segments (Jκ1 CE, Jκ2 CE,
Jκ4 CE, and Jκ5 CE). Gene segments are indicated by boxes and RSSs by triangles. The relative
positions of the EcoRI and SacI restriction enzyme sites as well as the 3’ Jκ probe used (JκIII) are
shown. (b) Demonstration of usage of IL7 pre-B cell cultures. Bone marrow from Rag-/- or Artemis-/mice harboring an IgH transgene that promotes development to the pre-B cell stage is harvested
(B220+, IgM-). These cells preferentially proliferate in the presence of IL-7 and following 5-10 days in
culture are the predominant cell type (see FACS plot). Upon withdrawal of IL7, these cells arrest in
G1, express Rag and undergo rearrangement of the endogenous kappa light chain locus. Southern
blot analysis of recombination at the IgL-κ locus in Rag-/-:IgHtg and Artemis-/-:IgHtg is provided demonstrating the accumulation of unrepaired coding ends following IL7 withdrawal in the Artemis-/- but not
the Rag-/- cells.
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Figure 15. H2AX prevents resection of persistent coding ends in primary cells.
(a) Southern blot analysis of recombination at the IgL-κ locus in Artemis-/-:IgHtg and
Artemis-/-:H2AX-/- :IgHtg IL7 pre-B cell cultures while in IL7 or following removal of IL7 for
the indicated amount of time. (b) Southern blot of TdT-assisted PCR products of IgLκ
CE intermediates in bone marrow pre-B cells from two Artemis-/-:IgHtg and Artemis-/:H2AX-/-:IgHtg mice 48 hours after IL-7 withdrawal. Expected products for Jκ1 and Jκ2
CEs are indicated. PCR products from samples not treated with TdT are shown as a
negative control. IL2 gene PCR is provided as a DNA loading control.

77

a.
Lig IV-/-:H2AX-/-:
DELCJ-128
Empty
0

H2

Em

UR

4
A

39

AX

48 96

H2AXS139A
0 48 96 STI (h)

5

Lig IV-/-:H2AX-/-:
DELCJ-128
y
pt

H2AX
0 48 96

S1

3

AX

H2

anti-H2AX

CEs

2

anti-GAPDH
1
C4b probe
Cβ probe
EcoRV digest

b.

Artemis-/-:
DELCJ-81

Artemis-/-:H2AX-/-:
DELCJ-124
Empty

r

t
en

Pa

H2AX

H2AXS139A

0 48 96 0 48 96 0 48 96 0 48 96 STI (h)

Artemis :H2AX :
DELCJ-124
-/-

-/-

UR
CJ

5
4

A

39

S1

AX 2AX
H

H2

3

anti-H2AX

CEs

2

anti-GAPDH

1

C4b probe
Cβ probe
EcoRV digest

Figure 16. Phosphorylation of H2AX is required to prevent aberrant resection of persisten coding ends. (a) Western blot analysis showing H2AX levels in LigIV-/-:H2AX-/-:DELCJ-128
abl pre-B cells reconstituted with WT (H2AX) or mutant H2AX (H2AXS139A) and Southern blot
analysis of pMX-DELCJ rearrangement in these cells. (b) As in (a) but for Artemis-/-:H2AX-/:DELCJ-124 reconstituted with WT (H2AX) or mutant H2AX (H2AXS139A).
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Figure 17. Mdc is required to prevent resection of persistent hairpin-sealed coding ends.
Southern blot analysis of pMX-DELCJ rearrangement on EcoRV-digested genomic DNA from
WT:DELCJ-119.6, Artemis-/-:DELCJ-81 and Artemis-/-:Mdc-/-:DELCJ-2 and -23 Abl pre-B cells treated
with STI571 for the indicated amount of time. Southern blots were carried out as described in
Figure 11.
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Figure 18. ATM activity is required to promote end resection. (a) Analysis of pMXDELCJ rearrangement in two Artemis-/- (Artemis-/-:DELCJ-81 and -7) and two Artemis-/:H2AX-/- (Artemis-/-:H2AX-/-:DELCJ-124 and -95) abl pre-B cells treated with STI571 for the
indicated amount of time and treated with either the ATM-specific inhibitor KU55933 (+) or
a DMSO vehicle control (-). (b) Southern blot analysis of pMX-DELCJ rearrangement on
non-denatured (n) and denatured (d) EcoRV-digested genomic DNA samples from
Artemis-/-:H2AX-/-:DELCJ-94 Abl pre-B cells treated with STI571 for 48 hours.
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Figure 19. CtIP mediates opening and resection of persistent hairpin-sealed coding ends. (a)
Western blot analysis of Artemis-/-:H2AX-/-:DELCJ-124 and -95 Abl pre-B cells expressing CtIPspecific shRNA. GAPDH or Erk2 are shown as loading controls. (b) Southern blot analysis of
pMX-DELCJ rearrangement in Artemis-/-:H2AX-/-:DELCJ-124 and -95 Abl pre-B cells expressing either
non-targeting (NT) or CtIP-specific (CtIP) shRNAs and treated with STI571 for the indicated amount
of time. (c) Southern blot analysis of pMX-DELCJ rearrangement in Artemis-/-:H2AX-/-:DELCJ-95 cells
treated with STI571 for 48 hours. DNA was run under non-denaturing (n) and denaturing (d) conditions.
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Figure 20. CtIP mediates resection of persistent open coding ends in the absence of H2AX.
(a) Western blot analysis demonstrating CtIP knockdown for LigIV-/-:H2AX-/-:DELCJ-128 and -168
expressing CtIP-specific or non-targeting shRNA constructs. GAPDH is shown as a loading
control. (b) Southern blot analysis of pMX-DELCJ rearrangement in LigIV-/-:H2AX-/-:DELCJ-128 and
-168 expressing either non-targeting (NT) or CtIP-specific (CtIP) shRNAs and treated with STI571
for the indicated amount of time.
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Figure 21. Coding joints formed exhibit significant deletions and usage of microhomologies. (a) Schematic of pMX-DELCJ showing relative positions of the oligonucleotides used to
amplify aberrant pMX-DELCJ joints and the oligonucleotide used as a probe. (b) PCR of pMXDELCJ coding joints in WT:DELCJ-119.6, Artemis-/-:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-124 and
-95 abl pre-B cells treated with STI571 for 0 (-) or 96 (+) hours using the pC and IRES REV5
oligonucleotides. PCR products were probed with the IRES REV4 oligonucleotide. Bands
representing un-rearranged pMX-DELCJ substrate (UR) and an unprocessed coding joint (CJ) are
indicated. Coding joints with deletion are visualized as hybridizing fragments lower in molecular
weight than the CJ species. IL2 is shown as a loading control. (c-d) Nucleotide deletions (c) and
microhomologies (d) in pMX-DELCJ coding joints formed in WT:DELCJ, Artemis-/-:DELCJ and
Artemis-/-:H2AX-/-:DELCJ Abl pre-B cells treated with STI571 .
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Figure 22. Detection of coding joint formation mediated by the homologous LTR
sequences. (a) Schematic of pMX-DELCJ showing relative positions of the oligonucleotides used to amplify joints formed due to the homology of the LTRs and the oligonucleotide used as a probe. (b) PCR of pMX-DELCJ coding joints in Artemis-/-:DELCJ and
Artemis-/-:H2AX-/-:DELCJ abl pre-B cells not treated (-) or treated (+) with STI571 and
vehicle or KU-55933 (iATM) using integration specific primers designed to detect
homology-mediated joining that deletes pMX-DELCJ leaving a single LTR.
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Table 5. Coding joint sequences in Artemis-/-:H2AX-/- Abl pre-B cells show significant
deletions and microhomologies . Coding joints sequences from WT:DELCJ-119.6, Artemis-/:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-124 and -95 abl pre-B cells treated with STI571 for 96
hours and amplified using the pB and pC oligonucleotides described in Chapter 4. PCR products
were cloned and sequenced.
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CTATATGC
71
TTTTCCACCATATT
ACCATATT
87
GCCGGTGTGCGTTT
GTGCGTTT
61
TACAATTCCGCCCC
TCCCGCCC
8
CCGCTTGGAATAAG
GGAATAAG
47
TCTATATGTCTATA
TGTCTATA
76
CAGCCTACAATTCC
ACAATTCC
CAGCCTACAATTC
TACAATTC
CAGCCTACAATT
CTACAATT
AATTCCGCCCCCCC
GCCCCCCC

# Lost
0
40
169
0
25
2
2
0
35
3
0
19
11
21
8
20
117
28
*2

20
2
87
40
118
69
3
15

*2

121
3
0
6
30

*6

6
5
4
12
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5' CE
AACGTCTG
AACGTCTG
CTACCATTACCAAC
CTACCATT
CTCAAAGTAGACGG
CTCAAAGT
AACGTCTG
AACGTCTG
CTTGTCTGGTGTCA
CTTGTCTG
GGAACGTCTG
GGAACGTC
GGAACGTCTG
GGAACGTC
AACGTCTG
AACGTCTG
CCATTACCAACTTG
CCATTACC
AGGAACGTCTG
AGGAACGT
AACGTCTG
AACGTCTG
TGGTGTCAAAAATA
TGGTGTCA
AAAATAATAGGAAC
AAAATAAT
TCTGGTGTCAAAAA
TCTGGTGT
ATAATAGGAACGTC
ATAATAGG
CTGGTGTCAAAAAT
CTGGTGTC
CCGACCCCGGGGGT
CCGACCCC
CAACTTGTCTGGTG
CAACTTGT
CTGGTGTCAAAAAT
CTGGTGTC
GGAACGTCTG
GGAACGTC
TGCCGGATCTCGCG
TGCCGGAT
TCGCTACCATTACC
TCGCTACC
GCCGACCCCGGGGG
GCCGACCC
CGACTCTAGAATTC
CGACTCTA
AGGAACGTCTG
AGGAACGT
GTCAAAAATAATAG
GTCAAAAA
GCTGCCGACCCCGG
GCTGCCGA
AGGAACGTCTG
AGGAACGT
AACGTCTG
AACGTCTG
AATAGGAACGTCTG
AATAGGAA
ACCAACTTGTCTGG
ACCAACTT

N/P
ATG
G
TCTTA
CG
CC
G
CCG
CAGG
GACTTGTC
TG
AA
GGACCTA
CT
CCGG
GG
C
TCG
GA
G
CCG
TA
G
GCC
AGT
AGGCTG
G
AGGA
CCGCTG
A
TAGG
T

3' CE
# Lost
CAGCCTACAATT
CTACAATT
4
GCCGAAGCCGCTTG
GCCGCTTG
40
GGTCTGTTGAATGT
TTGAATGT
197
CCCCCCCCCTAACG
CCCTAACG
22
CAGCCTAC
CAGCCTAC
0
CCCCCCCCTAACGT
CCTAACGT
23
ACAATTCCGCCCCC
CCGCCCCC
15
AATTCCGCCCCCCC
GCCCCCCC
14
TACTGGCCGAAGCC
CCGAAGCC
37
CAGCCTAC
CAGCCTAC
0
CAGCCTACA
AGCCTACA
1
TTCCGCCCCCCCCC
CCCCCCCC
16
ATTCCGCCCCCCCC
CCCCCCCC
15
TGGCCGAAGCCGCT
AAGCCGCT
40
CGCCCCCCCCCCTA
CCCCCCTA
19
CAGCCTACAAT
CCTACAAT
3
CTCGCCAAAGGAAAAAGGAAA
179
GATTTTCCACCATA
CCACCATA
87
GCCCCCCCCCCTAA
GGCCGAAG
35
ACAATTCCGCCCCC
CCGCCCCC
12
GGCCGGTGTGCGTT
TGTGCGTT
62
TGGAATAAGGCCGG
AAGGCCGG
54
AAGCCGCTTGGAAT
CTTGGATT
46
TTCCGCCCCCCCCC
CCCCCCCC
16
CAGCCTAC
CAGCCTAC
0
CAGCCTAC
GCCTACGA
3
GTGATTTTCCACCA
TTCCACCA
85
CAGCCTAC
CAGCCTAC
0
CAGCCTACA
AGCCTACA
1
CCTACAATTCCGCCC
TTCCGCCC
9
CTTGGAATAAGGCCG
TAAGGCCG
53

Artemis-/-:H2AX-/-DELCJ
# Lost
333
326
175
168
40
69
151
177
35
26
25
178
134
75
159
153
24
37
3
98
167
133
46
165
154
71
56
90
47
47
136
212
5
24
26
231
76
23
86
33
71
157
272
202
186
51
47
226
290
161
57

5' CE
AGACCTCTGGCGGC
AGACCTCT
CTGGCGGCAGCCTA
CTGGCGGC
CCTCAAAGTAGACG
CCT CAAAG
AGTAGACGGCATCG
AGTAGACG
ACCATTACCAACTT
ACCATTAC
CGACTCTAGAATTC
CGACTCTA
GCAGCTTGGATACA
GCAGCTTG
CCACCGCCCTCAAA
CCACCGCC
CCAACTTGTCTGGT
CCAACTTG
TTGTCTGGTGTCAA
TTGT CTGG
GTCTGGTGTCAAAA
GTCTG GTG
ACCGCCCTCAAAGT
ACCGCCCT
GCCCACGTGAAGGC
GCCCACGT
CGGCCGCGACTCTA
CGGCCGCG
GCATCGCAGCTTGG
GCATCGCA
TCGCAGCTTGGATA
TCGCAGCT
TGTCTGGTGTCAAA
TGTCTG GG
TACCATTACCAACT
TACCAT TA
AGGAACGTCTG
AGGAACGT
TCTAGACTGCCGGA
TCTAGA CT
AAGTAGACGGCATC
AAGTAGAC
CCACGTGAAGGCTG
CCACGT GA
GCCGGTCGCTACCA
GCCGGTCG
AAGTAGACGGCATC
AAGTAGAC
ATCGCAGCTTGGAT
ATCGCAGC
CGACTCTAGAATTC
CGACTC TA
AACTGAGCGCCGGT
AACTGAGC
CTGCCGGATCTCGC
CTGCCGGA
GCCGGTCGCTACCA
GCCGGTCG
GCCGGTCGCTACCA
GCCGGTCG
GCCGCCCACGTGAA
GCCGCCCA
CTGGAAAGGACCTT
CTGGAAAG
ATAGGAACGTCTGC
ATAGGAAC
TTGTCTGGTGTCAA
TTGTCTG G
ACTTGTCTGGTGTC
ACTTGTC T
TAAGAACCTAGAAC
TAAGAACC
GCGGCCGCGACTCT
GCGGCCGC
TGTCTGGTGTCAAA
TGTCTGG T
GCCGGATCTCGCGG
GCCGGATC
ATTACCAACTTGTC
ATTACCA A
CGCGACTCTAGAAT
CGCGACTC
GGCATCGCAGCTTG
GGCATCGC
TACCGAGTCGGCGA
TACCGAGT
CCTTACACAGTCCT
CCTTACA C
TGACCACCCCCACC
TGACCAC C
AGCGCCGGTCGCTA
AGCGCCGG
CCGGTCGCTACCAT
CCGGTCGC
AACCTAGAACCTCG
AACCTAGA
ACCGGTGGTACCTC
ACCGGTGG
CGGCATCGCAGCTT
CGGCATCG
TCCAACTGAGCGCC
TCCAACTG

N/P

3' CE
# Lost
CCCTCTCGCCAAAG
CGCCAAAG
171
TGCGGCCAAAAGCC
CAAAAGCC
306
CCAAAGGAATGCGA
GAATGCAA
178
TTGACGAGCATTCC
AGCATTCC
145
CGTTACTGGCCGAA
TGGCCGAA
30
TGTCTATATGTGAT
TATGTTAT
76
TTCTTGACGAGCAT
ACGAGCAT
146
CTCGCCAAAGGAAT
AAAGGAAT
177
CGCTTGGAATAAGG
GAATAAGG
48
TACTGGCCGAAGCC
CCGAAGCC
35
AATGTGAGGGCCCG
AGGGCCCG
113
ATTCCTAGGGGTCT
AGGGGTCT
155
TGCCGTCTTTTGGC
CTTTTGGC
101
TGTGCGTTTGTCTA
TTTGTCTA
68
AATGCAAGGTCTGT
AGGTCTGT
187
GACCCTTTGCAGGC
TTGCTGGC
265
ACCTGGCCCTGTCT
CCCTGTCT
132
GGAATAAGGCCGGT
AGGCCGGT
54
GCCGGTGTGCGTTT
GTGCGTTT
62
CAGCCTACAATTCC
ACAATTCC
6
GGAAACCTGGCCCT
CTGGCCCT
129
TGACGAGCATTCCT
GCATTCCT
148
TGGCCGAAGCCGCT
AAGCCGCT
40
GGAAACCTGGCCCT
CTGGCCCT
129
TATTGCCGTCTTTT
CGTCTTTT
99
ACGTTACTGGCCGA
CTGGCCGA
31
AGCCGCTTGGAATA
TTGGAATA
49
GGCCGAAGCCGCTT
AGCCGCTT
39
CCTAGGGGTCTTTC
GGTCTTTC
160
GCAAGGTCTGTTGA
TCTGTTGA
192
TTCCTAGGGGTCTT
GGGGTCTT
159
GGAATGCAAGGTCT
CAAGGTCT
188
CAGCCTACA
AGCCTACA
1
CCGAAGCCGCTTGG
CCGCTTGG
43
TAACGTTACTGGCC
TACTGGCC
31
GAATGCAAGGTCTG
AAGGTCTG
188
CCCCCCCCTAACGT
CCTAACGT
23
TACAATTCCGCCCC
TCCGCCCC
11
GGCAGCGGAACCCC
GGAACCCC
276
CTTGGAATAAGGCC
ATAAGGCC
52
CGAAGCCGCTTGGA
CGCTTGGA
44
GGGGTCTTTCCCCT
TTT-CCCT
165
GAGCATTCCTAGGG
TCCTAGGG
153
AGGGCCCGGAAACC
CGGAAACC
122
GGAAGCAGTTCCTC
AGTTCCTC
217
CCGAAGCCGCTTGG
CCGCTTGG
40
CCCCCCCCCTAACG
CCCTAACG
18
GGTCTTTCCCCTCT
TCCCCTCT
167
CAGTTCCTCTGGAA
CTCTGGAA
222
CCTCTCGCCAAAGG
GCCAAAGG
176
GAATAAGGCCGGTG
GGCCGGTG
56
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# Lost
17
94
81
18
189
135
142
195
218
169
174
198
187
14
4
77
125
149
139
0
304
222
173
59
63
19
60
10
121
53
100
85
28
113
106
184
15
0
19
127

5' CE
GTGTCAAAAATAAT
GTGTCAAA
TCTAGACTGCCGGA
TCTAGACT
CTCGCGGCCGCGAC
CTCGCGGC
GGTGTCAAAAATAA
GGTGTCAA
TGCTGACCACCCCC
TGCTGACC
ACACGCCGCCCACG
ACACGCCG
GTGAAGGCTGCCGA
GTGAAGGC
CAGTCCTGCTGACC
CTGTCCTG
ACCTCGCTGGAAAG
ACCTCGCT
CAAAGTAGACGGCA
CAAAGTAG
GCCCTCAAAGTAGA
GCCCTCAA
ACCGCCCTCAAAGT
ACCGCCCT
CTGACCACCCCCAC
CTGACCAC
AAAAATAATAGGAA
AAAAATAA
TAGGAACGTCTG
TAGGAACG
CGCGGCCGCGACTC
CGCGGCCG
GAAGGCTGCCGACC
GAAGGCTG
AGCTTGGATACACG
AGCTTGGA
CACGCCGCCCACGT
CACGCCGC
AACGTCTG
AACGTCTG
GAACAACTGGACCG
GAACAACT
AGAACCTAAAACAG
AGAACCTA
CGCCCTCAAAGTAG
CGCCCTCA
ATTCCAACTGAGCG
TTTCCAAC
TAGAATTCCAACTG
TAGAATTC
TGGTGTCAAAAATA
TGGTGTCA
AATTCCAACTGAGC
AATTCCAA
AATAATAGGAACGT
AATAATAG
GCTGCCGACCCCGG
GCTGCCGA
ACTGAGCGCCGGTC
ACTGAGCG
CCATCCTCTAGACT
CCATCCTC
CCGGATCTCGCGGC
CCGGATCT
CAACTTGTCTGGTG
CAACTTGT
CCCCGGGGGTGGAC
CCCCGGGG
GGTGGACCATCCTC
GGTGGACC
ACCACCCCCACCGC
ACCACCCC
GTCAAAAATAATAG
GTCAAAAA
AACGTCTG
AACGTTTG
TGGTGTCAAAAATA
TGGTGTCA
GTGAAGGCTGCCGA
GTGAAGGC

N/P

A
AACCT
C
CGA
G
GA
GG
GT
GT
GT
CGG
G
GGG
A
CCA
AG
C
CAGC
CACA
GTC

3' CE
# Lost
ATTCCGCCCCCCCC
CCCCCCCC
16
CCCTAACGTTACTG
CGTTACTG
28
TTGCCGTC-TTTGA
TCTTTTGA
99
AATTCCGCCCCCCC
GCCCCCCC
14
TCTGTTGAATGTCG
GAATGCCG
199
TGATTTTCCACCAT
TCCACCAT
86
GAATGTCGTGAAGG
CGTGAAGG
205
CGCCAAAGGAATGC
AGGAATGC
190
CTCGCCAAAGGAAT
AAAGC-AT
178
AAGGAATGCAAGGT
TGCAAGGT
185
GTCTGTTGAATGTC
TGAATGTC
196
GTTGAATGTCGTGA
TGTCGTGA
202
TCTGCGGCCAAAAG
GCCAAAAG
95
AACGTTACTGGCCG
ACTGGCCG
30
CCCCTAACGTTACT
ACGTTACT
25
TTCCTAGGGGTCTT
GGGGTCTT
160
TGGCAATGTGAGGG
TGTGAGGG
112
CCCTCTCGCCAAAG
CGCCAAAG
175
TTCCTAGGGGTCTT
GGGTCTTT
160
CAGCCTAC
CAGCCTAC
0
TCTGTTGAATGTCG
GAATGTCG
199
CTTTCCCCTCTCGC
CCTCTCGC
168
ATAAGGCCGGTGTG
CCGGTGTG
82
GCCCCCCCCCCTAA
CCCCCTAA
20
CGAGCATTCCTAGG
TTCCTAGG
153
CCCCCCCCCTAACG
CCCTAACG
22
ATGTGATTTTCCAC
TTTTCCAC
83
GGCCGAAGCCGCTT
AGCCGCTT
41
CCCTAACGTTACTG
CGTTACTG
28
CGCCCCCCCCCCTA
CCCCCCTA
20
GCCGAAGCCGCTTG
GCCGCTTG
42
TCTATATGTGATTT
TGTTATTT
78
ACGTTACTGGCCGA
CTGGCCGA
33
CCGTCTTTTGGCAA
TTTGGCAA
104
CATTCCTAGGGGTC
TAGGGGTC
158
CGGAAACCTGGCCC
CCTGGCCC
128
GTTACTGGCCGAAG
GGCCGAAG
35
CTACAATTCCGCCC
TTCCGCCC
10
TACAATTCCGCCCC
TCCGCCCC
11
ACCTGGCCCTGTCT
CCCTGTCT
133

Chapter 5

ATM Activates a Broad Genetic Program
in Response to RAG DNA DSBs
(reprinted with modification(270))
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The relatively mild defect in the repair of RAG DNA DSBs during V(D)J recombination in
ATM-deficient cells does not likely entirely account for the lymphopenia observed in ataxia
telangiectasia. We considered the possibility that the more global effects of ATM activation in
response to DNA damage, specifically its ability to activate gene transcription, might also affect
lymphocyte development(73).
ATM, in response to genotoxic DNA damage, promotes cell cycle checkpoint activation
and apoptosis through the activation of p53(244-247). It is known that ATM similarly activates
p53 in response to persistent physiologic RAG DNA DSBs in developing lymphocytes, but
whether it does so in response to all RAG DNA DSBs, including those in wild-type cells that are
transient in nature, is not known(271). ATM also activates NF!B, a transcription factor with
targets that promote survival, in response to genotoxic damage, and the balance of the NF!B and
p53 pathways is thought to mediate cell outcome following genotoxic DNA damage(263, 264). If
RAG DNA DSBs promote the ATM-mediated activation of p53, it is possible that ATM might
simultaneously promote the transcription of pro-survival factors via the activation NF!B. The sum
of these two pathways could be important for negotiating a balance between survival and
apoptosis in the developing lymphocyte following a RAG DNA DSB, essentially affording the cell
a window of opportunity in which to repair the break. Furthermore, while NF!B may solely be
acting to promote the transcription of pro-survival factors, it is more likely that this multi-functional
transcription factor would simultaneously modulate the expression of other genes that might be
important for the developing lymphocyte.
Deficiencies in ATM, then, would eliminate the activation of these transcriptional
programs and thereby potentially negatively impact lymphocyte development. We wished to
determine whether ATM activates NF!B in response to transient RAG DNA DSBs and to fully
characterize the transcriptional program initiated by ATM in response to these breaks.
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Persistent RAG DNA DSBs activate NF!B via the classical pathway.
RAG DNA DSBs in a WT cell are transient in nature, and, as such, signals emanating
from those breaks might also be transient in nature. As discussed in Chapter 3, we reasoned that
the analysis of cells with persistent DSBs would increase our ability to detect the activation of
transcriptional pathways in response to RAG DNA DSBs. We chose initially to compare the
activation of NF!B in response to RAG DNA DSBs in cells deficient in components of the NHEJ-/-

pathway, Artemis Abl pre-B cells, where breaks are made but not repaired in response to STI
-/-

treatment to similarly treated Rag Abl pre-B cells where breaks are never made due to the lack
of a functional RAG-holocomplex. NF!B activation was assessed by EMSA (electrophoretic
mobility shift assays) wherein labeled oligo probes consisting of NF!B binding sites are incubated
with nuclear extracts from the cells of interest and ran on a poly-acrylamide gel. If NF!B is
activated in these cells, it should be present in the nucleus and will bind to the oligo probe. This
binding will retard the flow of the oligo in the gel leading to a “shift” of the oligo probe(289). By
-/-

EMSA, we detect robust NF!B activation in the Artemis Abl pre-B cell lines but not the Rag

-/-

lines at 48 hours of STI treatment (Figure 23a). Importantly, this is at the same time that we see
-/-

an accumulation of unrepaired J! coding ends in the Artemis deficient cells (Figure 23b). Also,
we do not see activation in cells deficient in both Artemis and ATM (Figure 23a) or in Artemis

-/-

cells treated with a small molecule inhibitor of ATM though breaks are clearly present in these
cells (Figure 23b), demonstrating that ATM is mediating this DSB-dependent NF!B activation.
NF!B activation by ATM in response to genotoxic DNA damage occurs through the
classical pathway in a manner dependent on the phosphorylation of NEMO(263). We carried out
a number of tests to determine whether NF!B is similarly activated in response to RAG DNA
DSBs. One way to characterize the activation of NF!B is to add antibodies specific for the two
components of the classical NF!B heterodimer (p50:p65) to the nuclear extracts prior to EMSA.
The binding of these antibodies to their respective proteins will cause a further retardation
(“super-shift”) of the oligo during PAGE(289). Indeed, we find that both p50 and p65 antibodies
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-/-

cause a super-shift in the EMSA with lysates from the Artemis cells. This is visualized as a
-/-

disappearance of the band seen in the Artemis lanes upon addition of antibodies specific for p50
or p65 and the detection of higher molecular weight species in these lanes (Figure 24a).
Additionally, we find that NF!B activation, as read-out by EMSA, is completely blocked in
-/-

Artemis cells transfected with a N-terminally truncated dominant negative version of I!B" which
primarily affects the classical pathway(307) (Figure 24b). Finally, incubating cells with a cellpermeable mutant NEMO binding domain peptide that prevents the association of NEMO with
IKK" and IKK# thereby preventing the activation of the IKK complex(308) inhibits NF!B activation
by EMSA while a mutant peptide does not (Figure 24c). These data are all consistent with the
idea that ATM activates NF!B via the classical pathway in response to RAG DNA-DSBs as it
does in response to genotoxic DNA damage.
Characterizing RAG DNA DSB-dependent transcriptional changes by microarray analysis.
We wished to determine what genes are affected by the activation of NF!B in response
to RAG DNA DSBs in the developing lymphocyte and whether ATM or other transducers might
additionally activate other transcription factors in response to these physiologic breaks. Thus, we
designed the microarray-based experiments described below to more fully characterize the
transcriptional program(s) activated in response to these physiologic DNA DSBs.
As with the EMSA analyses, we began by comparing the transcriptional profiles of STI-/-

-/-

-/-

treated Artemis Abl pre-B cells to STI-treated Rag Abl pre-B cells. The Rag Abl pre-B cells
serve as a critical control in our microarray analyses as STI is known to cause many changes in
-/-

gene expression(280). By comparing the transcriptional profiles of similarly treated Rag and
-/-

Artemis cells, we are able to distinguish STI-induced changes in transcription from those caused
by the formation of RAG DNA DSBs.
ATM is thought to be the primary transducer of the DNA damage response in G1 of the
cell cycle(73). However, we considered the possibility that other transducers might also activate
pathways downstream of RAG DNA DSBs. To determine which of the transcriptional changes
were dependent on ATM signaling, we compared the transcriptional response to RAG DNA DSBs
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-/-

in STI-treated Artemis Abl pre-B cells to those deficient in both Artemis and ATM. Finally, ATM
in response to DNA damage is known to activate primarily p53 and NF!B(244-247, 263, 264).
Considering that other transcriptional regulators such as Stat3 and FOXO-1 are also
phosphorylated by ATM in response to DNA damage, it is likely that ATM modulates the activity
of other transcriptional pathways as well(71). To begin to address this possibility, we transfected
-/-

Artemis cells with a dominant negative version of I!B" that is N-terminally truncated and
functions as a dominant negative preventing activation of primarily the classical pathway(307).
-/-

We simultaneously performed microarray analysis on these STI treated Artemis :IkB!-"N Abl
pre-B cells.
-/-

-/-

-/-

-/-

-/-

All cell lines (Rag , Artemis , Artemis :Atm and Artemis :I#B!-"N) were treated with
-/-

STI for 48 hours prior to RNA isolation. Furthermore, we confirmed that all Artemis cells used
had similar level of breaks by Southern blot prior to microarray analysis to minimize differences in
transcription due to the differential accumulation of un-repaired breaks. Three independently
derived cell lines of each genotype were analyzed preventing us from inappropriately identifying
differences in transcription due to cell line variation as RAG DNA DSB-dependent changes and
furthermore to give us confidence in picking out any small but relevant changes in gene
expression.
Results of the microarray analysis yielded a relatively concise cohort of genes (364)
whose expression was modulated in response to RAG DNA DSBs, as they exhibited a !2-fold
-/-

change in expression in all three Artemis cell lines, as compared to the mean expression level in
-/-

the three RAG-2 cell lines (Figure 25a). Of these, approximately half (189) of these genes
-/-

-/-

depended on ATM as expression was diminished in the Artemis :Atm Abl pre-B cells as
-/-

compared to the Artemis Abl pre-B cells (Figure 25a). Finally, 75 of the 364 genes exhibited
transcriptional changes that were dependent on NF!B (Figure 25a). A large fraction of the
microarray data was confirmed by qrtPCR and by protein analysis where possible (Figure 25b
and Figure 26). Specifically, we note an increase in the expression of Bcl-3, Pim-2, CD40,
-/-

CD62L, CD69 and common $-chain upon STI treatment in the Artemis but not Rag-2
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-/-

or

-/-

-/-

-/-

Artemis :Atm , or Artemis :I#B!-"N (with the exception of CD62L) Abl pre-B cells (Figure 25b).
-/-

Also, we detect increases in Pim-2 protein levels (all three isoforms) in Artemis but not Rag-2
-/-

-/-

-/-

or Artemis :Atm Abl pre-B cells upon STI treatment (Figure 26a). Finally, we note that the
-/-

surface expression of CD40 and CD69 is similarly selectively increased in the Artemis Abl pre-B
cells in response to STI treatment (Figure 26b). Furthermore, we performed qrtPCR on Abl pre-B
cells treated for varying amounts of time with STI to establish kinetic profiles of RAG-induced
transcriptional changes (Figure 27). We noted that the transcription of each of these genes had
different kinetic profiles. Interestingly, some like CD69 had a very transient increase in
transcription and protein expression peaking at 48 hours and disappearing by 72 h even though
the inciting stimulus (unrepaired RAG DNA DSB) was still present. Others like CD40 show slow
and gradual increases in expression but hit a plateau near 48 hours and still others, like Pim-2
and Bcl-3, gradually increase throughout the 96-hour STI treatment.
It was important to confirm that these gene changes were not due to Artemis-deficiency
-/-

-/-

alone. We analyzed the expression of a cohort of the genes in Rag :Artemis cell lines (Figure
28a) reasoning that these cells, while deficient in Artemis would not make DNA DSBs.
Importantly, we did not note significant changes in the expression of the RAG DNA DSBdependent genes in these cells in upon STI treatment (Figure 28a). Secondly, we also analyzed
the expression of this cohort of RAG DNA DSB-dependent genes in Abl pre-B cell lines derived
-/-

from mice deficient in other components of the NHEJ pathway (Ku80 and scid). These cells
contain unrepaired RAG DNA DSBs but contain a functional Artemis protein. Importantly, these
cells do exhibit similar RAG-induced transcriptional changes (Figure 28b) as was seen in the
-/-

Artemis Abl pre-B cells. Thus, these genetic changes are not likely due to Artemis-deficiency
per se.
These data demonstrate that, in response to RAG-induced DSBs, ATM activates NF!B
but additionally other transcription factors that lead to the promotion of a broad transcriptional
program. Notably, while some genes up-regulated in response to RAG DNA DSBs such as Pim2 and Bcl-3 have known roles in promoting survival, many of the genes (CD40, CD69, Cd62L)
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breaks have no known function in the canonical DNA damage response. Rather, the known
functions of these gene products implicate them in lymphocyte development and function. For
example, a number of genes belonging in this category have been implicated in migration and
trafficking (Swap70(309), CD69(310, 311), L-Selectin(312)) in mature lymphocytes. Importantly,
then, this program transcends the canonical DNA damage response, activating genes whose
expression could have important ramifications for the developing lymphocyte.
Persistent RAG DNA DSBs activate a similar genetic program in vivo.
To determine whether a similar genetic program is activated by RAG DSBs in vivo, we
-/-

-/-

isolated bone marrow from Rag :IgHtg and Artemis :IgHtg mice. As described in Chapter 4,
lymphocyte development in these mice is arrested at the pre-B cell stage, being promoted to this
stage by the immunoglobulin heavy chain transgene; however, as these cells are unable to
undergo V(D)J recombination, they do not progress to the immature pre-B cell stage (Figure 29a).
-/-

The Rag :IgHtg mice cannot initiate V(D)J recombination because they cannot make DNA DSBs,
-/-

while the Artemis :IgHtg mice cannot complete V(D)J recombination because they cannot repair
RAG DNA DSBs. We were able to isolate RNA from the bone marrow of these mice and submit
it for microarray analysis just as was done for the Abl pre-B cells. In doing so, we determined that
109 of the 364 RAG DSB-responsive genes were also up-regulated at least 1.2 fold in the
-/-

-/-

Artemis :IgHtg mice as compared to samples from Rag :IgHtg mice (Figure 29a). The
asynchronous nature of RAG break induction in these cells in vivo likely explains the generally
lower changes in gene transcription in these cells. However, and importantly, although these
changes were less dramatic, they were confirmed by qrtPCR and additionally led to the expected
relevant changes in protein expression with surface expression of CD40, CD69, CD62L and
-/-

CD80 all significantly higher in the Artemis :IgHtg bone marrow pre-B cells as compared to Rag
:IgHtg mice bone marrow pre-B cells (Figure 29b). Thus, we conclude that RAG DNA DSBs in
vivo activate a similar genetic program.
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-/-

Transient RAG DNA DSBs activate NF!B.
All data presented thus far supports the notion that persistent RAG DNA DSBs can
activate a cohort of genes as all studies were performed in NHEJ-deficient cells. That these
persistent DSBs might activate signaling pathways not generally activated during V(D)J
recombination in WT cells where breaks are efficiently repaired was a distinct possibility. In this
regard, we did not detect NF!B activation by EMSA in WT Abl pre-B cells that had been
incubated with STI (Figure 30). For the gene changes we have identified to generally affect
lymphocyte development, it is important that they be activated by all RAG DNA DSBs, not just
those that persist unrepaired.
To determine whether transient RAG DNA DSBs can similarly activate NF!B and thus
likely other components of this transcriptional program, we decided to introduce an NF!B reporter
into WT cells that would enable us to detect NF"B activation on a cell-by-cell basis. Our reporter
is a retrovirus containing 5-tandem NF!B-responsive elements driving the expression of GFP on
the antisense strand. Thus, GFP would be produced only upon activation of NF"B. The
production of GFP could be analyzed by FACS (Figure 31a). We further reasoned that, as these
cells are arrested in G1 of the cell cycle, that any GFP produced would remain in that cell, and
thus we could detect activation of NF"B that had occurred at any point in time even after the
repair of the break (Figure 31b).
We began by introducing our retroviral reporter into a Rag-2 deficient cell Abl pre-B cell
-/-

line (RAG-2 NRE, Figure 31b). We show that, in these lines, there is very little NF!B activation
upon STI treatment in the absence of RAG proteins (Figure 31b, 32, and 33a). However,
irradiation of these RAG-deficient lines, which induces a large number of DSBs, led to a robust
GFP expression (Figure 32) demonstrating that this reporter enabled us to detect NF!B activation
in response to DNA damage. GFP production in these cells is ATM- and NF!B dependent as it
does not occur when these irradiated cells are treated with the ATM inhibitor or the BAY inhibitor
that prevents the phosphorylation of I!B" thereby preventing NF!B activation(263).
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At this point, confident that our reporter system was working, we retrovirally introduced
-/-

Rag-2 back into the RAG-2 NRE cells thus creating a system wherein breaks could be made
-/-

and repaired normally upon STI treatment (RAG-2 NRE R2, Figure 31b). Upon reconstitution of
the RAG complex, STI treatment leads to DSB induction and efficient repair of the RAG DNA
DSBs. A significant fraction of cells turn GFP+ indicating that transient RAG DNA DSBs that are
repaired normally do activate NF"B (Figure 33a). Again, this GFP production was dependent on
both ATM and NF!B as it was prevented by both the iATM and the BAY inhibitor (Figure 33a).
Next, we sorted these GFP+ cells and GFP- cells by flow-cytometric assisted cell sorting. The
GFP+ cells isolated had a 5-fold greater amount of CJ formation as compared to the GFPpopulation as assayed by PCR analysis, demonstrating that the cells that had activated NF!B
had undergone rearrangement (Figure 33b and c). Furthermore, we detect changes in the
expression of the RAG-dependent genes in the GFP+ cells as compared to the GFP- cells.
Therefore, we conclude that RAG-DNA DSBs that are made and repaired normally do, in fact,
activate the transcriptional program we had observed initially using the NHEJ-deficient Abl pre-B
cells.
Further supporting the notion that transient breaks activate the described transcriptional
program is our ability to detect significantly higher levels of CD40, CD69, and CD62L (genes
known to be activated by ATM in response to persistent RAG DNA DSBs) on the surface of WT
+

-

-/-

pre-B cells (B220 :IgM ) by FACS as compared to Atm cells at a similar developmental stage
+

-

(Figure 34). This B220 :IgM population consists primarily of pre-B cells that would be actively
rearranging the endogenous kappa locus. Thus, we have identified a RAG-DNA DSB dependent
transcriptional program that includes genes with no known function in the canonical DNA DSB
response. Furthermore, these changes are observed in WT cells, not just those with persistent
DSBs.
Conclusion
Following a genotoxic insult, ATM activates transcriptional pathways that mediate the
balance between cell survival and death, namely NF"B and p53. In response to RAG DSBs in
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the developing lymphocyte (both WT and NHEJ-deficient cells), we demonstrate that ATM,
through the activation of NF!B and other transcription factors, activates a broad genetic program
that transcends this canonical DNA damage response and includes genes whose known
functions are integral to lymphocyte development. We hypothesize that these signals emanating
from a RAG DNA DSB are integrated with the numerous other cellular cues to overall guide
lymphocyte development.
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Figure 23. Persistent RAG DNA DSBs activate NFκB. (a) NFκB EMSA of nuclear
lysates from Rag2-/-, Artemis-/- and Artemis-/-:Atm-/- abl pre-B cells treated with STI571
for the indicated number of hours. NFY EMSA is shown as a control. (b) Southern blot
analysis of Rag DSBs (coding ends, CEs) generated at the Jκ gene segments in the
IgLκ locus in cells treated with STI571 for the indicated number of hours. Bands
generated by the germline (GL) IgL-κ locus and Jκ1 and Jκ2 CEs are indicated. The
schematic of the products shows the relative positions of the restriction sites (EcoRI
and SacI) and probe (filled rectangle) used for analysis.
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Figure 24. RAG DNA DSBs activate NF κB via the classical pathway. (a) NFκB supershift
using antibodies to p50 or p65. (b) NFκB EMSA of nuclear lysates from Artemis-/- Abl pre-B
cell lines that express an IκBα−dominant negative, IκBα-ΔN, generated by transfection of the
parent Artemis-/- line as indicated treated with STI571 for either 0 or 48 h. (c) NFκB EMSA of
nuclear lysates from Artemis-/- Abl pre-B cell lines treated with STI571 in the presence of
increasing concentrations of either a cell-permeable NEMO binding domain peptide (NBD) or
a control cell-permeable NBD mutant peptide (MUT). NFY EMSAs are shown as loading
controls.

99

Bredemeyer & Helmink et al. Nature 2008.

a.

Rag2-/-

Artemis-/-

364 genes > 2-fold or
Artemis-/-:Atm-/-

175 genes
Atm-independent

189 genes
Atm-dependent

Artemis-/-:IκBα-ΔN

114 genes

75 genes

NFκB-independent

NFκB-dependent

b.
Relative Expression

Bcl-3
6
4
2
0

p=0.02

Rag2
Artemis-/Art-/-:Atm-/Art-/-:
IκBα-ΔN
-/-

untreated

+STI571

Pim-2
150

Relative Expression

p=0.02

untreated

+STI571

p=0.003

100

20

50

10

0

untreated

+STI571

0

700
600
500
400
300
200
100
0

p=0.0002

untreated

+STI571

p=0.03

untreated

+STI571

common γ-chain

CD69

CD62L
250
200
150
100
50
0

CD40
30

250
200
150
100
50
0

p=0.03

untreated

+STI571

Figure 25. Global changes in gene expression in response to RAG DNA DSBs. (a) Schematic
of gene expression changes in response to Rag DSBs by microarray analyses. (b) RT-PCR analysis
κ
of mRNA isolated from Rag2-/- (white bars), Artemis-/- (red bars), Artemis-/(blue bars) and
Artemis-/-:Atm-/- (grey bars) abl pre-B cells treated with STI571 for 0 or 48 hours. Mean and standard
deviation from two experiments. P values calculated using a one-tailed t-test.
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Figure 26. RAG-dependent gene expression changes cause changes in protein expression. (a) Western blot analysis of Pim-2 expression in abl pre-B cells treated with STI571 for 48
hours. The three isoforms of Pim-2 are shown. Erk2 is shown as a protein loading control.
(b) Flow cytometric analysis of CD40 and CD69 protein expression on abl pre-B cells treated
with STI571 for 48 or 96 h. Red histogram represents cells treated with STI571 alone; blue
histogram represents cells treated with STI571 and KU-55933 (iATM).
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Figure 27. Time course of gene expression changes in response to RAG DNA DSBs.
RT-PCR analysis of gene expression in abl pre-B cells treated with STI571 for different
periods of time. Asterisks indicate that the difference between the Rag2-/- and Artemis-/cell lines is significant (p<0.05).
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Figure 28. Gene expression changes are not a result of Artemis-deficiency per se. RT-PCR
analysis of expression of the indicated genes in untreated and STI571-treated (a) Rag2-/-, Artemis-/-,
and Artemis-/-:Rag2-/- or (b) Rag2-/-, scid, and Ku70-/- abl pre-B cells. Values are mean and standard
deviation from two experiments. P values were calculated using a one-tailed t-test.
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Figure 29. Gene expression changes downstream of RAG DNA DSBs in primary cells. (a)
Schematic of gene expression analysis carried out on bone marrow pre-B cells. Gene expression
profiling was carried out on RNA isolated from purified B220+:IgM- cells from the bone marrow of
Rag1-/-:IgHtg and Artemis-/-:IgHtg mice. (b) Flow cytometric analyses of CD40, CD69, CD80 and
CD62L expression by B220+:IgM- bone marrow B cells (primarily pre-B cells) from Rag1-/-:IgHtg and
Artemis-/-:IgHtg mice (gated cells in a). Histograms for specific antibodies (red) and isotype controls
(blue) are shown.
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Figure 30. NFκB is not detectable in response to transient Rag DNA DSBs by EMSA.
NFκB EMSA of nuclear lysates from wild type (WT) and Artemis-/- abl pre-B cells treated with
STI571 for the indicated times. NFY EMSA is shown as a control.
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Figure 31. A reporter to detect NFκB activation in response to transient DNA DSBs. (a)
Schematic of the pMSCV-NRE-GFP retrovirus, showing the Thy1 cDNA (T), the five tandem NFκB
responsive elements (NRE), and the GFP cDNA in the anti-sense orientation. (b) Schematic of
pMSCV NRE-GFP activation and GFP expression by treated and untreated Rag2-/-:NRE and
Rag2-/-:NRE:R2 cells. Transcription of the NRE-GFP cassette is indicated by the filled arrow from
NRE and green shading of the GFP cDNA rectangle. The cessation of GFP transcription, as
indicated by the white filled GFP cDNA rectangle, after repair of Rag-mediated DSBs is presumed.
The presence of GFP in the cell is indicated by green shading of the cell. Rag DSBs are indicated
by the discontinuity between the V and J gene segment, and a coding joint is indicated by the
juxtaposition of the V and J gene segment. The retrovirally introduced Rag2 cDNA in Rag2-/:NRE:R2 cells is shown (R2).
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Figure 32. NFκB reporter detects activation of NFκB by genotoxic agents. Activation of
NFκB in Rag2-/-:NRE cells in response to IR induced DSBs. Rag2-/-:NRE abl pre-B cells were
treated with STI571 for 24 hours, then either not irradiated (no IR) or irradiated with 0.5 Gy (IR)
and treated with vehicle alone, the Atm inhibitor KU-55933 (iAtm), or the inhibitor of IκB phosphorylation, BAY 11-7085 (BAY). Cells were analyzed for GFP expression from pMSCV-NREGFP by flow cytometry 12 hours post-irradiation.
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Figure 33. Transient Rag DNA DSBs activate NFκB. (a) Flow cytometric analysis of GFP
expression in Rag2-/-:NRE and Rag2-/-:NRE:R2 cells treated with STI571 for 48 hours in the presence or absence of the Atm inhibitor KU-55933 (iAtm). The percentage of GFP+ cells is indicated.
(b) Schematic of the pMX-DELCJ retroviral recombination substrate. Shown is the GFP cDNA in the
anti-sense orientation flanked by RSs (open triangles). Also shown are the IRES-human CD4
(I-hCD4) cassette, the long terminal repeats (LTRs), and the retroviral packaging sequence (ψ). The
relative position of the pC and pB oligonucleotides (arrows) used for PCR analysis of coding joint
(CJ) formation and the pD oligonucleotide (bar) used to probe the PCR products are also shown.
(c) Rag2-/-:NRE and Rag2-/-:NRE:R2 abl pre-B cells were un-treated (-) or treated with STI571 for 48
hours (+) and GFP+ and GFP- Rag2-/-:NRE:R2 abl pre-B cells isolated by flow cytometric cell
sorting. Serial 4-fold dilutions of genomic DNA from all cells was assayed for pMX-DELCJ
rearrangement by PCR.
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Figure 34. Transient breaks in vivo activate a broad genetic program. Flow cytometric
analyses of CD40, CD69 and CD62L expression by B220+:IgM- bone marrow B cells (gated
cells in dot plot) from WT and Atm-/- mice. Histograms for the specific antibodies (red) and
isotype control (blue) are shown.
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Discussion
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The generation of a functional antigen receptor gene in developing lymphocytes requires
that the second exon be assembled through a process known as V(D)J recombination, which
necessarily involves the generation and repair of DNA double-strand breaks made by the RAG
endonuclease(1-3). Double strand breaks incurred during G1 of the cell cycle activate ATM, a
PI3-kinase-like-kinase (PIKK) that, in response to genotoxic DNA damage, is known to
phosphorylate hundreds of proteins with unique and diverse functions that coordinate the DNA
damage response(71-73). Notably, deficiencies in ATM lead to ataxia-telangiectasia, a syndrome
characterized by lymphopenia, genomic instability and a predisposition to tumors involving
antigen receptor loci(99). These findings indicate that ATM plays a critical role downstream of
RAG-mediated DNA DSBs during V(D)J recombination. The work presented here defines novel
pathways activated by ATM in response to RAG DNA DSBs. Taken together with previous
findings, the major ATM-dependent effector functions of the DNA damage response activated by
RAG DNA DSBs include the following:
1—ATM promotes the efficient, proper repair of RAG DNA DSBs by maintaining coding ends in a
stable post-cleavage complex through the MRN complex.
2—ATM promotes the activation of a broad genetic program that promotes the survival of cells
actively undergoing V(D)J recombination but that also has potential diverse implications for
lymphocyte development and function.
3—ATM activates p53-dependent apoptotic pathways in response to persistent unrepaired RAG
DNA DSBs.
4—ATM phosphorylates H2AX to prevent resection of unrepaired coding ends and their aberrant
resolution by homology-mediated pathways in G1 of the cell cycle.
Below I discuss how defects in each of these functions likely underlie the phenotypic
manifestations of ATM-deficiency, namely lymphopenia and a predisposition to lymphoid tumors
involving antigen receptor loci.
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Lymphopenia of ATM-Deficiency
Lymphopenia caused by a defect in the repair of RAG DNA DSBs.
V(D)J recombination is the process by which the antigen receptors that are absolutely
required for lymphocyte development are assembled. As such, defects in the generation or repair
of RAG-induced DNA DSBs during V(D)J recombination can result in severe lymphopenia. As
discussed above, SCID and RS-SCID patients harbor mutations in the RAG components that
prevent DSB generation or in NHEJ factors that prevent the repair of the RAG-induced DSBs,
respectively(65). Interestingly, A-T patients and ATM-deficient mice exhibit a phenotype that
might be described as mild RS SCID. The patients and mice have a mild lymphopenia with
reduced numbers of T cells primarily(111, 112). Furthermore, ATM-deficient mice are sensitive to
ionizing irradiation, and AT patients have sensitivities to DSB-generating chemotherapeutic
agents further suggesting that there may be a general defect in repair of DNA DSBs in the
absence of ATM(122). Unlike the known core NHEJ-factors, however, we show that ATM is not
absolutely required for V(D)J recombination and a majority of IR-induced breaks are repaired in
the absence of ATM activity (122, 140). However, we reasoned that a non-absolute defect in the
repair of RAG DNA DSBs could also impart radiosensitivity and cripple V(D)J recombination
which would impact total lymphocyte numbers.
We demonstrate that ATM-deficient lymphocytes do, in fact, have a defect in the repair of
RAG DNA DSBs characterized by an accumulation of unrepaired coding ends and an overall
decrease in normal coding joint formation during rearrangement by both deletion and
inversion(107, 108). Additionally, during rearrangement by inversion, ATM-deficient cells form
aberrant hybrid joints with near equal kinetics as normal CJs(107).
How do we explain the decrease in normal CJ formation during rearrangement by
deletion and inversion and the increase in HJ formation during rearrangement by inversion only?
This defect is currently most aptly explained by a requirement for ATM in promoting the stability of
the post-cleavage complex(107). One would predict that the loss of coding ends from this
complex would lead to a decrease in CJ formation as ends that drift apart cannot be efficiently
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joined. In fact, there is much redundancy amongst DNA repair factors that tether the broken DNA
ends in many DNA repair pathways suggesting that keeping these broken ends in close physical
proximity is absolutely required for efficient joining. Indeed, in our ATM-deficient cells, FISH
analysis supported this hypothesis; unrepaired coding ends are more frequently separated from
-/-

one another in Atm cells as compared to WT cells(107). This defect would affect rearrangement
by deletion and by inversion. Furthermore, instability of the post-cleavage complex might also
explain the aberrant formation of hybrid joints only during rearrangement by inversion. During
rearrangement by inversion, a decrease in the stability of the post-cleavage complex would allow
the intervening sequence to escape from the complex. A resulting joint between the remaining
coding end and signal end to form a HJ may reflect an act of desperation on the cell’s behalf to
maintain genomic integrity. During rearrangement by deletion, the intervening sequence is
normally lost. Instability of the post-cleavage complex would not worsen this situation. In fact,
hybrid joint formation during rearrangement by deletion would require that the intervening
segment of DNA that is normally excised be inverted and maintained within the complex. Thus,
we believe that the aberrant HJ formation during inversional rearrangement and the decrease in
CJ formation during both deletional and inversional rearrangment can both be attributed to a
decrease in the stability of the post-cleavage complex(107).
This activity of ATM during the repair of RAG induced DNA DSBs requires its kinase
activity as treating wild-type cells with an ATM-specific kinase inhibitor leads to a phenotype
similar to that of ATM deficiency(107). Presumably, then, ATM does not have a direct structural
role in promoting post-cleavage complex stability. Rather, it may rely on the phosphorylationdependent end stabilizing activities of an ATM substrate(s) at the break site. In this regard, the
MRN complex is a potential candidate substrate. As discussed above, Mre11 can align two
broken DNA ends and Rad50 can tether two broken DNA ends(75, 76, 78, 81, 83, 86). All three
components of the MRN complex (Mre11, Rad50, and Nbs1) are phosphorylated by ATM(71,
300-302). Indeed, we demonstrate here that MRN-deficient cells have a similar, though milder,
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repair defect as that characterized in the ATM-deficient cells. We note an increase in the number
of HJs and a decrease in CJ efficiency.
Mice and patients deficient in any MRN component exhibit phenotypes that mimic ATMdeficiency(117, 291-298). Many have reasoned that the similarities in these phenotypes could
simply reflect the role of the MRN complex as sensor in the DNA damage response in recruiting
ATM and promoting ATM activity(70, 77, 90, 91, 104, 291, 299). Thus, the repair defect we see
in the MRN-deficient cells may simply reflect an inability to fully activate ATM and the DNA
damage response. That is, MRN may be acting upstream of ATM to promote the proper repair of
RAG DNA DSBs. However, we do not see a global decrease in the phosphorylation of ATM
substrates such as H2AX or the activation of ATM dependent DNA damage response pathways
such as NF!B activation. These data suggest that MRN has important roles downstream of ATM
in promoting the stability of the post-cleavage complex during the repair of RAG-mediated DSBs.
Does this repair defect observed in the ATM and MRN-deficient cells explain the
lymphopenia observed in patients and mice with deficiencies in these factors? In both situations,
T cell numbers are depleted moreso than B cell numbers(108, 292). In both ATM- and Nbsdeficient mice, we note a block in thymocyte development that results in decreased numbers of
TCR-" intermediate DP thymocytes and partially explains the paucity of fully developed T
cells(108). To reach this stage of development the thymocytes must rearrange the TCR# allele
and the resulting TCR must be capable of positive selection(108). Often, a single round of V(D)J
recombination does not produce a receptor that fulfill this requirements and successive
rearrangements must take place. Failed repair at any juncture could result in thymocyte
death(108). Thus, slightly attenuated efficiency of CJ formation during TCR# rearrangement
could explain this block in thymocyte development(108). The repair defect of ATM- and MRNdeficiency may at least partially explain the T cell lymphopenia. However, we would note that the
joining is likely similarly impaired in thymocytes at other stages of development and B cells
undergoing V(D)J recombination but not manifested as a decrease in these populations as the
antigen receptor loci rearranged in these cells at other developmental stages do not undergo
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successive rearrangements to the same extent that T cells undergoing alpha
rearrangement(108). Analysis of rearrangement of the TCR# locus and numbers of DP
intermediates may simply be a more sensitive assay for defects in CJ formation in the
endogenous loci.
We conclude that the described defect in the repair of RAG DNA DSBs contributes to the
lymphopenia of ATM-deficient mice and humans as well as those deficient in MRN complex. We
would note, however, that the described repair defect only leads to an ~50% reduction in CJ
formation and is not likely to completely account for this aspect of the ATM-deficient
phenotype(107, 108). Thus, we sought to identify other ways in which ATM might affect
lymphocyte development.
Lymphopenia caused by defects in the RAG-dependent genetic program.
The canonical DNA damage response is largely concerned with promoting survival and
cell cycle checkpoints during the repair of the break and initiating apoptosis in the event that the
break cannot be repaired(73). In this regard, ATM activates p53 in cells with persistent RAG
DNA DSBs(244). To this point, however, it was difficult to determine whether every RAG break or
just those that remained unrepaired initiated the DNA damage response. Indeed, activating p53
in response to each RAG DNA DSB would be problematic because all lymphocytes must make
and repair numerous RAG DNA DSBs during the course of development. The activation of p53,
which initiates cell cycle checkpoints as well as apoptotic pathways, in response to each transient
RAG DNA DSB, would significantly decrease the number of lymphocytes that successfully
undergo V(D)J recombination. However, ATM might activate p53 in response to every RAG DNA
DSB if it could simultaneously activate pro-survival pathways. The balance of these two
pathways might determine cell survival. In this regard, ATM activates both p53 and NF!B in
response to genotoxic DNA damage(244, 247, 269). Furthermore, inactivation of NF!B signaling
leads to increased IR sensitivity, demonstrating that NF!B activation by ATM promotes cell
survival following DNA damage(247). Similarly, we detect robust NF!B activation in response to
persistent RAG DNA DSBs in NHEJ-deficient lymphocytes. Interestingly, we also detect NF!B
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activation in response to transient RAG DNA DSBs in WT cells undergoing V(D)J recombination.
Thus, it is likely that all RAG DNA DSBs activate the DNA damage response and result in
transcriptional changes within the developing lymphocyte.
Lymphocytes with RAG DNA DSBs exhibit higher levels of pro-survival genes such as
Pim-2 and Bcl-3 than observed in cells without RAG DNA DSBs. These transcriptional changes
are dependent on both ATM and NF!B. Pim2 expression promotes the survival of lymphocytes
following withdrawal of IL-7, a situation that mimics the environment of a lymphocyte undergoing
V(D)J recombination; pre-B cells undergoing rearrangement of the kappa locus actively move
away from IL-7 producing stromal cells(313). Thus, the ATM-dependent up-regulation of Pim-2 in
response to RAG DNA DSBs might promote the survival of cells actively undergoing V(D)J
recombination in an IL-7-depleted environment(J. Bednarski, unpublished). We conclude that the
activation of NF!B by ATM in response to each RAG DNA DSB may promote the survival of cells
undergoing V(D)J recombination and may be required to counteract the activation of p53 by the
same DNA DSB. Defects in the activation and regulation of these pathways might lead to a
disruption of the pro-life and pro-death balance in these developing lymphocytes and might also
contribute to the lymphopenia observed in the setting of ATM-deficiency.
Lymphopenia caused by defects in the RAG-dependent genetic program.
We often think of the cellular response to DNA DSBs as a “damage” response. As
discussed above, the canonical DNA damage response is known primarily to promote survival
and cell cycle checkpoints during the repair of the break and initiating apoptosis in the event that
the break cannot be repaired(244). In lymphocytes, however, RAG DNA DSBs are requisite
intermediates in a process that is absolutely required for their proper development(1-3). Even
transient RAG DNA DSBs can activate these DNA damage response pathways. As such, this
“damage” response is likewise a part of normal development and the signaling pathways initiated
in response to RAG-mediated DNA DSBs could affect lymphocyte development and/or function.
With these thoughts in mind, we decided to more fully characterize the transcriptional
pathways activated by ATM in response to RAG DNA DSBs. Comparing the microarray analysis
116
!

data of lymphocytes with RAG DNA DSBs and those without DNA DSBs enabled us to globally
determine the transcriptional changes afforded by the RAG DNA DSB. Analysis of this
microarray data revealed that the transcriptional pathways activated by ATM in response to DNA
DSBs are more numerous and diverse than previously thought; ATM activates a broad genetic
program in response to RAG DNA DSBs. Only half of the ATM-dependent transcriptional
changes caused by RAG DNA DSBs are mediated by NF!B. The others, we reason, are caused
by transcription factors similarly directly or indirectly activated by ATM. It is notable that other
transcription factors such as Stat3 and Foxo1 have SQ/TQ motifs that could be potentially
modified by ATM(71).
A large fraction of this broad genetic program initiated by RAG DNA DSBs includes
genes with no known function in the canonical DNA damage response. Rather, these are genes
whose known functions implicate them in lymphocyte development and/or function. For example,
a subset of these genes (L-selectin, Swap70, and CD69) have known roles in lymphocyte homing
and migration(309-312). This suggests that RAG DNA DSBs might cause changes in the cell that
somehow affect the localization of lymphocytes undergoing V(D)J recombination, perhaps
through alterations in the expression levels of cell surface receptors. In support of this possibility,
we find that lymphocytes harboring RAG dependent DNA DSBs partition differently between the
peripheral blood and bone marrow than lymphocytes without breaks. The transcriptional
changes, then, initiated by RAG DNA DSBs can have physiological consequences for the
developing lymphocyte. While this is just one example, we believe that future work will elucidate
additional developmental or functional consequences of the broad transcriptional program
activated by ATM in response to RAG DNA DSBs. ATM influences lymphocyte development in
ways not directly related to DNA repair or the survival of lymphocytes with breaks. Defects in
this program might additionally contribute to the lymphopenia and immunodeficiency of ATMdeficient mice and humans.
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Lymphopenia—A Combination of Two Distinct Defects
Based on the collected evidence, we propose that the lymphopenia observed in the
setting of ATM-deficiency is caused by two primary factors. First, defects in the repair of RAG
DNA DSBs lead to a smaller number of developing lymphocytes that successfully undergo V(D)J
recombination to produce a functional antigen receptor gene. Second, ATM is required to
activate a broad transcriptional program in response to RAG DNA DSBs. This program promotes
the survival of cells actively undergoing V(D)J through the activation of NF!B. However, ATM
also activates the transcription of genes that may affect lymphocyte development and/or function
in additional and diverse ways.
A Predisposition to Lymphoid Tumors Involving Antigen Receptor Loci
In addition to lymphopenia, ATM-deficient mice and humans have a predisposition to
lymphoid malignancies with translocations involving antigen receptor genes. The development of
lymphoid malignancy requires a failure of the DNA damage response at multiple levels. Thus,
just as defects in multiple ATM-dependent pathways can contribute to lymphopenia, the same is
likely true for the development of lymphoid malignancies.
ATM deficiency causes a combined repair and checkpoint defect.
We have described a repair defect in ATM-deficient cells and mice that leads to an
accumulation of unrepaired coding ends(107, 108). Notably, ATM is also required to promote
p53 activation in response to DNA damage(244). Thus, in the absence of ATM, a single protein,
we have essentially recapitulated the phenotype of mice deficient in both NHEJ and p53dependent pathways that develop lymphoid malignancies at a young age(150).
It is thought that broken DNA ends form translocations primarily by joining with other
broken DNA ends present in that particular cell(314). Cells arrested in G1-phase of the cell cycle
generally have very few DNA DSBs besides RAG DNA DSBs. This is evidenced by the fact that
-/-

we rarely see $-H2AX foci in G1-arrested Rag Abl pre-B cells(211, 276). While RAG DNA DSBs
can occur outside the confines of the antigen receptor genetic loci, this is rare. Thus, unrepaired
coding ends would not have ample opportunity to form translocations in G1. However, the
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combined defect in repair and cell cycle checkpoint allows these ends to persist through multiple
rounds of cell division(202, 272). During cell division, many DSBs are produced during DNA
replication and other cellular processes. Thus, the persistence of these ends throughout the cell
cycle would greatly increase the chance that they would form translocations(202, 272). The
combined repair and checkpoint defect in ATM-deficient mice and humans likely contributes to
the predisposition to lymphoid tumors with translocations involving antigen-receptor loci.
ATM actively prevents the aberrant resolution of persistent DNA ends.
However, we reasoned that ATM might play an additional active role in preventing
unrepaired coding ends from accessing aberrant repair pathways, effectively shuttling cells that
harbor these persistent breaks towards p53-mediated pathways. As discussed in the
introduction, DNA repair pathway choice is determined at the level of end-resection(139). Even
small amounts of end resection prevent NHEJ and commit the cell to repair through alternative
homology-mediated pathways(140-142, 176). Cells undergoing V(D)J recombination are
arrested in G1, where no sister chromatid is present; thus, repair by homology-mediated
pathways would be particularly deleterious as it would lead to deletions and/or translocations.
During HR, end resection is initiated through the cooperative action of Mre11 and CtIP(76, 129136). Importantly, we have shown that Mre11 functions during V(D)J recombination as a
component of the MRN complex and is present at RAG DNA DSB sites. Mre11 possesses both
endo- and exo-nucleolytic activities but is not able to efficiently open the hairpin-sealed coding
-/-

ends in Artemis cells(77, 81). Thus, we know that end resection is tightly regulated during V(D)J
recombination. We hypothesized that another ATM-dependent effector function of the DDR might
be to ensure that persistent unrepaired DNA ends are not resected in a manner inappropriate to
the stage of the cell cycle. Specifically, we predicted that unrepaired coding ends in the G1phase of the cell cycle during V(D)J recombination are not resected.
We further reasoned that ATM would modulate end-processing pathways through the
break-induced phosphorylation of one or more of substrates. In this regard, histone H2AX is
phosphorylated in chromatin flanking DNA DSBs, including those generated by the RAG119
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endonuclease forming $-H2AX(206, 211). $-H2AX is required for the maintenance of a host of
repair and signaling proteins at the site of a DNA DSB(233). H2AX-deficient cells have a
predisposition to genomic instability but no overt defect in the repair of RAG DNA DSBs, which is
what we might expect if H2AX functions mainly in dealing with rare persistent RAG DNA
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DSB(233, 235, 243). Furthermore, while hairpin-sealed coding ends in Artemis cells are rarely
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resolved as translocations, those in Artemis :H2AX cells are more frequently resolved as
translocations(243). The resolution of a hairpin-sealed coding end, at a minimum, would require
end opening. Thus, we hypothesized that H2AX might regulate the processing of unrepaired
coding ends and furthermore, that the phosphorylation of H2AX by ATM at the site of these RAG
DNA DSBs might be required to facilitate end processing. Accordingly, we designed experiments
to assess the integrity of unrepaired coding ends that accumulate in NHEJ-deficient cells in the
presence and absence of H2AX.
We find that, in the absence of H2AX, unrepaired coding ends are robustly resected. We
further demonstrate that the ATM-dependent phosphorylation of H2AX(forming $-H2AX) and
Mdc1, a factor that directly binds $-H2AX, are both required to prevent this resection. Finally, we
demonstrate that the end resection we see is mediated by CtIP, the mammalian homologue of
yeast endonclease Sae2. The coding ends that have undergone aberrant CtIP-dependent
processing are not efficiently joined by NHEJ. Furthermore, the joints that do form exhibit large
deletions and usage of homology-mediated repair. The numerous implications of this novel role
for $-H2AX during DNA repair as well as additional thoughts regarding the resection and joining of
these aberrantly processed ends are addressed below.
Regarding the End Resection
As discussed in the introduction, during HR, Mre11 and CtIP cooperate to initiate the
resection of broken DNA ends that allows for the formation of a long 3’ ssDNA overhang that
permits strand invasion(76, 129-136). However, the activity of CtIP and Mre11 is normally
restricted to post-replicative stages of the cell cycle. How, is it then, that H2AX prevents the CtIP-/-
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mediated opening and resection of persistent coding ends in Artemis :H2AX and Ligase IV
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:H2AX cells that are arrested in G1 of the cell cycle? We hypothesize, based on known proteinprotein interactions and crystallographic data, that the phosphorylation of H2AX may be required
to exclude CtIP from the site of a persistent RAG DNA DSB in G1-phase cells. As demonstrated
above, MRN functions during V(D)J recombination and Nbs1 has been demonstrated to localize
at RAG DNA DSBs(105). We also know that MRN and CtIP directly interact in mammalian
cells(89, 229, 230, 315). In fission yeast, Ctp1 (the homologue of CtIP) associates with the FHA
domain of Nbs(88, 89, 229-231, 315). Interestingly, MDC-1 binds to that same FHA domain of
mammalian Nbs1(89). In response to a DNA DSB, H2AX is rapidly phosphorylated and this
phosphorylated H2AX is subsequently bound by Mdc1(206, 214, 228). Mdc1 then interacts with
Nbs1 in a manner that is thought to potentiate ATM signaling(228, 316). However, in doing so,
we hypothesize that it may competitively displace CtIP associated with the MRN complex at the
break site. Such a model would be completely congruent with our findings as $-H2AX and Mdc1
are both required to prevent end resection, and furthermore, we now know that the MRN complex
functions during V(D)J recombination. We plan to test this hypothesis using ChIP assays to
determine whether CtIP is associated with RAG DNA DSBs and whether that association is
increased or altered in some manner in the absence of H2AX or Mdc1, perhaps explaining the
aberrant end resection observed in H2AX-deficient cells.
ATM is required to generate $-H2AX in chromatin flanking RAG DSBs(209-211). In turn,
MDC-1 amplifies DNA damage response signals, in part, by recruiting ATM to the site of a
DSB(228, 316). As such, we reasoned that ATM would be required to prevent the nucleolytic
resection of coding ends in G1-phase cells. However, we do not detect degradation of coding
-/-
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ends in Artemis :Atm Abl pre-B cells though $-H2AX formation is largely disrupted in these
cells. This seemed at odds with our data demonstrating that ATM-mediated phosphorylation of
H2AX is required to prevent end resection. However, we subsequently show that ATM kinase
activity is required to promote CtIP-mediated resection of persistent coding ends in the absence
-/-
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of H2AX. Inhibition of ATM kinase activity in Artemis :H2AX cells completely abrogates the
opening and resection of hairpin-sealed ends. Thus, ATM activates opposing pathways that
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regulate resection of persistent coding ends. How ATM promotes CtIP activity, however, is still
largely unknown. In Xenopus extracts that have characteristics of G1-phase cells, ATM activity is
also required for CtIP activity, possibly through affecting its recruitment to a DNA DSB. In this
system, CtIP is recruited to a DNA DSB after ATM and Nbs in a manner that requires MRN and
ATM kinase activity(135). We know that CtIP is phosphorylated by ATM in response to DNA
damage(71, 135, 317). However, in Xenopus extracts, mutation of all possible SQ/TQ sites in
CtIP does not alter the localization of CtIP to a DNA DSB suggesting that ATM might affect the
localization of CtIP indirectly(135). One possibility is that the ATM-dependent phosphorylation of
another substrate might recruit CtIP to the site of a DNA DSB. We would like to test whether
ATM kinase activity similarly alters the localization of CtIP in lymphocytes and whether the
phosphorylation of CtIP in response to DNA damage alters its localization. It is also notable that
CtIP has known functions as a transcriptional regulator, and the ATM-dependent phosphorylation
of CtIP can lead to alterations in gene expression(317). CtIP associates with CtBP and they
function together as a transcriptional co-repressor; interaction of CtIP and CtBP with BRCA1, for
example, leads to decreased expression of BRCA1 target genes p21 and GADD45(317).
Phosphorylation of CtIP by ATM causes its dissociation from BRCA1. This releases the
repression and the cellular levels of both p21 and GADD45 transcripts increase(317). Thus, the
-/-
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ATM-dependent end resection of the persistent coding ends in Artemis :H2AX and Ligase IV
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:H2AX cells could also be a consequence of indirect effects of CtIP on gene transcription. For
example, phosphorylation of CtIP may activate (de-repress) the transcription of a nuclease that
can promote the degradation of persistent coding ends.
While it is likely that Mre11 and CtIP cooperate to cause the resection of persistent
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coding ends in the Artemis :H2AX and Lig4 :H2AX cells, it is possible that CtIP is directly
modulating the activity of another nuclease. Though no nuclease activity of CtIP has been
formally demonstrated, CtIP contains a domain structurally similar to the catalytic domain of the
budding yeast endonuclease Sae2(135, 137). In vitro, CtIP can alter the nuclease activity of
Mre11(318). It is also notable that while Mre11 and CtIP are required to initiate resection during
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HR, other nucleases (Dna2/Sgs1 and Exo1 for example) are thought to cause the formation of
the ssDNA strand(137, 139). Thus, the degradation that we see may actually be a result of the
nuclease activity of Mre11 or potentially other cellular nucleases. Additional evidence from our
laboratory suggests that other nucleases play a role in the resection of unrepaired coding ends
during V(D)J recombination. Consistent with this possibility, the coding ends that escape from
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the post-cleavage complex in Atm cells are degraded at late time-points as are unrepaired
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coding ends in Lig IV :Atm cells; this end resection is not CtIP-mediated as we now know that
ATM is required to promote robust CtIP activity. However, this resection could also be regulated
by H2AX as H2AX phosphorylation is largely abrogated in the absence of ATM. In addition to the
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CtIP- and ATM-dependent resection of open coding ends in Ligase IV :H2AX Abl pre-B cells,
we note a delayed ATM-independent resection of these ends. Finally, we observe residual end
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resection upon knockdown of CtIP in both the Artemis :H2AX and Ligase IV :H2AX cells.
While the latter could be due to residual CtIP in these cells, it could also indicate that other
nucleases act on persistent RAG DNA DSBs. Together, these data suggest that the activity of
other nucleases must also be regulated during V(D)J recombination. By knockdown of candidate
nucleases, specifically those known to function during HR with CtIP and Mre11, we may be able
to further dissect components of the end processing pathways that collectively regulate the
outcome of unrepaired ends. These future experiments may also provide insight into whether
CtIP itself promotes end resection or does so by regulating the activity of other cellular nucleases.
Given the near normal repair of RAG DNA DSBs during V(D)J recombination in H2AXdeficient cells but the profound effect of H2AX-deficiency on persistent coding ends, we propose
that the phosphorylation of H2AX might be especially important to protect coding ends when they
are not joined efficiently. We predict that H2AX deficiency, when combined with defects that
decrease the efficiency of RAG DNA DSB repair would lead to dramatic defects in V(D)J
recombination. XLF or Cernunnos is a recently discovered NHEJ-component with an
undetermined role in V(D)J recombination(152, 319, 320). In other settings, however, XLF
associates with XRCC4 and Lig4 to alter the activity of this complex, increasing the efficiency of
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joining and also enhancing the diversity of DNA ends that can be ligated by this complex(152,
155, 157). Intriguingly, while H2AX and XLF alone have no demonstrable defect in the repair of
chromosomal RAG DNA DSBs in developing lymphocytes, a combined deficiency causes a
profound defect in coding joint formation, with unrepaired coding ends exhibiting robust resection
(unpublished data, Fred Alt lab). These findings support our hypothesis that H2AX is especially
important for cells in which breaks are not efficiently repaired; that is, XLF may cause a decrease
in joining efficiency that necessitates end protection by H2AX. Furthermore, XLF and H2AX may
serve a redundant function in preventing the resection of unrepaired ends since end degradation
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in double mutants is greater than seen in the Artemis :H2AX or Ligase IV :H2AX Abl pre B
cells alone. Furthermore, combined deficiency of H2AX and NHEJ-component XLF leads to
embryonic lethality ((278, 321) and unpublished communication), suggesting that their
cooperative action has additional roles for other types of DNA DSB repair. Determining how
H2AX and XLF cooperate to promote repair and prevent end resection is, thus, a high priority.
-/-

Finally, it remains puzzling that H2AX mice exhibit such profound genomic instability
that is increased even further with genotoxic DNA damage but still lack an overt defect in the
repair of RAG DNA DSBs(233, 235, 243). This may indicate that H2AX-deficiency impacts the
resolution of DNA DSBs generated by genotoxic agents moreso than those generated by the
RAG endonuclease. Importantly, RAG DNA DSBs are initiated by an enzymatic reaction that
includes a hairpin-sealed intermediate(1). RAG-generated DNA ends are maintained in a postcleavage complex that would presumably insulate them from the effects of cellular
nucleases(198). In contrast, broken DNA ends resulting from irradiation or other genotoxic
agents are diverse; many of these ends incorporate modified bases that must be processed prior
to joining, thus increasing the amount of time they persist(322). Furthermore, these ends are not
maintained in a post-synaptic complex. Thus, the ATM-dependent phosphorylation of H2AX at
such damage sites may be especially important in preventing end resection. We propose that the
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lack of a significant defect in V(D)J recombination in H2AX mice may reflect these unique
features of physiologic RAG DNA DSBs.
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Regarding the joints formed in Artemis :H2AX :DEL

CJ

Abl pre-B cells.
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Our observation that open resected ends in Artemis :H2AX cells are not efficiently
joined by NHEJ was especially surprising given that all requisite NHEJ components are present.
This finding suggests that the nature of resected end prevents joining in G1 of the cell cycle,
perhaps due to specific DNA end modifications or the generation of a significant ssDNA
overhang. Even small ssDNA overhangs can prevent Ku-binding to a DNA end, thereby inhibiting
NHEJ(140-142, 176). During HR, the combined activity of Mre11 and CtIP initiates a process that
results in a long ssDNA structure(76, 129-136). Therefore, we hypothesize that the combined
activities of Mre11 and CtIP might similarly generate a ssDNA fragment during the processing of
unrepaired coding ends in the absence of H2AX. This would preclude joining by NHEJ during G1
where these cells are arrested and may explain the persistent open coding ends we observe in
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the Artemis :H2AX Abl pre-B cells. Elucidating the structure of DNA ends generated in
Artemis-deficient cells that also lack H2AX will be an important goal of future studies.
It is notable that a low level of coding joints are formed successfully in our G1-arrested
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Artemis :H2AX Abl pre-B cells. However, PCR and sequence analyses of these joints reveal
significant deletions (>1 kB). During V(D)J recombination, deletions such as these would
preclude the formation of a functional antigen receptor gene. It is also possible this observation
may have uncovered a potential source of the general genomic instability observed in H2AX
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mice. Similar deletions at joints formed throughout the genome following genotoxic DNA damage
could cause genomic instability and possibly lead to malignant transformation. While
chromosomal instability is often thought of in terms of whole chromosome loss or translocation,
small deletions are frequent contributors to oncogenic transformation. In this regard, small
deletions in Brca-1 genes have been associated with breast and ovarian cancer; likewise,
deletions in p53 are observed in a wide variety of tumors(323-325). Thus, maintaining the
integrity of broken DNA prior to joining is crucial. Interestingly, H2AX may protect the genome
from small cancer-causing deletions during DNA DSB repair. It has been described that small
deletions in p53 led to a reduced latency of disease, specifically thymic lymphomas, in H2AX
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:p53 :RAG-2 mice as compared to p53 :RAG-2 mice(326). This noted predisposition to
small deletions during other types of DNA DSB repair may be due to the role of $-H2AX in
preventing the resection of broken DNA ends as demonstrated herein.
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Coding joints that form in Artemis :H2AX may derive from a subset of ends whose
processing does not generate a significant ssDNA overhang. As such, these ends could be
joined by classical NHEJ. Alternatively, these ends may be processed in ways that produce
structures incompatible with NHEJ. In this case, the low level of joints we observe may form via
an alternative homology-mediated pathway which is active but not efficient during G1. In support
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of this notion, we demonstrate that the ends that are joined in the Artemis :H2AX

Abl pre-B

cells more frequently use microhomologies (up to 50% of joins in Artemis :H2AX as compared
to less than 5% in WT cells) and the tracts of homology are generally longer. Importantly, the
number of joints with microhomology that we detect are likely an underestimate of the true
numbers since TdT is present and active in these cells. TdT adds nucleotides to DNA ends in a
non-templated fashion, and, in doing so, could create microhomologies that facilitate joining.
However, these joints would not be classified as microhomology-mediated as these sequences
would not be present in the germ-line. Thus, the addition of non-templated nucleotides by TdT
would obscure joining that does actually occur by homology. We are currently generating
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Artemis :H2AX :TdT mice and cell lines that will enable us to more accurately assess whether
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joins made in the Artemis :H2AX cells preferentially engage homology mediate repair pathways
to resolve unrepaired coding ends during G1. Importantly, the joining of unrepaired ends in a
homology-mediated manner during G1 is particularly dangerous as there is no sister chromatid
available to be used as a template for repair. These ends might use regions of homologous DNA
sequence on the same or other chromosomes to mediate joining, leading to larger chromosomal
deletions and/or translocations that could likewise cause genomic instability. We conclude that
this aberrant resection and joining, could, in addition to the described combined repair and
checkpoint defect, predispose ATM-deficient mice and humans to lymphoid tumors with
translocations involving the antigen receptor loci.
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Summary (see model in Figure 35)
Based on the work described here, we propose the following model for the functions of
ATM during normal lymphocyte development. ATM contributes to V(D)J recombination in two
main ways to generate normal numbers of functional lymphocytes. First, ATM maintains coding
ends within a stable post-cleavage complex to promote efficient and proper repair of RAG DNA
DSBs and enable developing lymphocytes to produce a functional antigen receptor gene.
Second, ATM, through the activation of NF!B and other transcription factors, induces the
activation of a broad genetic program that promotes the survival of lymphocytes while they
rearrange their antigen receptor loci. Moreover, this program includes gene products that are
required for proper lymphocyte development and/or function. In the event that RAG DNA DSBs
persist unrepaired, ATM activates p53 to ensure that cells harboring these breaks undergo
apoptosis. Additionally, ATM, through the phosphorylation of H2AX, actively prevents unrepaired
ends from being processed in ways that enable their aberrant resolution and effectively shuttles
the cells harboring these breaks towards apoptotic pathways. Together, these functions of ATM
downstream of RAG DNA DSBs explain the lymphopenia and predisposition to lymphoid tumors
observed in the absence of ATM.
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